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Abstract 
 
In Scotland, stroke is the third most common cause of death behind heart disease and 
cancer. However, most strokes are not fatal and can cause severe disability, with one third 
of survivors still functionally dependent after one year. The advent of recombinant tissue 
plasminogen activator (rT-PA) as a thrombolytic modality revolutionised the treatment for 
ischaemic stroke, providing a treatment aimed to promptly restore nutritional blood flow to 
the ischaemic penumbra, a transient tissue state which is amenable to salvage. Crucially, 
patient ineligibility from a multitude of factors (including the narrow time window for 
benefit and the risk of intracranial haemorrhage) means that fewer than 10% of all stroke 
patients are thrombolysed.  
 
Positive identification of penumbra is not employed in the current intravenous rT-PA 
administration strategy, which is instead based on two main prerequisites: stroke patients in 
whom intracerebral haemorrhage has been excluded with non-contrast computed 
tomography (CT) and who also present within 4.5 hours of symptom onset.  The technical 
impracticalities and limited availability of the gold standard penumbral imaging modality, 
multitracer 15O positron emission tomography (PET), and the lack of standardised 
thresholds to identify penumbra using non-contrast CT have hindered the development and 
inclusion of routine brain imaging in the management of acute stroke patients. An 
alternative research tool which may potentially be used in clinical practice is magnetic 
resonance imaging (MRI) which defines penumbra on the basis of diffusion-perfusion 
(DWI/PWI) mismatch. However, this provides an imprecise measure of penumbra and 
fails to identify tissue viability.  
 
The T2* Oxygen Challenge technique 
 
Current PET-derived definitions of penumbra use metabolic indices such as oxygen 
extraction fraction (OEF) and the cerebral metabolic rate of oxygen (CMRO2), which are 
not fully incorporated into MR definitions. This thesis presents an alternative MRI method 
for identifying the metabolic penumbra in a rodent model of focal cerebral ischaemia. This 
utilises an MRI sequence similar to that used in functional MRI (fMRI) techniques, and 
uses 100% oxygen inhalation as a biotracer to detect penumbral tissue. Specifically, by 
using a blood oxygen level dependent (BOLD) T2*-weighted sequence in which changes in 
the deoxyhaemoglobin:oxyhaemoglobin ratio are detected - in conjunction with a transient 
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hyperoxic challenge (Oxygen Challenge (OC) paradigm: 5 minutes breathing air followed 
by 5 minutes breathing 100% oxygen) - penumbral tissue can be distinguished from  
adjacent ischaemic core and benign oligaemia (Santosh et al, 2008).  
 
Characterisation of the T2* BOLD OC technique 
 
Changes in CBF, cerebral blood volume (CBV), tissue oxygenation, and oxidative 
metabolism can all influence the T2* signal (Ramsay et al, 1993; Corfield et al, 2001), so it 
was important to evaluate the possibility that factors other than tissue metabolism were 
influencing the signal change during OC. An initial study was performed which showed 
that baseline CBF did not influence T2* signal response to OC, whilst a greater increase in 
the percentage change in arterial oxygen saturation following OC caused an increased 
magnitude in T2* percentage signal change in contralateral tissue and penumbra, but not in 
ischaemic core. Arterial oxygen levels (PaO2) affect the magnitude of the T2* signal change 
to OC, with lower baseline PaO2 levels amplifying the T2* signal response in metabolically 
active regions, implying that careful control of physiological variables may optimise the 
T2*OC technique.  
   
Confirming metabolic activity in T2*OC-defined penumbra using [14C] 2-
deoxyglucose autoradiography 
 
The first validation study used [14C] 2-deoxyglucose autoradiography to determine the 
metabolic status of penumbra defined by T2*OC MRI. The results confirmed that glucose 
metabolism in the T2*OC-defined penumbra was comparable to contralateral values, 
whereas markedly different levels of glucose metabolism were evident in the ADC-derived 
ischaemic core and an adjacent region of increased 2DG phosphorylation. From this, it was 
concluded that metabolic information could be yielded from the ischaemic brain that may 
improve delineation of the penumbra using the OC technique.  
 
Consequences of reperfusion on the T2*OC-defined penumbra 
 
As penumbral tissue must fulfil the fundamental criteria of being potentially salvageable 
and responsive to therapy, the consequences of reperfusion on the T2*OC-defined 
penumbra was tested. This study confirmed that T2*OC-defined penumbra displayed a T2* 
signal change significantly higher than contralateral tissue during ischaemia which 
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subsequently returned to contralateral levels following reperfusion and did not progress to 
infarction when assessed at day 7 following stroke.  
 
Investigating the spatiotemporal characteristics of the T2*OC-defined penumbra 
 
Finally, the spatiotemporal characteristics of the T2*OC-defined penumbra were 
investigated and compared with DWI/PWI mismatch-defined penumbra.  Serial scanning 
demonstrated that T2*OC penumbra behaved in a similar manner to tissue defined by 
traditional mismatch criterion. The spatial location and tissue volumes of penumbra were 
similar with both methods, showing that, in animals where mismatch tissue volume 
reduced over time, T2*OC penumbra reduced similarly, and in animals where mismatch 
volume remained static over time, T2*OC-defined penumbra behaved similarly. 
Additionally, an interesting finding arose in the latter study which showed that ischaemic 
damage continues to progress beyond 4 hours following permanent MCAO, which may be 
relevant to the calculation of ADC and CBF thresholds used in defining DWI/PWI 
mismatch. 
 
Collectively, the preclinical data support the potential of T2*OC to discriminate tissue 
compartments in acute stroke based on metabolic status which thereby provides an 
alternative and improved means of defining the ischaemic penumbra. 
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 Chapter 
1  
 Introduction 
1.1 Stroke 
Stroke is the second most common cause of death and the leading cause of disability 
worldwide (Donnan et al, 2008). In the UK, stroke accounts for 9% of all deaths and is 
second only to coronary heart disease. The rate of stroke deaths varies geographically, with 
parts of Scotland having the highest rates in the UK; for example it is ~50% higher than in 
London (http://www.heartstats.org, Stroke Statistics 2009). The incidence of stroke death 
is expected to increase exponentially in the next 20 years for males and females (Mackay 
and Mensah, 2004), and it has been predicted that stroke will become the leading cause of 
death worldwide by 2025 (Feigin, 2005). However, most strokes are not fatal and as such it 
is the greatest cause of severe disability, in which one third of survivors are functionally 
dependent after one year (Adamson et al, 2004). As a result, the economic implications are 
considerable. In the UK, the cost of stroke to the health care system was £2.5 billion in 
2007, of which, £1.1 billion was devoted to inpatient hospital care and £900 million for 
residential care (http://www.heartstats.org Stroke Statistics 2009). 
 
1.1.1 Overview, definition and classification 
 
Stroke is defined by the World Health Organization as a rapidly developing loss of cerebral 
function (focal or global) originating from vascular disturbances, persisting beyond 24h or 
interrupted by death before 24 hours. The 24 hour time window is selected arbitrarily, 
although it allows differentiation between a transient ischaemic attack (in which the 
neurological symptoms resolve within 24 hours) and events of longer duration. Although 
stroke can be haemorrhagic – caused by an arterial aneurysm rupture or general 
arteriovenous malformation – the majority of strokes are ischaemic, accounting for 
approximately 80-87% of all cases of stroke (Chen et al, 2010; Rothwell et al, 2005; 
Donnan et al, 2008). Ischaemic stroke may be thrombotic or embolic, arising either from 
atherosclerotic plaques (thrombi), or from a displaced embolus such as a blood clot that 
travels from the heart to the brain and adheres to the arterial wall (Figure 1.1). 
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Atherosclerotic plaques can change morphologically, causing ulcerations, thrombosis, 
calcifications and haemorrhage. Unstable plaques which arise from endothelial disruption 
cause platelets to affix to the plaque to form a platelet-rich thrombus and the release of 
vasoactive substances including thromboxane A2 and serotonin, leading to further platelet 
aggregation and vasoconstriction (Zaman, Helft, Worthley, and Badimon, 2000). Clotting 
factors are also activated in the blood, and red blood cells aggregate to form a mesh of 
fibrin. This pathological cascade is combined with the presence of leukocytes that induce 
an inflammatory response, and the consequence is severe narrowing of the lumen which 
causes a local occlusion (Fuster et al, 1990). The result of a cerebral vascular occlusion is a 
severe downstream reduction in blood flow that restricts or precludes nutritive delivery, 
activating a cascade of deleterious biochemical and cellular events.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.  A. Ischaemic stroke arising from atherosclerotic plaques, in which blood flow 
is restricted by a thrombus and, B. embolic ischaemic stroke, where a travelling embolus 
lodges within a brain artery to preclude flow (Modified from Go, 2009) 
 
1.1.2  The rat as a stroke model  
The scope of cerebral ischaemia research is ever-expanding, ranging from the study of 
cultured systems such as brain cells and organotypic brain slices to the many in vivo 
models now available. Advances in our understanding of ischaemic brain damage have not 
translated into successful therapies to treat stroke patients, despite the completion of over 
260 clinical trials of acute stroke therapies (http://www.strokecenter.org). Specific animal 
models have enabled compounds and factors with therapeutic potential to be discovered, 
although their translation to the clinical domain has been notoriously difficult (Howells et 
 
A.      B. 
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al, 2010). O’Collins (2006) evaluated the preclinical data of 1026 treatments in acute 
experimental stroke, in which 603 were tested in focal ischaemia and, of which, 374 were 
found to be effective. Of these treatments which demonstrated efficacy in animal models, 
97 were taken into clinical trials, and only 1 was shown to be effective; thrombolysis with 
recombinant tissue plasminogen activator (rT-PA). This questioned whether or not the 
most efficacious drugs were chosen for clinical trials, and suggested that potential drugs 
must exhibit both evidence supporting clinical application and a very high level of 
experimental efficacy.  
 
The heterogeneity and complexity of human stroke may prevent a unitary animal model 
from being developed, and as such, there is no universal animal stroke model that can 
incorporate all the factors implicated in human stroke. Candidate species for human stroke 
models include sub-human primates, cats, rabbits and rodents (Tamura et al, 1996). Sub-
human primates with gyrencephalic brains are behaviourally and anatomically similar to 
humans, but their preclinical use is stunted by ethical and economic concerns (Cenci et al, 
2002). Most preclinical experiments are performed in homogenous cohorts of young, male 
rodents, and rodents are often bred for genetic homogeneity to ensure relatively 
reproducible infarcts.  Highly controlled experiments can assure consistency in the arterial 
occlusion site, the severity and duration of ischaemia, and pre- and post-ischaemia care. 
Rodent models of stroke are popular in the research domain due to the similarities in the 
cerebral vasculature of humans and rodents (Macrae, 1992), the resultant sensorimotor 
deficits and the pathophysiological processes associated with ischaemic damage (Cenci et 
al, 2002). However, human stroke is very heterogeneous, in which the occlusion site, the 
duration of ischaemia and the extent of collateral supply varies between patients. 
 
The causative mechanisms of ischaemic damage occur rapidly following blood vessel 
occlusion and they are relatively short-lived, and as such, many crucial early events of the 
ischaemic cascade may only be investigated using monitored animals. Multiple non-
invasive imaging techniques at the disposal of preclinical laboratories can be readily used 
for monitored animals in a controlled environment, and it would be unethical to expect a 
patient with a stroke to endure a prolonged scanning session in the acute phase of stroke. 
Additionally, in modalities that emit ionising radiation (computed tomography (CT), 
positron emission tomography (PET) and single photon emission computed tomography 
(SPECT)), multiple scans result in unacceptable radiation exposure in humans. It is 
common for stroke patients to present with high blood pressure, abnormal glucose or 
abnormal blood gases immediately following stroke. In animals, stroke outcome can be 
4 
 
somewhat controlled by careful monitoring and manipulation of physiological variables to 
maintain physiological limits or be adjusted to mimic abnormal levels.  These factors all 
contribute to the problems in translation from preclinical rodent studies to the complexities 
of acute human stroke. 
 
Cerebrovasculature 
 
Brain tissue is supplied by four major arteries that form an intricate communicating 
network. From the neck, the two common carotid arteries bifurcate into the internal (ICA) 
and external carotid (ECA) arteries, which join the circle of Willis and supply the facial 
muscles, respectively. The circle of Willis is a formation of several arteries at the base of 
the brain, from both internal carotid arteries and the basilar artery. The basilar artery – 
which supplies the cerebellum and brainstem - divides into the right and left posterior 
cerebral arteries. The internal carotid arteries branch into the anterior cerebral artery, the 
middle cerebral artery and the posterior communicating artery. The circle of Willis is 
completed when the two anterior cerebral arteries are joined by the anterior communicating 
artery and two posterior arteries are joined by the posterior communicating artery (Figure 
1.2).  The significance of this configuration is that distal collateral arteries can potentially 
preserve brain perfusion if part of the circle is stenosed, effectively acting as anastomoses.  
The main difference between the human and rat cerebrovasculature is that the ICA does 
not form part of the Circle of Willis in the human, which it does in the rat. 
 
Figure 1.2. Organisation of blood vessels in the brain for A. Human, and B. Rat  
(taken from Lee, 1995) 
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1.1.3 Rodent models of focal ischaemia  
 
Most strokes involve the middle cerebral artery (MCA) territory (Barnett, Mohr, Stein et 
al, 1992, Figure 1.3), accounting for 80% of cases in Caucasians (Derouesne et al, 1993; 
Warlow et al, 2003), and animal models of focal ischaemia usually involve occlusion of 
the MCA (McAuley, 1995).  
 
 
 
Figure 1.3. CT angiography displaying MCA occlusion (red arrow) in a stroke patient. 
Modified from Wong et al (1996) 
 
The susceptibility of the core MCA territory to damage following MCA occlusion is in part 
due to the severity of the ischaemic insult.  The small, penetrating arterial branches of the 
MCA that supply core tissues (much of the ventral cortex and striatum) are not supported 
by a collateral circulation, and therefore occlusion of one of these arteries is likely to cause 
uncompromised infarction (Ringelstein et al, 1992; Marinkovic et al, 1985). As such, a 
number of models of MCA occlusion have been developed to reproduce human stroke 
(Figure 1.5).  
 
Intraluminal filament model (ILF) 
 
The most commonly used method of inducing permanent or transient focal ischaemia is the 
intraluminal filament (ILF) model (Koizumi et al, 1986). This involves the insertion of a 
silicon rubber-coated monofilament into the external carotid artery, where it is introduced 
into the ICA and advanced to block the origin of the middle cerebral artery. The filament 
can remain in this position permanently, or retracted and removed to induce reperfusion.  
The ILF model is advantageous because it does not require a craniotomy, although 
adherence of the filament to the blood vessel walls may cause mechanical endothelial 
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damage. Additionally, the infarcts tend to be more variable than with some other middle 
cerebral artery occlusion (MCAO) models, with higher mortality often reported (Tamura et 
al, 1996; Minematsu et al, 1992). A typical pattern of ischaemic damage using the ILF 
method is shown with Magnetic Resonance Imaging (MRI) (Figure 1.4). 
   
   
   
   
Figure 1.4. T2-weighted coronal rat brain images at 24 hours following the intraluminal 
filament model of permanent MCAO (rostral (A) to caudal (H)). On T2 images, ischaemic 
tissue appears hyperintense due to its high water content, causing the cerebrospinal fluid 
(CSF) in the ventricles to also appear bright. Considerable brain swelling is evident in the 
ipsilateral hemisphere at this time point due to cerebral oedema, and this accounts for the 
midline shift. Small haemorrhages are also common in this model, for example in the 
caudate nucleus on Image E & F. As shown, the introduction of the intraluminal filament 
may also result in damage to tissue supported by the posterior cerebral artery and the 
posterior communicating artery  
 
 
A.    B. 
C.    D. 
E.    F. 
G.    H. 
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Electrocoagulation model 
 
A second MCAO model involves electrocoagulating the MCA following a craniotomy, 
which was developed by Robinson and colleagues (1975) and further modified by Tamura 
and colleagues (1981). Specifically, the Tamura model electrocoagulates a proximal region 
of MCA at the origin of the lenticostriatal branches and induces both cortical and striatal 
damage, whereas the technique by Robinson and colleagues involves electrocoagulation of 
a more distal region of the MCA which induces cortical damage only. Thus, the extent of 
ischaemic damage is dependent upon the position and length of the occlusion. The 
craniotomy diminishes the deleterious consequences of brain swelling following 
ischaemia, making this method popular due to the low mortality and high reproducibility. 
However, it cannot be used to study transient focal ischaemia. 
 
 
 
 
Figure 1.5. Two commonly used rodent MCAO models. A. Sagittal representation of the 
intraluminal filament method of MCAO, where the bulbed monofilament is introduced 
through the external and internal carotid arteries to the origin of the MCA, thus precluding 
flow and inducing ischaemia, and B. Coronal representation of the electrocoagulation 
method of MCAO, in which the MCA destroyed by electrocoagulation is coloured black. 
The pink shading represents the ischaemic territory following MCA occlusion. Illustration A 
courtesy of Chris Stock, University of Manchester 
 
Transient MCAO 
 
Identifying the permanence of the MCA occlusion in humans is complicated. Stroke 
patients also tend to experience varying levels of reperfusion which therefore offers 
another complex facet to its reproduction in animal models. Spontaneous reperfusion – 
partially or totally – accounts for ~24% of all stroke cases (Rha and Saver, 2007). In large 
arteries, persisting distal emboli and occlusions in the microcirculation may inhibit 
successful tissue reperfusion. The ILF model of MCAO is particularly useful for inducing 
A.      B. 
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transient focal ischaemia. In this model, the filament can be left in place for a set period of 
time, and reperfusion can then be induced by slow and careful retraction of the filament to 
induce restoration of flow to the previously ischaemic tissue. This can also uncover 
possible injury associated with late reperfusion into ischaemic tissue (reperfusion injury) 
and therefore reflects more closely the situation that occurs in the majority of human 
ischaemic strokes.  
 
1.1.4 Stroke pathophysiology 
 
Ischaemic stroke initiates a constellation of pathophysiological processes, including energy 
failure, increased intracellular calcium, excitotoxicity and secondary pathogenic 
mechanisms which increase the profundity of the insult, such as peri-infarct 
depolarisations, inflammation and apoptosis (Figure 1.6).  
 
 
Figure 1.6. The time course and impact of the pathophysiological cascade following 
cerebral ischaemia (Dirnagl et al, 1999) 
 
Energy Failure 
 
Focal ischaemia due to the blockage of an intracranial artery induces compromised 
cerebral metabolism associated with hypoxia and declining glucose provision.  An 
incipient effect of nutritive deprivation is the detectable and immediate silence in electrical 
activity (Astrup et al, 1977).  In the initial phase, ischaemia triggers energy failure through 
a loss of adenosine triphopshate (ATP). As a consequence, this initiates an elevation in 
extracellular potassium (K+) levels, due to leakage of K+ through the KATP channels, which 
are normally blocked by ATP. Depletion of high-energy phosphates rapidly leads to 
membrane ion pump failure (Wu, and Fujikawa, 2002), in which there is decreased activity 
of the Na+/K+-ATPase and Ca2+/H-ATPase pumps, as well as the reversal of the Na+-Ca2+ 
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exchanger (Phan et al, 2002). Consequently, this causes an elevation of intracellular Na+, 
Ca2+, and Cl− which results in cytotoxic oedema and leads to events triggered by excess 
intracellular Ca2+ (Durukan, and Tatlisumak, 2007).  
 
Elevation of intracellular Ca2+ 
 
There is an accumulation of free calcium in the cell following the failure of the ion pumps 
that would normally transport the calcium back out of the cell. Both neuronal and non-
neuronal cells become depolarised and voltage-dependent Ca2+-channels are activated. 
Depolarisation also initiates the release of neurotransmitters such as excitatory amino acids 
(glutamate) from presynaptic axon terminals into the synaptic cleft (Kristián and Siesjö, 
1996). In addition to changes in water, sodium and energy change, calcium is released 
from the mitochondria and endoplasmic reticulum to increase the concentration of free 
calcium within the cytosol. The rise in intracellular calcium ions activates membrane 
phospholipases A and C, which break down membrane phospholipids, resulting in the 
release of free arachidonic acid which directly increases membrane permeability and also 
has profound secondary metabolic events. It is presumed that cellular oedema occurs as an 
almost immediate consequence of cerebral ischaemia (Kristián and Siesjö, 1996). 
 
Excitotoxicity  
 
Excitotoxicity is the pathological process triggered by depletion of cellular energy by 
which nerve cells are damaged and killed by glutamate and similar substances. Following 
the perturbation of energy production and exhaustion of cellular ATP, the membrane 
potential is completely lost, resulting in depolarisation of neurons and glia (Dirnagl, 
Iadecola, and Moskowitz, 1999). In normal conditions, energy-dependent processes 
remove glutamate – which is stored in the synaptic terminals – from the extracellular 
space. During the stage of energy exhaustion, glutamate transporters cannot remove 
glutamate from the extracellular space due to the loss of ion gradients. As glutamate cannot 
be readily cleared, there is an opening of calcium channels due to the activation of the 
glutamate receptors (N-methyl-D-aspartate (NMDA), the alpha-amino-3-hydroxy-5-
methyl-4-isoxazolepropionate (AMPA) and metabotropic glutamate receptors (Durukan, 
and Tatlisumak, 2007).  
 
Excitotoxins like NMDA and kainic acid which bind to these receptors, as well as 
pathologically high levels of glutamate, can cause excitotoxicity by allowing high levels of 
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calcium ions to enter the cell. Calcium can also cause the release of more glutamate which 
exacerbates the insult. Ca2+ influx into cells activates a number of enzymes, including 
phospholipases, endonucleases and proteases, including calpain. These enzymes succeed in 
damaging cell structures such as components of the cytoskeleton, mitochondria, 
endoplasmic reticulum, plasma membrane and DNA. When free radicals and leukotrienes 
are formed, irreversible mitochondrial damage and necrotic and programmed cell death 
occur following increases in intracellular Ca2+ (Durukan, and Tatlisumak, 2007).  
 
Spreading depolarisations 
 
In the subsequent subacute phase, secondary mechanisms cause an expansion of the 
ischaemic damage into surrounding tissue. These include electrochemical waves called 
spreading depolarisations or depressions, and their incidence has been shown to correlate 
with infarct size in the rat (Dijkhuizen et al, 1999). With accumulations in glutamate and 
elevated extracellular K+ and Ca2+, tissue regions adjacent to the ischaemic core actively 
propagate recurring waves of depolarisations, ionic imbalances and glutamate beyond the 
ischaemic core to the at-risk, less hypoperfused tissue termed the ischaemic penumbra, 
thus expanding the lesion size (Hartings et al, 2003).  Such waves are termed peri-infarct 
depolarisations in this context, and in MCAO rat studies, up to eight peri-infarct 
depolarisations have been observed over 3 hours post-stroke (Mies et al, 1993; Back et al, 
1996).  Lastly, a cascade of injurious mechanisms that further recruit tissue into the infarct 
may persist for a few days, including cytotoxic oedema (ionic disturbances largely due to 
sodium, calcium, lactate and hydrogen ions), inflammation and apoptosis.  
 
Apoptosis  
 
Apoptosis – or programmed cell death – is a genetically controlled series of events which 
acts to save biological components of a cell about to die. This enables utilisation of these 
parts through either macrophages or phagocytes and it is vital for the sustenance of the 
organism. For example, the P53 gene – a tumour suppressor – prevents tumour growth by 
inducing apoptosis in tumour cells as they begin proliferating (Lee and Bernstein, 1995). 
This mechanism occurs when a cell has been exposed to an environment in which it cannot 
survive – e.g., an environment undergoing oxygen and glucose depletion (Feril, 2005). By 
triggering ‘cell-suicide’ (Tortora and Grabowski, 2000: p94) genes, a number of enzymes 
begin attacking the cell, resulting in cell fragmentation and phagocytic uptake.  The 
initiation of apoptosis enables the body’s immune reaction to be minimal, which in turn 
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saves energy (Albert, 2004). There is not an immune response because the cell’s contents 
are phagocytosed before they get the opportunity to leak into surrounding spaces, unlike 
necrosis – where the cells burst and spill their contents into the neighbourhood (Raff, 
1998). Also, a cell with considerable injury would begin to procure nutrients from its host, 
and therefore it is advantageous to destroy one cell as opposed to weakening a multitude of 
cells. Apoptosis differs from necrosis – accidental cell death as opposed to programmed 
death – in that it is controlled and orderly, and requires energy. Apoptosis requires 
caspases, which act to cleave proteins in the cell for easy phagocytotic ingestion. They 
cleave a protein that normally holds a DNA-degrading enzyme (a DNase) in an inactive 
form, freeing the DNase to carve the DNA in the cell's nucleus (Enari, Sakahira, et al, 
1998). They also cleave protein constituents of the cell's skeleton and other proteins 
involved in the attachment of cells to their neighbours, thereby helping the dying cell to 
detach and round up, making it easy to ingest (Raff, 1998).  
 
Both caspase-dependent and caspase-independent pathways in apoptosis have been 
implicated following stroke.  The genes for caspases as well as genes that suppress (such as 
Bcl2, Iap) or augment (Bax, Trp53) cell death are activated in both early and late stages of 
ischaemia. Caspases 1 and 3 are known to play a fundamental role in apoptosis during 
ischaemia.  Since the capases are protein cleavers, they have been shown to modify 
homeostasis and repair proteins that end up disassembling and killing the cells. Capsases 
become activated when cytochrome C, released from mitochondria, activates an 
apoptosome complex (apoptosis-activating factor (APAF1) plus pro-caspase 9) in the 
presence of deoxyadenosine triphosphate (dATP), a nucleotide used in cells for DNA 
synthesis. Cytochrome C can enter the cytosol from its location on the external side of the 
inner mitochondrial membrane.  The formation of the apoptosome complex, which is 
suppressed by BCL2L1, promotes clipping and activation of caspase 3 (Hara et al, 1997).  
Following ischaemia, neurons are particularly susceptible to cell death due to the action of 
caspases. After MCA occlusion in rodents, cytochrome C release and caspase processing 
are evident between 6 and 9 hours, and apoptotic cell death is shown between 24 and 72 
hours (Dirnagl, Iadecola, and Moskowitz, 1999).  
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1.1.5 Neuroprotectants 
Ca2+ channel blockers 
 
In short, following ischaemia, the lack of oxygen affects the production of ATP in the 
neurons, which in turn induces failure of ATP-reliant ion transfer pumps. This causes 
cellular depolarisation, and the intracellular influx of calcium, sodium cations and chloride 
anions. The ion pumps can no longer transport calcium out of the cell, and intracellular 
calcium levels increase significantly. Consequently, the presence of calcium triggers the 
release of the excitatory amino acid neurotransmitter glutamate and activates enzymes 
which lead to increased free radical production. The rationale behind giving Ca2+ blockers 
is to decrease the influx of Ca2+ through ion channels into cells. Buchan and colleagues 
(1994) presented evidence that SNX-111, a selective N-type (neuronal type) calcium 
channel blocker, reduced neuronal injury in a model of forebrain ischaemia in rats after a 
recovery interval of 7 days. SNX-111 was highly neuroprotective, even when administered 
after a delay of 24 hours following reperfusion. However, upon assessing injury at 4 weeks 
post-ischaemia, neuronal protection was no longer apparent. Overall, it failed to provide 
neuroprotection, indicating its ability to delay neuronal death instead of prevent it. It may 
have offered a role to extend the therapeutic window, and although it reached phase II 
trials, it was discontinued due to its ability to induce severe hypotension which exacerbated 
injury (Buchan et al, 1994). Also, the L-type calcium channel blocker nimodipine has 
reduced ischaemic damage in animal models (Mandir et al, 2000), although it did not have 
a beneficial effect in patients when administered 24 to 48 hours after stroke. It seemed 
more efficacious when taken within 12 hours, although it again induced hypotension 
(Weinberger, 2006). 
 
Glutamate receptor antagonists  
 
Glutamate-receptor antagonists such as MK-801 (a potent anticonvulsant) have 
demonstrated efficacy in decreasing neuronal damage in animal models. The NMDA 
receptor-mediated calcium influx is blocked using MK-801, a non-competitive NMDA 
antagonist. NMDA antagonists do not, however, improve outcome in clinical trials, as they 
do not protect against oxidative stress that damages the surrounding neuropil (Weinberger, 
2006). The effect of MK-801 was physiological rather than pharmacological, as the effect 
was facilitated by inducing hypothermia in the animals and increasing the blood flow, 
rather than blocking the NMDA receptor channel. Neuroprotectants such as MK-801 have 
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a number of contraindications, including deleterious cardiovascular events and expressed 
toxicity in certain areas of the brain such as the cingulate cortex. 
 
Anaesthetics and anticonvulsants 
 
Anaesthetics and anticonvulsants act to inhibit the release of neurotransmitters during 
ischaemia. Pentobarbital in gerbil models has reduced ischaemic damage, and this may be 
due to a reduction in metabolic demand and inhibited release of catecholamine in the 
striatum (Levy and Brierly, 1979). Ketamine has been shown to reduce extracellular 
plasma catecholamines in rat models with cerebral ischaemia (Hoffman, Pelligrino, 
Werner, et al, 1992). Other anticonvulsants, including lubeluzole (Grotta, 1997), 
clomethiazole (Wahlgren, et al, 1999) and gavestinel showed initial promise, but 
subsequent trials denigrated their potential utility (Diener et al , 2000; Lyden et al, 2002; 
Sacco et al, 2001).  
 
Caspase inhibitors 
 
The blocking of apoptosis is the rationale behind the development of caspase inhibitors, 
and they have been shown to suppress cell death (Han et al, 2002). The therapeutic 
window seems to be temporally related to the onset of caspase activation, and caspase 
inhibitors attenuate ischaemic brain injury and neurological function when administered up 
to the point of protease activation (Lo, Dalkara and Moskowitz, 2003; Fink et al, 1998). 
However, caspase inhibitors do not reduce infarct size in all brain ischaemia models. 
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1.2 The ischaemic penumbra       
1.2.1 Definition      
Much of our understanding of the acute period of MCA stroke derives from models 
established in animal studies.  Using a primate model, the ischaemic brain was initially 
compartmentalised by Lindsay Symon and colleagues in the 1970s, whom identified a 
mismatch between electrical cerebral function and blood flow at various thresholds, in 
which there was an area of hypoperfused tissue with cellular dysfunction but not death –
demonstrated by somato-sensory evoked potentials (Symon, Pasztor and Branston, 1974). 
Importantly, they established that reduced cerebral function in hypoperfused tissue had the 
potential to return to normal following full restoration of blood flow.  
 
As such, the pathophysiology of the ischaemic brain was defined in terms of four distinct 
tissue compartments (Figure 1.7); brain tissue unaffected by stroke, an ischaemic core 
which will ultimately die, tissue destined to survive (benign oligaemic tissue), and 
functionally impaired but structurally intact tissue with the potential to die or survive 
(Astrup, Siesjo and Symon, 1981). This latter region was termed the ischaemic penumbra 
(from the latin paene ‘almost’ and umbra ‘shadow’ – an astronomical sobriquet explaining 
the outer region of a shadow cast by earth during a partial eclipse) because of its location 
around the ischaemic core and its transitory nature (Figure 1.8). 
 
 
 
Figure 1.7.  The compartmental model of ischaemic brain injury. The unaffected site (1) is 
the outermost region, followed by an area of benign oligaemia (2) that does not require 
reperfusion to survive. The ischaemic penumbra (3) is at risk of irreversible cell death, and 
surrounds the irreversibly damaged ischaemic core (4). 
Adapted from Lee et al (2005) 
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Hakim (1987) further broadened the definition and outlined the clinical relevance by 
explaining that penumbra is ‘fundamentally reversible’, presenting a therapeutic window 
of opportunity. However, over time and without intervention, this penumbral tissue 
becomes incorporated into the irreversibly damaged, ischaemic core. Thus, an all-
encapsulating definition of penumbra is that it is functionally impaired ischaemic tissue 
potentially destined for infarction which, unless salvaged by reperfusion or otherwise 
supported, will become incorporated into the infarct core. For the penumbra to be 
classified as a clinical measure, the salvage of the tissue must improve clinical outcomes 
(Donnan et al, 2007).  
 
Figure 1.8.  Depiction of the nature of ischaemic injury, with penumbral tissue surrounding 
an ischaemic core following blockage of a cerebral artery. Adapted from Allan and 
Rothwell (2001) 
 
1.2.2 Cerebral blood flow following stroke     
Whilst the brain comprises 2% of total body weight in humans, its utilisation of both 
oxygen and glucose is not correlated with its size, accounting for ~20% of oxygen 
consumption and ~25% glucose consumption in the blood. Due to such a high metabolic 
demand, the brain acquires 15% of the resting cardiac output (Winn, Dacey, and Mayberg, 
1989). These characteristics of the brain, coupled with its inability to hold appreciable, 
Ischaemic Core 
Middle cerebral artery 
Blocked blood vessel 
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endogenous energy reserves (Marieb, 1998) make this organ reliant on the continual 
delivery of oxygen and nutrients by circulating blood and particularly vulnerable to 
changes in blood supply.  If its blood supply is impeded, irreversible cell death ensues as 
quickly as 5 minutes.   
 
The cerebral vessels possess the ability to deliver a constant supply of blood despite 
systemic blood pressure (BP) fluctuations. The mean arterial blood pressure (MABP) can 
be altered over a fairly wide range – between about 50 and 150 mmHg without affecting 
cerebral blood flow (CBF). This phenomenon is called ‘autoregulation’ and can be defined 
as the ability of cerebral resistance vessels to alter in response to changes in perfusion 
pressure (Stan et al, 2004). Specifically, this attains constancy in blood flow, allowing 
consistent nutritive delivery to the brain (Johnson, 1964).  Autoregulation is basically an 
inhibitory feedback system, and as mean arterial blood pressure can enter high and low 
limits due to hypertension or hypotension, the change in calibre of cerebrovascular vessels 
counteracts these phenomena by constricting or dilating, respectively. When blood 
pressure falls, physiological mechanisms attempt to maintain flow to prevent ischaemia. 
Similarly, when blood pressure rises, the same mechanism stops the blood flow from 
increasing to excessive levels. If this did occur, cerebral oedema could develop and the 
brain would enlarge because of the increase in cerebral arterial blood volume. 
 
Autoregulation and stroke 
 
Cerebral autoregulation is also a major self-defence mechanism against secondary 
ischaemic insults after traumatic brain injury and subarachnoid haemorrhage, and 
impairment of cerebral autoregulation has been shown to affect prognosis (Czosnyka et al, 
1996). Stroke can induce a loss of cerebral autoregulation, and the complications 
associated with this are, in part, responsible for consequential brain damage post-ischaemic 
insult, indicative of oedema formation and secondary ischaemia. Thus, the loss of 
autoregulation may play a vital role in secondary deterioration of stroke patients (Dohmen, 
2006).  
 
Cerebral vasoregulation involves several complex mechanisms adapting blood flow to 
fluctuations of systemic blood pressure. Autonomic BP and metabolic vasoregulation are 
impaired after stroke and cerebral blood flow then depends on systemic BP (Dawson, 
Panerai and Potter, 2003). With severe strokes, autoregulation has been seen to remain 
preserved despite failure of the plethora of regulatory mechanisms. This presentation of 
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preserved autoregulation is false, however, and may possibly be due to several interacting 
mechanisms including changes in cerebral tissue pressure and changes in blood flow 
(Paulson, 1972). Loss of autoregulation in acute cerebral lesions tends to be due to tissue 
ischaemia and/or acidosis. Cerebral resistance vessels then dilate in an attempt to increase 
blood flow. The actual level of the blood flow in such regions not only depends on the 
degree of vasodilatation, but also on other factors such as intracranial pressure, local 
cerebral oedema and vascular obstruction.  
 
The major factor responsible for adjustments in intrinsic blood flow is the metabolic 
demand of the tissue, and thus blood flow is related to the requirement of the local neurons 
to expend energy for activity – the principal consumer of energy in the brain. Therefore, 
blood flow is controlled by the extent of neuronal activity at certain brain regions, which 
gives rise to autoregulatory mechanisms that enable such flow modifications. In short, the 
more functionally active a region of brain is, the greater the metabolic demand and the 
greater the blood flow. Cerebral blood flow is measured in millilitres per 100g of brain 
tissue per minute. These values vary between species, and CBF and cerebral glucose 
utilisation rate (CMRglc) are inversely proportional to the size of the animal (Table 1.1).  
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Species 
 
CBF 
(mL/100g/min) 
CMRglc 
(mL/100g/min) 
Human 54 31 
Rat 107 69 
 
Table 1.1. CBF and CMRglc of the rat and human. Adapted from Harper (1990) 
 
Following stroke, in terms of blood flow, there is a significant topographical gradient of 
CBF reduction across the vascular territory. Tissue in end artery territory has the greatest 
severity of ischaemia, where total or profound loss of CBF represents tissue that will 
progress to infarct. As the brain has a complex array of anastomosing vasculature, the 
region adjacent to the core is marginally supplied by collaterals, which represents tissue 
experiencing less-severe ischaemia.  
 
Perfusion thresholds for functional integrity 
 
Astrup, Siesjo and Symons (1979) implemented a three-part model with the thresholds of 
cerebral blood flow associated with normal functioning, penumbral tissue, and ischaemic 
core, identified by inducing ischaemia in a primate MCA occlusion model. Tissue 
compartments of the brain following stroke can be classified by the extent and duration of 
ischaemia. Following the blockage of a vessel, the end artery territory (ischaemic core) has 
CBF of <10 to 15 mL/100 g per min in primates. Ischaemic damage occurs rapidly – often 
under 1 hour – and the morphological changes in the tissue are irreversible. Intermediate 
tissue around the periphery of this core – the penumbral region – experiences a more 
modest reduction in CBF, where flow is ~15% to 40% of normal levels. Unless blood flow 
is restored, penumbral tissue will eventually become incorporated into the infarct, and this 
evolution can take a number of hours (Pulsinelli, 1992). Thirdly, benign oligaemic tissue - 
classified as tissue which is not expected to progress to infarction under normal 
circumstances in humans - can range from normal CBF values down to ~20 mL/100g/min 
(Baron et al, 2001). This tissue survives within the hyperacute stage following stroke 
(within 12 hours), but its fate is less definite following persistent occlusion.  One may 
expect this region to enter a less severely hypoperfused state (above 30 mL/100g/min), 
which prevents the tissue undergoing infarction (Linskey et al, 1994). The benign 
oligaemic region is not completely invulnerable to infarction, as accompanying factors 
such as hyperglycaemia, fever and hypotension may induce progressive damage.  
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Figure 1.9. CBF thresholds shown depict the situation in sub-human primates. Adapted 
from Astrup et al (1977) 
 
The CBF thresholds (Figure 1.9) to differentiate between normal, penumbral and infarcted 
core are based on animal experiments, although their diagnostic accuracy in humans are 
poorly established (Latchaw et al, 2003). The human thresholds are: 
1. Normal, unaffected tissue (including benign oligaemia): CBF  ~50 mL/100g/min   
(Muir et al, 2006)  
2. Penumbra: 10 to 17 mL/100g/min  
3. Infarct core: <10 mL/100g/min (Moustafa and Baron, 2007) 
 
1.2.3 Autoregulatory responses in the ischaemic brain 
 
Unaffected brain tissue following stroke 
 
In the unaffected, normal region of the brain (Region 1, Figure 1.10), the regional CBF is 
about 50-60 mL/100g/min in humans (~100 mL/100g/min in rats). A reduction in blood 
flow is associated with a reduction in cerebral perfusion pressure (CPP), which induces a 
vasodilatory reaction in the blood vessels affected (Region 2, Figure 1.10). In the 
autoregulated area, this introduces more blood to the region, which attempts to maintain 
CBF, and this mechanism will remain intact if the BP remains between about 50 and 150 
mmHg.  In this region, autoregulation is sufficient to sustain an adequate CBF.  
 
The benign oligaemic region 
 
In benign oligaemic tissue (Region 3, Figure 1.10), there is neither functional impairment 
nor morphological abnormality. The region is indicative of reduced cerebral perfusion 
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pressure (CPP), moderately reduced CBF, an increased oxygen extraction fraction (OEF), 
and a normal cerebral metabolic rate of oxygen (CMRO2).  OEF refers to the matching of 
cerebral blood flow to metabolism, and the CMRO2 reflects oxygen consumption, which is 
the difference of oxygen flowing in and out of a region (Boas et al, 2003). The increased 
OEF is the compensatory mechanism – known as the ‘perfusion reserve’ – and it allows 
normal CMRO2 to be maintained.  
 
Penumbral region 
 
As CPP decreases further, the CMRO2 cannot be maintained, even when the OEF 
increases. This is because the perfusion reserve is depleted, and the neurons become 
impaired when metabolism is critically impaired. This penumbral tissue (Region 4, Figure 
1.10) is metabolically exhausted yet the integrity of the cells is maintained. There are a 
number of established markers of the ischaemic penumbra; a region with increased OEF 
(Baron et al, 1984), a mismatch between neuronal integrity and CBF (Heiss et al, 1997) 
and a mismatch of cerebral protein synthesis and energy depletion (Hata et al, 1998). 
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Figure 1.10.  Haemodynamic and metabolic changes in various tissue compartments 
following ischaemia, represented as; 1. Unaffected area, 2. The autoregulated region, 3. 
The benign oligaemic, 4. The ischaemic penumbra, and 5. The ischaemic core. Adapted 
from Maeda et al (1993) 
CPP = cerebral perfusion pressure; CBV = cerebral blood volume; CBF = cerebral blood 
flow; MTT = mean transit time; OEF = oxygen extraction fraction; and CMRO2 = cerebral 
metabolic rate of oxygen 
 
1.2.4 Biochemical and metabolic thresholds for definition of penumbra 
 
A number of established markers (Figure 1.11) have been employed to characterise the 
ischaemic penumbra. Major vascular occlusion is a dynamic and complex phenomenon, in 
which the severity and duration thresholds for tissue viability are dependent upon factors 
including cell type, the health of the collateral vessels, residual flow, and biochemical 
events. Demarcating penumbra from intact tissue is more complex at lower flow rates, 
since increasingly more pathophysiological disturbances occur. The advent of multimodal 
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imaging methods to identify these biochemical processes and thresholds has further 
complicated penumbra definition and contributed to the idea of multiple penumbras (Sharp 
et al, 2000) by characterising its molecular expression pattern, as opposed to the classically 
described blood flow and physiologic descriptions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. The pathophysiological disturbances that occur within the penumbra and 
ischaemic core as blood flow levels decrease (Adapted from Hossmann and Mies (2007)) 
 
As the markers for identifying penumbra tend to be generated from animal models - often 
identified using invasive, terminal tissue-sectioning procedures - there is a difficulty in 
translating this information and establishing the relationship between penumbra salvage 
and improved clinical outcome. Such is the complexity and heterogeneity of stroke, the 
reason that there is no established penumbral marker is because research groups tend to 
focus on a specific biological process in the ischaemic model.  Instead of studying the 
characteristics of the penumbra, many groups have a biochemical process in mind that may 
complement the body of work on an ischaemic insult as a whole. Whilst a group may focus 
on the significance of suppressed protein synthesis following an ischaemic insult, another 
group may study the mismatch between stimulation of anaerobic glycolysis and CBF. 
Although both groups satisfy the criteria for the ischaemic penumbra identification, the 
rationale for their studies varies, their regions of interest are variable and the thresholds of 
cerebral blood flow in the rat differ for protein synthesis (at 55 mL/100g/min) and 
anaerobic glycolysis (at 35 mL/100g/min), for example (Hossmann, 1994).  
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1.2.5 Difficulties in defining the ischaemic penumbra in stroke patients 
 
A fundamental issue that hinders the development of a sophisticated predictive model of 
tissue viability is the lack of standardised parameters. Warach (2001) notes that there are 
no absolute viability thresholds that are independent of time, and also that there is no time 
window of tissue viability. Warach (2001) suggests that the various markers of tissue 
viability such as apparent diffusion coefficient (ADC) and CBF must be combined to 
improve their predictive power, and that they need to be tested on the stroke population as 
a whole. Then, the models can be compared, and if there are no significant differences, the 
model of least complexity will be the gold standard in the clinical domain.  
 
For preclinical MR imaging of acute stroke, the simplest research tool is diffusion-
perfusion (DWI/PWI) mismatch. However, this has still to be validated both preclinically 
and clinically, and at present there is no consensus as to what thresholds should be used for 
diffusion and perfusion.   Therefore, until a more accurate MR model is characterised and 
validated, positron emission tomography (PET) (see section 1.3.2 for definition) will 
continue to represent the gold standard for imaging the penumbra. 
 
Bandera and colleagues (2006) performed a systematic review to assess the evidence 
available on CBF thresholds for differentiating between ischaemic core and penumbra in 
adult stroke patients. They found that out of 237 reviewed papers, only 7 satisfied their 
inclusion criteria. Papers were excluded for a number of reasons; data were recorded from 
animal studies/experimental models, studies were on paediatric patients, the clinical 
diagnosis was not stroke, unreported CBF thresholds, review papers, and studies where 
there was no comparison with the gold standard. Within the seven papers, CBF thresholds 
for penumbra and ischaemic core varied, from 14.1 to 35.0 and from 4.8 to 8.4 
mL/100g/min, respectively. 
 
The ischaemic penumbra can be defined in animal models by directly relating flow 
measurements to the functional state of the tissue. To enable penumbra definition to be 
transferrable to the clinical situation, there are three measurements required (Heiss, 2003): 
1. Quantification of flow in the ischaemic core and adjacent hypoperfused regions;  
2. The integrity of the tissue in the affected areas with regards to irreversible damage or 
preserved viability; 
3. The duration and extent of reduced blood flow in the various tissue compartments  
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At present, there is an inability to generate a real-time measure of blood flow. Only 
momentary measurements of tissue characteristics can be observed, when the progression 
of infarct and the imminent recruitment of the penumbra to the ischaemic core are of vital 
importance. The upshot of measuring real-time haemodynamic parameters is that they can 
allow us to make predictions about the fate of the tissue.  
 
1.2.6 Salvaging the ischaemic penumbra      
 
By improving blood flow or interfering with the ischaemic cascade, penumbra has the 
potential for rescue. Penumbral salvage is associated with neurological improvement and 
recovery, and therefore it is the target for acute stroke therapy (Molina and Saver, 2005). 
There is no direct treatment measure to reduce the extent of neurologic injury (The 
National Institute of Neurological Disorders and Stroke rT-PA Stroke Study Group, 1995). 
For ischaemic injury, blockage removal and blood flow restoration take primacy. The 
penumbra takes a central role in therapeutic interventions. 
 
1.2.6.1  Reperfusion therapies 
 
Of all the therapeutic strategies for acute ischaemic stroke, the most dramatically effective 
intervention is reperfusion (Molina and Saver, 2005). Ischaemic stroke refers to the sudden 
loss of blood flow in a cerebral artery due to a blockage.  Mechanical or drug-induced 
restoration of blood flow with its accompanying nutritive delivery by reperfusion enables 
salvage of previously injured (penumbral) tissue (Figure 1.12). As a result, adequate tissue 
viability is retained in this penumbral tissue, and infarct evolution is halted. Rapid 
reperfusion of the artery by thrombolysis has been shown to produce a favourable clinical 
outcome such as reduced final infarct volume and improved clinical outcome scores 
(Felberg et al, 2002; Uchino et al, 2005) in selected patients (NINDS rT-PA Stroke Study 
Group, 1995).  
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Figure 1.12. 3D CT image of the Circle of Willis of an acute stroke patient with an 
occluded middle cerebral artery identified by the missing vessel (red arrow) (A) and 
following thrombolysis (B), where flow is restored to previously ischaemic regions (Images 
provided by Professor K Muir, Southern General Hospital) 
 
Disability and mortality are reduced by admission to specialised stroke units (Rudd et al, 
2005).  Other than this, the only widely approved drug treatment for acute cerebral 
ischaemia is recombinant tissue plasminogen activator (rT-PA). Before thrombolysis was 
approved by the US Food and Drug Administration for acute ischaemic stroke in 1996 (i.v 
rT-PA; therapeutic time window of less than 3 hours of stroke onset) (Adams et al, 1996), 
stroke was considered to have a bleak prognosis, and patients were treated non-urgently. 
Since then, clinical experience and randomised i.v (intravenous) rT-PA trials have shown a 
time-dependent effectiveness, in that patients experience the greatest benefit within the 
first 90 minutes (Donnan et al, 2004). However, many patients are ineligible for 
thrombolytic therapy, in that fewer than 10% of all stroke patients can be thrombolysed 
(Cocho et al, 2005; Molina and Saver, 2005). The low treatment rates with i.v. rT-PA (for 
example 1-7% in the USA following FDA approval (Wardlaw et al, 2009)) partly reflects 
delays in presentation and institutional barriers to rapid medical assessment (Katzan et al, 
2004, Kahn et al, 2005), but also that clinical uncertainty prevents treatment in many 
circumstances, including patients awaking with symptoms in whom onset time is unclear, 
rapidly improving or mild symptoms, and perceived concern about bleeding risks in 
treating patients with mild strokes (Barber, 2001).  
 
RT-PA is an enzyme that catalyses the conversion of plasminogen to plasmin, which can 
then degrade and dissolve the clot.  Within the acute stages of ischaemia, the benefit of 
such therapy is at least an order of magnitude greater than aspirin – another 
A.      B. 
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pharmacological agent with a proven (modest) efficacy for treating ischaemic stroke 
(Molina and Saver, 2005). According to the National Institute of Neurological Disorders 
and Stroke (NINDS) trials, for every 1000 patients treated with rT-PA, around 323 will 
attain a better outcome (Saver, J.L, 2004).  It has been shown, from randomised i.v. rT-PA 
trials, that its effectiveness is time-dependent.  
 
Initially, as further clinical trials showed no benefit of rT-PA treatment after the 3-h limit 
(Clark et al, 1999; Hacke et al, 1998), it was thought that the risk/benefit ratio did not 
justify its use beyond 3 hours (Intercollegiate Stroke Working Party, 2004). However, 
studies have reported substantial delays in presentation following stroke (Katzan et al, 
2004; Lacy et al, 2001) including a study based in Oxford which showed only 31% of 
stroke patients presenting within 3 hours  (Salisbury et al, 1998).   
 
Barber and colleagues (2001) analysed eligibility for thrombolysis in patients admitted to 
all four Calgary hospitals in Canada. They categorised the patients according to the time of 
presentation; within the 3 hour time window and presenting beyond it. They noted that, of 
the 27% of patients presenting within the time window, only 27% received i.v rT-PA, the 
majority were excluded according to the criteria in (Figure 1.13).  As such, 31% of patients 
were not given i.v rT-PA because their symptoms were either considered too mild or were 
rapidly improving. Overall, a third of this 31 percentile were left either dependent or dead. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
Figure 1.13. Pie charts representing the percentage of ischaemic stroke patients 
presenting within the time window and the clinical outcomes, and the reasons for 
presenting out with the time window (Barber et al, 2001). OTT – uncertain time of onset. 
Admin and other clinical reasons refer to clinical uncertainty – such as patients awaking 
with symptoms in whom onset time is unclear, perceived concern about bleeding risks in 
treating mild strokes, emergency department referral delay and significant comorbidity 
 
In May 2009, the American Heart Association (AHA)/American Stroke Association (ASA) 
extended the window for acute ischaemic stroke, approving rT-PA as a treatment between 
3 and 4.5 hours post-symptom onset. The decision was primarily based on findings from 
the third European Cooperative Acute Stroke Study (ECASS III) trial, which confirmed a 
significant reduction in disability at the 90 day time period after rT-PA treatment between 
3-4.5 hours (Hacke et al, 2008). The exclusion criteria applied in the trial design included 
patients over 80, a National Institutes of Health (NIH) stroke scale score>25, history of 
previous stroke or diabetes, or if taking oral anticoagulants.  
 
More recently, a time profile of benefit and harm for rT-Pa in a pooled analysis of eight 
randomised trials concluded that one in three patients had improved outcomes when treated 
between 1 and 3 hours from symptom onset, whilst one in six benefitted in the 3-4.5 h time 
window. Significantly, risk may outweigh benefit beyond the 4.5h time point (Lees et al, 
2010), and this finding was supported by a previous Cochrane meta-analysis (Wardlaw et 
al, 2009). 
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Figure 1.14. Combined data from NINDS, ECASS and ATLANTIS investigators observing 
the effects of timing of thrombolysis on stroke outcome. Patients treated within 90 min had 
the most improved 3-month outcomes, whilst patients treated between 90 and 360 min 
also experienced improvements. Beyond 360 min, the effect is not evident (NINDS, 
ECASS and ATLANTIS investigators, 2004) OR: Odds ratios, OTT: onset to start of 
treatment. The dark blue slope is the odds ratio estimated by the model, and the dashed 
lines represent the upper and lower 95% confidence intervals (CI). The light blue line at 
1.0 reflects the adjusted odds ratio where the outcome of thrombolysis group is equal to 
the placebo group 
 
NINDS, ECASS and ATLANTIS (Alteplase Thrombolysis for Acute Noninterventional 
Therapy in Ischemic Stroke) investigators combined data for a pooled analysis (2004) 
which reported the effects of timing on outcome. It showed that patients treated within 90 
min had improved 3-month outcomes and in patients treated up to the 360 min time point, 
improved outcomes were still observed. However, the odds of favourable 3-month 
outcome increases as onset to start of treatment (OTT) decreased. Interestingly, if the OTT 
is beyond 4.5 hours, the beneficial effect may no longer be evident. The researchers 
divided the OTT into 90 min intervals (0–90, 91–180, 181–270, and 271–360) and the ratio 
of patients with a favourable outcome (modified Rankin Scale (mRS) 0, 1, or 2; National 
Institutes of Health Stroke Scale 0-1 and Barthel Index 95-100) was analysed in 2779 
patients. There was a significant correlation of outcome with time from symptom onset. 
The odds ratios for the favourable outcome were 2.81, 1.55, 1.4 and 1.15, respectively, 
with the last OR missing statistical significance. Figure 1.14 shows the odds ratio for a 
favourable outcome at 3 months in rT-PA-treated patients compared with controls by OTT.  
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It showed that the lower 95% CI intersects with 1.0 at 285 min after symptom onset and 
the point estimate of the odds of a favourable outcome is close to 1·0 at 360 min, 
suggesting reduced probability of benefit beyond this time. The lower 95% CI defines the 
lower range of the CI, and when the OR reaches 1.0, the odds of a favourable outcome in 
the thrombolysis treatment group is the same rate as the placebo group. The findings 
suggest that the beneficial effect of rT-PA might extend beyond 3 h since the odds ratio for 
a favourable outcome was 1·40 (1·05–1·85) for those treated within 181–270 min. Within 
the first 3 hours there were significant OR changes at 10-minute increments (Fiebach and 
Schellinger, 2003). 
 
Despite a good likelihood of an excellent neurological outcome with early reperfusion, late 
reperfusion may paradoxically induce a serious of pathophysiological responses which 
result in potentially fatal outcomes, including cerebral oedema or intracranial haemorrhage  
(ICH) (The NINDS t-PA Stroke Study Group, 1997). Haemorrhagic transformation, 
identified 24-36 hours following stroke is more frequent after reperfusion, regardless of the 
modality used to induce recanalisation, such as anti-thrombotics, mechanical recanalisation 
and intravenous lytics (Khatri et al, 2007). Regarding animal models, reperfusion 
following a prolonged period of ischaemia may actually increase final infarct size, 
compared to permanent ischaemia models (for example, ischaemia lasting 120-300 mins 
(Aronowski et al, 1997) and 180 mins (Yang and Betz, 1994)). As such, thrombolytic 
therapy can potentially exacerbate ischaemic injury for certain patients, whilst dramatically 
improving clinical outcomes in others. rT-PA is contraindicated for haemorrhagic strokes 
and carries a risk for increased ICH in ischaemic stroke potentially inducing 1 fatal ICH in 
every 20 patients treated (Figure 1.15) (Wardlaw, del Zoppo, and Yamaguchi, 2003).  
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Figure 1.15. Evidence of intracerebral haemorrhage following stroke on 10 stroke patients 
treated with rT-PA. The NINDS t-PA Stroke Study Group (1997). Haemorrhages are 
displayed as hyperintense regions in this MRI sequence 
 
1.2.6.2 Influence of admission to specialised stroke units on outcome 
 
Admission to a specialised stroke unit has been shown to improve the neurological 
outcome from stroke. Rudd and colleagues (2005), using data from the 2001 to 2002 
National Stroke Audit, assessed the effectiveness of stroke unit care in England, Wales, and 
Northern Ireland in delivering effective processes of care and in reducing case fatality and 
disability (Rudd et al, 2005). They found that the risk of death in patients receiving stroke 
unit care was estimated to be ~75% that of the risk from having no stroke unit care. This 
favourable outcome was in agreement with previous studies, including clinical trials by the 
Stroke Unit Trialists’ Collaboration (SUTC), where there were fewer deaths and less 
morbidity in patients residing in stroke units (Stroke Unit Trialists’ Collaboration, 2002). 
 
In 2002, stroke unit care in the UK only accounted for one third of stroke victims            
(Intercollegiate Working Party for Stroke, 2001-02:  
http:// www.rcplondon.ac.uk/college/ceeu/strokeconciseauditreport.pdf). Given that there 
are approximately 120,000 first strokes per year with a 30% mortality rate after one year 
(in England and Wales), only 40,000 receive care from specialised units. Non-specialised 
units are responsible for mortality rates 14-25% higher than stroke units (Stroke Unit 
Trialists’ Collaboration, 2002). Thus, stroke unit care availability for all patients would 
translate to potentially saving 3500-6000 lives a year. 
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1.3 Multimodal identification of penumbral tissue 
 
Advancements in brain imaging modalities may introduce more stringent prerequisites for 
patients to qualify for penumbral salvage either with current therapy or recruited into 
clinical trials to test new therapies. Criterion such as perfusion status and the physiological 
and biochemical condition of ischaemic tissue are becoming more accurately defined to 
improve patient selection (Table 1.3).  
 
The evolution of the ischaemic penumbra for individual patients is dependent upon time 
from onset, the adequacy of collateral blood flow, temperature, and systemic metabolic 
disturbances (e.g., glucose level, acidosis) (Fisher, 1997). This implies that the volume and 
concomitant loss of penumbral tissue varies between patients, and thus the time window 
for thrombolytic treatment is entirely subjective. The processes that advance loss of 
penumbra into ischaemic core may differ from patient to patient, and thus in the future, 
clinical intervention may be specific to the individual.  
 
Failure to identify efficacy in both thrombolysis and neuroprotection trials (Kidwell et al, 
2001) could have arisen from treatment being administered in some patients at a time point 
when no salvageable (penumbral) tissue remained, but potentially also to recruitment of 
patients lacking target penumbral tissue even within conventional time windows (Muir, 
2002). The possible improvement in safety with selection for thrombolysis based on more 
advanced penumbral imaging has been suggested (Schellinger 2003). Neuroimaging 
techniques have influenced the ability to evaluate the extent of stroke damage, as well as 
introducing a surrogate for treatment outcome assessment and criteria for treatment 
administration. 
 
1.3.1 Computed tomography (CT) 
 
Computed tomography is currently the most accessible clinical technique for identification 
of the ischaemic penumbra due to its speed of image generation, its wide availability and 
practicality. Plain CT scans cannot identify the penumbra, but CT perfusion (CTP) 
techniques using injection of a contrast medium bolus are showing promise. CT perfusion 
imaging defines penumbra using changes in CBV, CBF and MTT (mean transit time).  
Using CT, the ischaemic core has been defined as a region with CBV below 2 mL/100g 
and relative MTT above or equal to 145% of the contralateral value. Autoregulation is 
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compromised in the ischaemic core, which results in lowering of CBV. CTP defines 
penumbral tissue as a region with increased cerebral blood volume (relative to the 
ischaemic core due to local vasodilatation, where autoregulatory processes compensate for 
reduced relative (rCBF)), as well as reduced CBF and increased MTT.  However, it suffers 
similar problems to MRI-based perfusion-weighted imaging (Chapter 1.3.3.4) as there are 
no proven thresholds for defining the outer limit of the penumbra to differentiate it from 
benign oligaemic tissue. It may perhaps be less accurate than the diffusion-perfusion 
mismatch technique (an established MR research tool) (Chapter 1.3.3.5), as there is no 
equivalent to DWI data of injured tissue on CTP. CT is therefore still incompletely 
validated for penumbral identification in acute stroke treatment studies, and whole brain 
coverage is not yet readily available. Radiation exposure may prevent serial scanning, and 
iodinated contrast agent administration may cause nephropathy and allergy (Ebinger et al, 
2009). 
 
1.3.2 Positron Emission Tomography (PET) 
 
The gold standard for clinical assessment of penumbra is PET, which detects gamma rays 
emitted indirectly by a positron emitting radioisotope bound to a ligand. A 3D image can 
be tomographically reconstructed that is based on the concentration of the administered 
tracer. Multitracer PET using 15O or H215O as ligands can quantitatively identify tissue 
metabolic state and can be used to characterise the penumbra as tissue with reduced CBF, 
preserved CMRO2 and an increased OEF (Baron, 1999; Ebinger et al, 2009) (Figure 1.16). 
This signature of penumbral tissue was termed ‘misery perfusion’ by Baron and colleagues 
(1981). In humans, oxygen metabolism and CBF thresholds of irreversibly damaged tissue 
have been defined as 65 µmol/100g/min and 12 mL/100g/min, respectively (Heiss, 2003).  
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Figure 1.16. Multimodal imaging 5 hours post-stroke in a human patient. Penumbra is 
defined as a region with reduced CBF, preserved CMRO2 and increased OEF, which 
correlates approximately with MRI findings (DWI hyperintensity and time to peak (TTP) 
delay of 4 seconds). Adapted from Heiss et al (2004) 
 
Serial PET has been used experimentally which demonstrates the spatial and temporal 
evolution of penumbra following MCAO (Heiss, 1994; Touzani et al, 1995). Perfusion and 
non-perfusion based markers of ischaemic tissue (such as the hypoxic ligand [18F]-
fluoromisonidazole (FMISO) and the neuronal receptor ligand [11C]-flumazenil (FMZ)) are 
becoming more accurately defined to improve patient selection (Takasawa et al, 2008). 
FMZ can identify the integrity of neurons and it can detect damage in the acute phase post-
stroke, whereas FMISO identifies hypoxic tissue expressed as regions of increased tracer 
uptake (Heiss, 2003). The technique was supported by Takasawa and colleagues (2007), 
who noted increased FMISO uptake in the first hours in a MCAO rat model when 
reperfusion was not induced and the tissue was not yet irreversibly damaged. However, 
increased FMISO uptake has been shown 20 hours post-stroke in the peri-infarct tissue in 
the rat (Saita et al, 2004) despite reversal of MCAO following reperfusion. The authors 
suggested that peri-infarct oedema, small vessel occlusion, or the ‘no-reflow’ phenomenon 
may have caused persistent hypoxia. This may also have been a methodological problem, 
in that the intraluminal filament MCAO technique may have induced vascular injury or 
resulted in incomplete reperfusion.  
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Although PET is an accurate means of physiological monitoring which permits 
quantitative measurements, it is impractical for clinical use (Schellinger et al, 2003; Muir 
and Santosh, 2005). It necessitates arterial catheterisation for blood sampling, and it is 
prohibited when the administration of thrombolytics is planned (Heiss et al, 1998). 
Additionally, multiple scans cannot be performed due to the radiation dose administered, 
and it is expensive, technically challenging and of limited availability in stroke units 
(Schellinger et al, 2003; Muir and Santosh, 2005). As such, MRI is preferred for 
penumbral imaging in the experimental research domain. 
 
1.3.3 Magnetic Resonance Imaging (MRI)   
 
The emergence of MRI as a potent and robust modality for imaging anatomy, pathology, 
organ function and even neural activity has elevated it to the technique of choice for 
assessing many diseases of the central nervous system. By affording such high resolution 
of anatomical structures, as well as enabling manipulation of image appearance due to the 
multitude of sequences available, MRI offers a high degree of specificity in the 
neuroscience domain.  
 
MRI is a non-invasive method of imaging the human body, based on the electromagnetic 
activity of atomic nuclei. The presence of a strong external magnetic field takes advantage 
of the intrinsic characteristics of hydrogen nuclei (1H), which are abundant in the body.  
Each hydrogen nucleus consists of a single positively charged proton which rotates around 
its own axis - a property known as spin.  The positive charge inherent in these particles 
causes their spins to induce a small magnetic field referred to as the magnetic moment.  
When a subject is placed in a magnetic field such as an MRI scanner, the protons are 
forced to align in one of two possible positions - protons will align either parallel or anti-
parallel with the magnetic field. When radio waves are sent toward these hydrogen atoms, 
the alignment of the magnetisation is altered. This causes the emittance of a weak radio 
signal that can be amplified and detected by a scanner. Different types of tissues send back 
different signals, allowing differentiation between internal structures, which leads to a 
reconstruction of the image of the body. Specific MRI techniques can be used to depict 
specific attributes of the tissues of interest, enabling disease processes to be suitably 
characterised.  
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To enable structural imaging, the MR system requires the following components: 
1. A large magnet to generate the magnetic field;  
2. Shim coils to make the magnetic field as homogeneous as possible;  
3. A radiofrequency (RF) coil to transmit a radio signal into the body part being imaged;  
4. A receiver coil to detect the returning radio signals;  
5. Gradient coils to provide spatial localisation of the signals, and;  
6. A computer to reconstruct the radio signals into the final image 
 
The magnetic field is achieved by generating a current with the use of a superconducting 
electromagnet. This current is introduced through a superconducting wire – resistance is 
eliminated by cooling the wire with liquid helium to 4K (−269°C). For example, seven 
Tesla (7T) refers to the magnetic field strength of the scanner, which is 175,000 times 
more powerful than the magnetic field of the Earth. The rationale for providing a scanner 
with such high magnetic fields is to enable the best signal to noise ratio in samples of small 
dimension (such as a rat or mouse brain). The 7T scanner which was used in this thesis is 
shown in Figure 1.17.  
 
 
Figure 1.17. The Bruker Biospec 7 Tesla MRI scanner at the Glasgow Experimental MRI 
Centre (GEMRIC), University of Glasgow. 
(http://www.gla.ac.uk/departments/glasgowexperimentalmricentre) 
 
The translation of MRI to medicine is aided by the fact that water makes up more than two 
thirds of the weight of the human body. MRI harnesses the intrinsic nature of this water by 
delineating between the various water content of tissue and organs. Crucially, changes in 
water content are indicative of a number of pathologies – reflected in MR images. The 
signal-influencing characteristics of interest are the relaxation time constants; the 
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longitudinal (T1) and transverse (T2) relaxation times. The relaxation times vary for 
different tissues and structures. For example, water protons move rapidly, and this prevents 
them from relinquishing their energy with ease. This means that the relaxation time is long, 
and because the tissues of the body have varying water contents, the T1 and transverse T2 
relaxation times differ. 
 
1.3.3.1 Relevant MRI physics   
 
MRI signals are generated by nuclei with a positive charge, such as 31P and 1H. This 
indicates that the nucleus has an excess proton which is unpaired, unlike the remaining 
positively charged protons that are attached to a negatively charged electron. The 
constituent parts of water are OH- and H+. H+ is an elementary particle that has both a 
positive and negative pole (the respective distributive charges from the single orbiting 
proton and electron) and the positive charge causes the particle to possess spin, and thus 
generates a magnetic field.  
 
The spin of a particle causes the subject’s protons in an MR magnet to align in a high or 
low energy state. The high energy state refers to when the north pole of the spin is aligned 
with the south pole of the magnetic field, and the low energy state indicates when the north 
pole of the spin aligns with the north pole of the magnet. As the proton has an electrical 
charge, it has a magnetic moment, which gives it a magnetic property. This latter 
characteristic therefore makes it particularly reactive to external magnetic fields and 
electromagnetic waves. As MR scanners require the reception of a signal via a receiver 
coil, images can be generated when a voltage is applied – this occurs when the proton 
moves as a result of the application of external fields and waves. 
 
The movement of the proton can be explained in a vector model that uses a standard 
coordinate system (Figure 1.18). The force is represented as an arrow, in which the 
strength is represented by the length of the arrow. The X, Y and Z coordinates enable the 
positional changes of the proton to be depicted under the influence of the magnetic field. 
The main magnetic field is often represented as B0, and its direction is in the z plane, from 
bottom to top. 
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Figure 1.18. The dimensions of the magnetic field are shown as x, y and z. Z refers to the 
main magnetic field, whilst the xy-plane is perpendicular to the z-axis 
 
The z axis corresponds to the direction of the bore of the magnet, and this is known as the 
longitudinal direction (shown as the red arrow in Figure 1.18). As the protons spin, they 
are being forced into alignment by the magnetic field. This induces a torque that provides 
an angular momentum, enabling it to retain the spatial orientation of its rotation axis. The 
angular momentum affects the movement of the rotational axis of the spins, and the nuclei 
undergo precession that is proportional to the frequency of the applied magnetic field 
strength – this is called the Larmor frequency, shown as; 
 
ω0 = γ0 · B0 
 
where; 
ω0, is the Larmor frequency in megahertz [MHz], 
γ0, the gyromagnetic ratio, a constant specific to a particular nucleus, and,  
B0, the strength of the magnetic field in tesla [T]. 
 
Longitudinal magnetisation, MZ, accumulates in the z-direction when the spin system 
relaxes and retains its initial stable state. This occurs because the magnetic vectors 
representing the individual magnetic moments amass. The magnetic resonance signal is 
very faint, and therefore the strength of the magnet is required to be sufficiently powerful 
to obtain any signal at all. The spins can be parallel or anti-parallel to the magnetic field, 
although most are in the parallel state. The net magnetisation is actually due to this 
difference, and is named the net magnetisation vector (NMV). In the magnetic field of an 
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MRI scanner at room temperature, there is approximately the same number of proton 
nuclei aligned with the main magnetic field B0 as counter-aligned. The aligned position is 
slightly favoured, as the nucleus is at a lower energy in this position. For every one-million 
nuclei, there is about one extra nucleus aligned with the B0 field as opposed to the field. 
This results in a net or macroscopic magnetization pointing in the direction of the main 
magnetic field. 
 
An electromagnetic wave can then be introduced to this environment. This wave of energy 
is proportional to the Larmor frequency and is known as the resonance condition. This is 
applied by generating an electromagnetic wave with a radio transmitter, and via an antenna 
coil. The energy absorption can be quantified by the extent to which the longitudinal 
magnetisation is tipped from the z-direction towards the xy-plane. If the radiofrequency 
(RF) pulse is strong enough, and applied for long enough, then all of the longitudinal 
magnetisation is tipped exactly 90o (Figure 1.19), which is known as transverse 
magnetisation. 
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A      B  
 
 
C      D 
 
 
Figure 1.19. Protons spin randomly when there is no magnetic field (A), and soon align 
mainly in the low energy state in a magnetic field (B). This causes longitudinal 
magnetisation (C) until an RF pulse can be generated to induce transverse magnetisation 
(D). (Weishaupt, Kochli, and Marincek, 2006: p1-5) 
 
Relaxation 
 
Spin lattice relaxation time (T1) and spin-spin relaxation time (T2) weighted imaging are 
commonly used techniques. For image contrast, these methods are dependent upon the 
longitudinal and transverse relaxation of different tissue types, respectively. Water has a 
long relaxation time because the protons are moving too fast to easily give up their energy. 
Different tissues contain various amounts of water; therefore, they will experience different 
RF PULSE 
With no magnetic field, the spins 
rotate around their axes in random 
directions 
Slightly more spins align parallel to 
the magnetic field when it is present 
An RF pulse, when the spins are
aligned parallel to the magnet, 
causing directional spin changes 
The pulse shifts the direction of the 
spins by exactly 90o, causing 
transverse magnetisation, Mxy 
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T1 and T2 relaxation times. Transverse magnetisation is weakened by spin-lattice 
interaction and spin-spin interaction.  
 
T1 relaxation 
 
T1 is the decay constant for the recovery of the z component of the nuclear spin 
magnetization, as it retains its stable, longitudinal position. The magnetisation on the xy-
plane decreases and the MR signal fades in proportion. The restoration of the Mz 
magnetisation results and this is known as longitudinal relaxation, or T1 recovery, which 
always increases with time (Figure 1.20). 
 
The time constant for this recovery is T1 and is dependent on the strength of the external 
magnetic field, B0, and the internal motion of the molecules (Brownian motion). Biological 
tissues have T1 values of half a second to several seconds at 1.5T (Weishaupt, Kochli, and 
Marincek, 2006: pp7).   
 
 
Figure 1.20. A depiction of T1 relaxation, where the flip angle gradually decreases. The 
regrowth of Mz magnetisation is achieved as transverse magnetisation decays. Relaxation 
is shown as a function of time as Mz magnetisation is restored. (Weishaupt, Kochli, and 
Marincek, 2006: p8) 
 
T2 and T2* relaxation 
 
Phase refers to the position of a magnetic moment on its circular processional path, and is 
expressed as an angle. If there are two spins, A and B, precessing at the same speed in the 
Mxy 
Mz 
T1 
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xy-plane, and if B is ahead of A in its angular motion by 10o, then we say B has a phase of 
+10 relative to A. Conversely, a spin C that is behind A by 30o has a phase of -30o. 
 
Immediately after excitation, part of the spins precesses synchronously. These spins 
therefore have a phase of 0o, and are said to be in phase. This state is known as phase 
coherence.  
 
 
Figure 1.21. The spins dephase when they lose energy to one another, resulting in the 
loss of transverse magnetisation. T2 signal decreases with time 
 
Phase coherence is gradually lost, as some spins advance while others fall behind on their 
precessional paths. There is a reduction of magnetisation as the energy is shifted from the 
high energy state to the low energy state, causing the MR signal to fade. The rate at which 
transverse magnetisation relaxes is known as T2 relaxation, and this decreases with time 
(Figure 1.21). Transverse relaxation differs from longitudinal relaxation in that the spins do 
not dissipate energy to their surroundings but instead exchange energy with each other. T2 
denotes the process of energy transfer between spins, whilst T2* refers to the effects of 
additional field inhomogeneities contributing to dephasing. T1 and T2 occur independently, 
but also occur more or less simultaneously. 
 
Repetition Time (TR) 
 
T1 influence 
 
To generate an image, the signal at the tissue has to be measured numerous times. 
Repetition time (TR) is the amount of time that exists between successive pulse sequences 
applied to the same slice. When TR is long, more excited spins rotate back to the z-plane 
T2 
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and contribute to the return to longitudinal magnetisation. The more magnetisations that 
can be excited with the next RF pulse, the larger the MR signal that can be collected.  
 
When TR is short (less than 600 msec), image contrast is strongly affected by T1. Tissues 
with a short T1 therefore undergo relaxation rapidly, and more nuclei are ready to 
experience excitation when the next pulse is initiated. Therefore, they give off a large 
signal, and the images appear bright. Tissues with long T1 have fewer nuclei that retained 
their longitudinal magnetisation after the first pulse, and so less are available for the next 
pulse. They emit a weak signal, and appear as dark images. An image acquired with a short 
TR is T1-weighted because it contains mostly T1 information. 
 
By measuring the signal very soon after the last 90° pulse (a short TR), a discrepancy 
between the magnetisation of each tissue develops.  Conversely, by allowing a longer time 
to pass (a longer TR), the magnetisation between the tissues reduces. By having a short 
TR, the magnetisation of tissues will be most diverse, allowing differentiation of structures 
to be achieved. 
 
T2 influence 
 
Signal differences between tissue types arise from differences in T2. This is achieved by 
waiting for different amounts of signal decay to occur before taking a signal measurement. 
When the echo time (TE) is altered, the change in signal resulting from differences in the 
T2 of tissues is either enhanced or attenuated. Echo time relates to the time taken to collect 
the MR signal once the excitation pulse has been generated. Thus, a short TE would reduce 
the time required for the signal amplitudes in different tissue to change. A larger difference 
would exist if the TE was longer, as more time passes to enable signal amplitudes in the 
tissues to vary. In short, increasing the TE enhances differences in signal arising from 
differences in the T2 of tissues. 
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Tissue T1-weighted image T2-weighted image 
Fat Bright Bright 
Aqueous liquid Dark Bright 
Tumour Dark Bright 
Inflammatory tissue Dark Bright 
Muscle Dark Dark 
Connective tissue Dark Dark 
Haematoma, acute Dark Dark 
Haematoma, subacute Bright Bright 
Fibrous cartilage Dark Dark 
Hyaline cartilage Bright Bright 
Compact bone Dark Dark 
Air No signal No signal 
 
Table 1.2. MR signal intensities of various tissues under T2- and T1-weighted sequences 
 
Echo-planar imaging (EPI) 
 
EPI is a very fast MR imaging technique capable of acquiring an entire MR image in only 
a fraction of a second. In single-shot echo-planar imaging, all the spatial-encoding data of 
an image can be obtained after a single radio-frequency excitation, whereas multishot 
echo-planar imaging results in high-quality images comparable to conventional MR 
images. Additionally, echo planar imaging offers major advantages over conventional MR 
imaging, including reduced imaging time, the elimination of motion artefacts, and the 
ability to image rapid physiologic processes of the human body (Poustchi-Amin et al, 
2001). 
 
There are a numerous physiological and logistical constraints in performing diffusion-
weighted imaging (DWI) and perfusion-weighted imaging (PWI), so EPI is used. EPI can 
be thought of as an ‘add on’ to a pulse sequence, to acquire more signals from each 
excitation pulse. It requires strong and rapidly switched frequency-encoding gradients. An 
echo train consisting of up to 128 echoes can be acquired. In this way, it is possible to 
obtain an image with a resolution of 256 x 128 after a single excitation pulse in 70 msec, 
corresponding to 16 images per second. Although EPI is ultrafast, it cannot compensate for 
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field inhomogeneities, causing the signal to decay with T2*. Also, a very strong and fast 
gradient is required due to this T2* signal decay because there is limited time for echo 
collection. 
 
EPI for stroke 
 
EPI is a recent technique that can be used to visualize physiologic parameters in addition to 
measuring diffusion coefficients of the ischaemic brain. Changes in brain oxygenation can 
be monitored by using gradient echo and EPI, in which deoxygenated blood acts as a 
susceptibility contrast agent. EPI can be used in conjunction with bolus injection of 
intravenous paramagnetic agents to assess cerebral perfusion and functional changes in 
cerebral blood volume (CBV)  
(Sen, 2007 at http://www.emedicine.com/neuro/topic431.htm). 
The major advantage of using EPI for stroke imaging is its insensitivity to patient 
movement artefacts of brain bulk motion, which severely compromises the quality of DWI 
scans. Incorporating EPI, DWI and PWI into an acute stroke protocol that includes rapid 
MR angiography, T1-weighted, T2-weighted, proton density, susceptibility-weighted and 
fluid-attenuated inversion recovery (FLAIR) sequences can take only 20 to 25 mins to 
perform. An acute stroke protocol using only EPI, DWI and PWI may be completed in 5 to 
10 mins.  
 
1.3.3.2 MRI in experimental stroke       
 
In terms of prevalence, MR imaging in acute stroke is currently second to CT. A 
significant factor in CT taking precedence is the longer acquisition times needed for some 
MRI techniques. However, technical improvements in MRI software and hardware now 
mean that a plethora of MRI scans can be obtained within 15 minutes providing vital 
information, including evidence of intracerebral haemorrhage, location of thrombus, the 
perfusion status, an approximation of the duration of the ischaemic event, location and 
extent of ischaemic injury, and blood brain barrier breakdown. MRI techniques can also be 
used as surrogate markers to assess patient outcomes following therapeutic intervention.  
In the investigation of ischaemic stroke, conventional, structural magnetic resonance 
imaging techniques are valuable for the assessment of infarct size and location beyond the 
first 12 to 24 hours after stroke onset, and can be combined with MR angiography to non-
invasively assess the intracranial and extracranial vasculature. However, during the critical 
first 6 to 12 hours, the probable period of greatest therapeutic opportunity, these methods 
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do not adequately assess the severity and extent of ischaemia (Baird and Warach, 1998; 
Kidwell et al, 2003).  
 
Developments in MR imaging are showing great promise for the detection of developing 
focal cerebral ischaemic lesions within the first hours. These include: 
1. Diffusion-weighted imaging (DWI), which provides physiologic information about the 
diffusion of water, thereby detecting one of the first elements in the pathophysiologic 
cascade leading to ischaemic injury;  
2. Perfusion imaging (PWI), which depicts blood flow, and thus provides information on 
the severity and extent of ischaemia. 
 
1.3.3.3 Diffusion-weighted imaging (DWI) 
 
Diffusion is regarded as the redistribution of molecules from a region of high concentration 
to a region of low concentration. Applied to MRI, it is the technique that shows the signal 
intensity changes that are due to water motion by diffusion (Weishaupt, Kochli, Marincek, 
2006). In a magnetic field, protons carried by moving water correspond to the relative 
intensity of diffusion of water molecules in each voxel. DWI is based on the sensitivity of 
magnetic resonance to motion, which shows the signal intensity changes that are due to 
water motion by diffusion. Water has isotropic diffusion properties, meaning that the 
molecules are free to move in any direction. The rate of diffusion, termed the diffusion 
coefficient (D) is measured in millimetres squared per second (mm2/sec). This rate is 
influenced by the cellular architecture in terms of anisotropy versus isotropy (where the 
diffusion rate appears to be the same when measured along any axis). As such, to include 
these factors that affect observed diffusion, the rate of diffusion is termed the ‘apparent 
diffusion coefficient’ (ADC). A high value of D, or ADC, indicates a region of high 
motion and as such, there will be a lower signal in DWI. The corresponding ADC map will 
display this as a bright region (as it has a high self-diffusion coefficient). 
 
A commonly used technique for generating diffusion-weighted images is with Pulsed 
Gradient Spin Echo (PGSE), which was invented by Stejskal and Tanner (1965). This 
consists of a 90o-180o spin-echo pair of RF pulses with equal gradients on either side of the 
180o pulse; the first pulsed gradient induces protons to precess at different rates, which will 
dephase and cause signal loss. The second gradient will rephase the proton spins. As some 
protons have moved between pulse times, the signal is attenuated. Therefore, the pulse 
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sequence is sensitive to diffusion. The Stejskal-Tanner equation simply relates diffusion 
related measurements (S) to measurements without diffusion weighting (S0); 
 
)exp()0( bDSS −=
 
 
Where; 
b is a known property of the gradient pulse sequence (the ‘diffusion weighting factor’), 
S(0) relates to measurements without diffusion weighting, and D is the diffusion 
coefficient - the property of the tissue which you want to affect the image. DWI can be 
performed as little as twice with different DW gradients to create an 'apparent diffusion 
coefficient'. 
 
Cerebral ischaemia below a critical cerebral blood flow threshold results in disruption of 
energy metabolism with a consequent failure of ion pumps and anoxic cell membrane 
depolarisation. The activity of the ion pumps (e.g. Na+/K+ ATPase pump) is ATP 
dependent. As local cerebral blood flow drops below a critical threshold the energy supply 
to such cells becomes inadequate, resulting in pump failure since it is ATP dependent.  The 
membrane permeability is increased and water shifts from the extracellular space to the 
intracellular space resulting in cytotoxic oedema, cell swelling and restricted diffusion 
(Kesavadas et al, 2003). Under normal conditions, water protons have the ability to diffuse 
relatively freely in the extracellular space resulting in a lower signal on DWI images. 
Following ischaemia, hyperintensity on DWI signifies restriction of the ability of water 
protons to freely diffuse due to the reduced extracellular space caused by the development 
of cytotoxic oedema. It is possible to obtain a quantitative measure relating to the 
properties of diffusion occurring within a particular voxel (volume picture element). This 
value, the ADC, can then be mapped as an image, using diffusion as the contrast. These are 
known as ADC maps, and an area of acute ischaemic damage that is bright on a diffusion-
weighted image (reduced mobility of water protons) will appear dark on the corresponding 
ADC map (smaller diffusion constant). A decrease in the ADC of the ischaemic brain 
tissue has been shown to coincide with the onset of cytotoxic oedema (Davis et al, 1994).  
Regions of reduced ADC have been taken as a guide to irreversibly damaged tissue, but 
evidence shows that rapid reperfusion can salvage some tissue within the ADC-defined 
lesion (Hassegawa et al, 1994). ADC values in ischaemic areas can be lower by 50% or 
more than those of normal brain areas. Diffusion weighted imaging can identify ischaemic 
changes in under an hour following stroke, whereas CT scans and T2-weighted MRI can 
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only identify ischaemic damage between 3 and 12 hours post-stroke, respectively, which is 
useful in the acute period following stroke (Roberts et al, 2002). Sample ADC map and T2- 
and diffusion-weighted imaging post-ischaemia is shown in Figure 1.22. 
 
 
 
 
 
  
   
Figure 1.22. T2-weighted image, diffusion-weighted image (DWI), and apparent diffusion 
coefficient (ADC) map of hyperacute ischaemic stroke in a human studied 2 hours after 
the onset of a right hemiparesis and global aphasia. Ischaemic damage appears bright on 
DWI and dark on ADC maps in left MCA territory, whereas the T2-weighted image appears 
normal. (Baird and Warach, 1998) 
 
In humans, ADC values tend to remain unchanged until CBF drops below 20 
mL/100g/min. The most severely ischaemic tissue generally has the lowest ADC value, 
which the values increase outwardly as the CBF deficit reduces. Therefore, ADC can be 
used as a surrogate marker of tissue viability (Kraemer et al, 2005). There is a proportional 
relationship between ADC and the CMRO2 in the severe ischaemic core, but variability in 
ADC values in penumbra undermines its utility in predicting the fate of this tissue 
(Guadagno et al, 2006). Despite this, ADC is a useful research tool – albeit a poor 
predictor of stroke outcome – and in concert with perfusion imaging, it can provide further 
information on tissue at risk. 
 
1.3.3.4 Perfusion-weighted imaging (PWI) 
 
MR imaging can be used to quantitatively assess the extent of tissue perfusion. Blood flow 
is measured in vivo by monitoring the signal changes that are induced by a tracer entering 
the tissue of interest. Commonly-used PWI techniques include monitoring the signal 
Infarct 
T2-weighted  DWI  ADC map  
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changes following the introduction of a non-diffusible tracer such as gadolinium (known as 
dynamic susceptibility contrast (DSC)) or by using blood itself as an endogenous tracer 
(arterial spin labelling (ASL)). DSC bolus tracking is commonly used clinically, whereby 
patients are given an intravenous contrast agent. However, CBF values generated with this 
technique tend to overestimate the region of perfusion deficit when compared with PET 
techniques (Zaro-Weber et al, 2009).   
 
Arterial Spin Labelling 
 
ASL is a multislice modality that does not require the injection of a contrast agent to 
quantify cerebral blood flow. Instead, it is a noninvasive technique that uses 
electromagnetically labelled arterial water as an endogenous contrast agent.  The effects of 
arterial tagging on distal images can be quantified in terms of tissue perfusion because the 
regional changes in signal intensity are determined.  
 
A continuous ASL (CASL) sequence employs a special RF labelling scheme known as 
flow-driven adiabatic inversion. ASL acts by continuously magnetically inverting (or 
labelling) the spins at a specific location (tagging slice) – using an inversion pulse – before 
they enter the slice to be imaged. In short, spins entering the tissue with higher flow are 
labelled first, and spins entering at lower flows are labelled later (Figure 1.23). 
 
Figure 1.23. Concept of arterial spin labelling, shown on a sagittal scan of a rat brain 
 
Quantitative perfusion maps can be calculated if other parameters (such as tissue T1 and 
the efficiency of spin labelling) also are measured. In order to produce a CBF map, the T1 
signal intensity is plotted as a function of time for both the selective and non-selective slice 
images. The signal difference between the two images is due to the water that was inverted 
Caudal 
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during the total inversion from the non-selective pulse moving into the slice; which is in 
turn proportional to the amount of inflowing blood. Effects of cerebral perfusion are 
assessed by comparing images obtained with and without arterial spin labelling.  The 
subtraction image (the labelled image subtracted from the non-labelled image) is 
dependent on the tagged blood that flowed into the imaging plane. The resulting CBF map 
is calculated from the difference between the two images and a mathematical equation 
(Figure 1.24).  
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Figure 1.24. Formula for continuous labelling, where; λ is the blood/tissue partition 
function (assumed to be 0.9), T1 is the tissue longitudinal relaxation time which introduces 
the time component, S0 and S1 are the image signals with inversion pulses applied to non-
labelled and labelled, respectively, and α is the efficiency of the inversion pulses. CBF is 
measured in millilitres per 100g of tissue per minute. 
 
The difference in signal between the labelled and unlabelled images is proportional to the 
inflow of blood (CBF) to the selected brain slice (Calamante, Gadian and Connelly, 2002). 
This is a relatively new technique which has not yet been tested on many clinical scanners, 
and therefore, its predictive value in stroke patients has not yet been validated. In rodent 
models, the utility of PWI as a predictor of outcome is less ambiguous, possibly due to the 
homogeneity of rodent stroke models compared to patients. Shen and colleagues (2004) 
used the absolute CBF values of <30 mL/100g/min as critically damaged tissue expected to 
evolve to infarct. This was supported by Meng and colleagues (2004), who set the 
abnormal perfusion threshold at 30±9 mL/100g/min, and described it as a 57±11% 
reduction in CBF, relative to mean contralateral hemisphere values. 
 
1.3.3.5 Diffusion-perfusion mismatch 
 
The introduction of diffusion-weighted and perfusion-weighted MRI into the clinical stroke 
domain in the 1990s transformed the field of acute stroke neuroimaging. One of the most 
promising concepts that arose from early reports of combining diffusion and perfusion 
imaging was the notion that diffusion–perfusion mismatch could identify the operational 
ischaemic penumbra (Baird and Warach, 1998; Kidwell, Alger and Saver, 2004). In this 
model, the diffusion abnormality on the DWI represents irreversibly injured ischaemic  
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core tissue – indicative of reduced mobility of water protons with oedema, causing 
restricted diffusion (high signal on DW images), whilst the perfusion deficit  –  which 
maps rCBF and thus estimates the total region at risk of infarction  –  represents areas of 
abnormal perfusion (Figure 1.25).  
 
Figure 1.25. Coronal images of acute permanent MCAO in the rat 1 hour post-stroke. The 
thresholded PWI (57% reduction of mean contralateral CBF values) illustrates the 
perfusion deficit, whilst the thresholded DWI (16.5% reduction in mean contralateral ADC 
values) is an indication of ischaemic damage. The thresholded area on the DWI is 
subtracted from the region of hypoperfusion, the mismatch corresponding to the 
ischaemic penumbra 
 
Typically, the hypoperfused area initially exceeds the area of reduced ADC generated from 
the DWI image – and this diffusion-perfusion mismatch (DWI/PWI mismatch) is taken as 
an approximation of the ischaemic penumbra (Schlaug et al, 1997).  There is a dearth of 
research offering explanatory descriptions of DWI/PWI mismatch patterns in stroke 
patients who present at later timepoints after onset of symptoms, and also information as to 
whether the presence of mismatch in these patients also holds the potential for beneficial 
therapeutic interventions (Neumann-Haefelin et al, 1999). In experimental animal studies, 
mismatch can be used to ascertain the efficacy of neuroprotectants, and has been used in 
clinical trials to characterise therapeutic efficacy in groups of stroke patients with similar 
lesion size and location (Baird & Warach, 1998). 
 
The use of DWI/PWI to select patients for thrombolysis up to 9 h after stroke-onset has 
been shown to improve clinical outcomes (Hacke, 2005), but there is no consensus as yet 
on the ADC and CBF viability thresholds that differentiate infarct, penumbra and healthy 
tissue (Warach, 2001). If the CBF threshold used to define the perfusion deficit is set too 
low, there will be an underestimation of penumbral tissue. Equally, if the threshold is not 
Ischaemic 
injury 
DWI PWI 
Perfusion deficit:   
Tissue at risk 
Mismatch 
maps 
Penumbra 
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low enough, the penumbra will be overestimated and may include benign oligaemic tissue. 
The ADC threshold is similarly crucial, as if the ADC threshold is too low, then the 
ischaemic core is underestimated  and therefore the area of mismatch will be overestimated 
and vice versa. The existence of a DWI/PWI mismatch has been documented within 6 
hours of onset in ~70% of individuals with MCA occlusion (Barber et al, 1999).  The 
mismatch tends to resolve after 24-48 hours (Perez et al, 2006), indicative of the penumbra 
becoming incorporated into the ischaemic core or oligaemic tissue being reperfused.  
 
The results of the diffusion and perfusion imaging evaluation for understanding stroke 
evolution (DEFUSE) study (Albers et al, 2006) support the validity of the mismatch 
hypothesis in patients treated with rT-PA therapy in the 3 to 6 h time window. This study 
showed that early reperfusion is associated with a more favourable clinical response in 
patients with the DWI/PWI mismatch profile, whereas patients without mismatch did not 
appear to benefit from reperfusion. There has been variation in the criteria used to 
determine the presence of mismatch (Parsons et al, 2002; Schellinger et al, 2000; Darby et 
al, 1999). In many studies, mismatch has been defined as PWI lesion volume of >120% of 
DWI lesion, but this threshold was chosen arbitrarily (Kakuda et al, 2008).     
 
Recent MRI research using DWI/PWI mismatch to identify penumbral tissue in patients 
presenting 3-6 hours after stroke onset suggested that phase III trials beyond 3 h after 
treatment onset were warranted. It showed that reperfusion was more common with rT-PA 
than with a placebo and was associated with less infarct growth (Davis et al, 2008).  In 
thrombolysis studies, patients with penumbral tissue identified by DWI/PWI mismatch 
experienced improved clinical outcomes up to 6 h after symptom onset, compared to the 
standard non-contrast CT–guided therapy (Köhrmann et al, 2006; Schellinger et al, 2007).  
 
Schellinger and colleagues (2007) compared the safety and efficacy of MRI- and CT-based 
thrombolysis within and beyond the 3 hour time window. The criterion for CT-based 
thrombolysis was to exclude patients with evidence of intracerebral haemorrhage. CT scan 
exclusion criterion (according to European Cooperative Acute Stroke Study [ECASS]) 
were intracranial tumours except small meningioma, hemorrhage of any degree or location, 
significant mass effect with midline shift, and acute hypodense parenchymal lesion or 
effacement of cerebral sulci in more than one third of the MCA territory criteria. The latter 
criteria stemmed from a retrospective evaluation of CTs from the ECASS study (1995) 
which suggested that if ischaemic changes were present in greater than 33% of the MCA 
territory, the patients had an increased risk of ICH. Safety outcomes were predefined as 
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symptomatic intracranial haemorrhage and mortality, whilst primary efficacy outcome was 
a favourable outcome (modified Rankin Scale (mRS) 0 to 1) at the 3-6 hour time point. 
They found that the use of MRI significantly reduced symptomatic intracranial 
haemorrhage. Additionally, MRI significantly predicted a favourable outcome (Figure 
1.26). It showed that 40% of patients had a mRS of 0-1 with MRI-based rT-PA 
administration within the 3-6 hour time point, and overall it appeared to be safer and more 
clinically efficacious compared to standard CT. 
 
 
Figure 1.26. 3-month outcome according to the mRS. MRI-based rT-PA within 3h of 
stroke onset was more clinically efficacious than CT –based rT-PA and MRI-based rT-PA 
at the 3-6h time point 
0. No symptoms at all 
1. No significant disability despite symptoms; able to carry out all usual duties and 
activities 
2. Slight disability; unable to carry out all previous activities, but able to look after own 
affairs without assistance 
3. Moderate disability; requiring some help, but able to walk without assistance 
4. Moderately severe disability; unable to walk without assistance and unable to attend to 
own bodily needs without assistance 
5. Severe disability; bedridden, incontinent and requiring constant nursing care and 
attention 
6. Dead       (Schellinger et al, 2007) 
 
1.3.3.6 Challenges to the mismatch model  
 
When mismatch was used to select patients for thrombolysis, it identified patterns that may 
define treatment responsiveness (DEFUSE study, Albers, Thijs & Wechsler et al, 2006) 
and it has been used to select patients for an extended time window (Hacke, 2005).  
However, the technique has not been validated clinically and has a number of limitations.  
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No DWI or ADC threshold has been determined which can differentiate between 
irreversibly damaged and potentially recoverable tissue (Guadagno et al, 2004) and when 
DWI/ADC thresholds are applied, the lesions identified can be fully or partially reversed 
by reperfusion in animal models and man (Kidwell et al, 2000) (Figure 1.27). This 
suggests that penumbral tissue may be within the ADC lesion (Figure 1.28). 
 
 
 
Figure 1.27. Evidence of reversible DWI-defined lesion in a human stroke patient 
following thrombolysis. Note the reduction in the DWI-defined lesion post-thrombolysis  
(Kidwell et al, 2000) 
 
Interestingly, after reversal of the DWI lesion in humans following thrombolysis, 
secondary injuries may result in the return of the DWI lesion (Kidwell et al, 2000).  As a 
consequence, thrombolysis may also benefit patients with no evidence of mismatch. Also, 
defining a threshold for the perfusion deficit is equally difficult and may include benign 
oligaemic tissue which is not at risk (Butcher et al, 2005; Takasawa et al, 2008).    
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Figure 1.28. Histograms of ADC voxel values within core (A) and penumbra (B) regions 
of interest (ROIs) and their mirror ROIs. There is an overlap of low ADC values between 
core and penumbra voxel populations, but also the reduced ADC in both core and 
penumbra relative to mirror ROIs (Guadagno et al, 2004) 
 
In animal stroke models, the amount of mismatch tissue has been shown to be very 
variable, and dependent upon the thresholds applied to ADC and CBF. Mismatch evolution 
varies between animal strains (Bardutzky et al, 2005) and the techniques applied to induce 
stroke (Henninger et al, 2006). These are crucial factors, as embolic MCAO models show 
the presence of penumbra for a long period of time compared to the intraluminal filament 
model (Zhang et al, 2001; Wang et al, 2001), suggesting that therapeutic time windows 
may be subjective. 
 
Selection of patients for thrombolysis using DWI/PWI has been attempted (DEFUSE and 
the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET)) in phase II trials 
which suggested that patients with large mismatch may have improved clinical outcomes 
following thrombolysis, although the DIAS-2 study indicated otherwise (Donnan et al, 
2009; Albers et al, 2006; Hacke et al, 2009; Davis et al, 2008). DIAS-2 defined the PWI 
deficit volume as >20% of the DWI lesion volume, whereas the DEFUSE and EPITHET 
volumetric measurements of mismatch were generated at a later time point. This 
highlighted the problem of quantifying CBF and mismatch, as there is no consensus over 
the thresholds to define the terms. Thresholds often tend to be in-house measurements, and 
the introduction of standardised parameters may simplify findings between groups and 
studies. 
B. 
 
A. 
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The penumbra per se is defined not only as a region of perfusion deficit but also of some 
remaining metabolic activity. The absence of a marker of tissue metabolism for penumbral 
definition in current MRI paradigms renders comparability with standard PET findings 
difficult and leaves interpretation susceptible to the varied approaches used to define the 
perfusion deficit. As such, technological advancements are in place which introduce a 
measurement of metabolic activity to mismatch estimation, including MRI assessments of 
CMRO2 (Xu et al, 2009) and MR-PET technology (Beyer and Pichler, 2009). 
Technique Infarct Penumbra Advantage Disadvantage 
PET Reduced CBF 
Reduced CBF 
but preserved 
CMRO2 and 
raised OEF 
Combines 
information on 
perfusion and 
metabolism, 
quantitative, 
physiologically 
accurate 
Technically 
challenging, 
expensive, limited 
availability, radiation, 
arterial catheterization 
SPECT 
>70% 
reduction of 
tracer signal 
40–70% 
reduction of 
tracer signal 
Complementary to 
CT and MRI, 
inexpensive 
No information about 
metabolism, semi-
quantitative, low 
resolution, radiation 
Computed 
Tomography 
perfusion 
Reduced 
CBV 
(<2 mL/100g) 
Reduced CBV & 
CBF, increased 
MTT 
Fast, inexpensive, 
widely available, 
practical 
Variable software, 
radiation, contrast 
agent, limited spatial 
coverage 
DWI/PWI 
mismatch 
DWI lesion 
volume 
PWI- volume 
minus DWI-
lesion volume 
No radiation, 
excellent resolution, 
early ischaemic 
changes, practical 
No agreed mismatch 
definition, contrast 
agent, no information 
on metabolism 
Clinical 
DWI/PWI 
mismatch 
DWI lesion 
volume 
NIHSS  8 
DWI  lesion 
 25 mL 
No radiation, no 
perfusion scan, 
clinical information 
included  
MR contraindications  
Clinical-CT 
mismatch 
CT lesion 
volume 
ASPECTS > 
expected based 
on NIHSS 
No perfusion scan, 
clinical information 
included, CT 
availability  
Radiation, low 
sensitivity for early 
ischaemic changes 
 
Table 1.3. Imaging modalities, the criteria used to identify ischaemic penumbra, and the 
advantages and disadvantages of each method 
ASPECTS = Alberta Stroke Program Early CT Score, CBF = cerebral blood flow, 
CBV = cerebral blood volume, CMRO2 = cerebral metabolism of oxygen, DWI = diffusion-
weighted imaging, MR = magnetic resonance, MTT = mean transit time, NIHSS = National 
Institute of Health Stroke Scale, OEF = cerebral oxygen extraction fraction, 
PET = positron emission tomography, SPECT = single photon emission computed 
tomography. Adapted from Ebinger et al (2009) 
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1.3.3.7 Functional MRI (fMRI) 
 
The fact that haemodynamics are intricately linked to neural activity has been known for 
over a century (Roy and Sherrington, 1890). This phenomenon has led to the development 
of functional MRI (fMRI) in which the activation of neural cells triggers an increase in 
local blood flow and oxygenation and can produce a small signal increase due to the 
magnetic properties of deoxyhaemoglobin – a by-product of oxidative metabolism.  
 
fMRI measures the haemodynamic response related to neural activity in the brain. The 
activity of neural cells in response to an external stimulus (e.g., visual or sensorimotor) 
results in an increased oxygen consumption. The brain region activated by an external 
stimulus locally consumes more oxygen which induces an increase in capillary blood flow 
and blood volume by local vasodilatation in order to meet this increased oxygen demand. 
This oxygen utilised by the neural cells is carried in the bloodstream by haemoglobin. 
Also, it is assumed that excess oxygen is supplied to the activated area because the 
increased blood flow exceeds the metabolic needs after some time. In response to 
functional activation, there is an increase in local CBF within 1-5 seconds. The increase in 
blood flow peaks after ~4-5 seconds before returning to basal levels. As a result, the 
concentrations of oxyhaemoglobin and deoxyhaemoglobin change from the normal range.  
 
Oxyhaemoglobin and deoxyhaemoglobin in the blood have differing magnetic properties 
which can be utilised as an endogenous contrast to identify the changes in local blood 
oxygenation following neural activation. Specifically, as CBF increases with neural 
activation, the paramagnetic deoxyhaemoglobin levels are reduced which then causes an 
increased signal intensity in T2*-weighted MRI images (Niemi et al, 1996).  
 
1.3.3.8 The Blood Oxygen-Level Dependent (BOLD) effect 
 
The T2* relaxation rate of blood depends on whether or not the haemoglobin is bound with 
oxygen. Haemoglobin not combined with oxygen (deoxyhaemoglobin) is paramagnetic 
because of unpaired electrons which shorten the T2* of surrounding water. In contrast, 
oxyhaemoglobin is slightly diamagnetic because all electrons are paired and thus it has a 
negligible effect on the relaxation times of surrounding water. The higher proportion of 
haemoglobin molecules bound with oxygen (oxyhaemoglobin) prolongs the T2* time of the 
surrounding water, which is indicative of a signal increase on T2* weighted images. By 
exposing rodents to varying concentrations of inspired oxygen, Ogawa and colleagues 
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(1993) were the first to demonstrate this blood oxygen level dependent (BOLD) MRI 
response. They showed that during cerebral hypoxia, the deoxyhaemoglobin levels were 
high, which caused a darkening of contrast in the veins which was much more pronounced 
when compared to hyperoxic changes. As a result, BOLD imaging may permit 
identification of tissue compartments within the ischaemic brain following stroke, such as 
penumbra and ischaemic core.  
T2 and T2* signal changes have been reported in animal stroke models (Kavec et al, 2001; 
Roussel et al, 1995) in response to reductions in CBF. The T2 reductions have been thought 
to be due to the increased levels of deoxyhaemoglobin and increased oxygen extraction 
fraction in the penumbra (Geisler et al, 2006). These changes were evident in the ADC 
lesion, in the periphery of the lesion, and in the surviving tissue, although the discrepancies 
in signal change in these regions of interest were not significant enough to provide 
adequate demarcation between ischaemic core and penumbral tissue.  
Additional information on metabolic state may improve penumbral definition. BOLD MRI 
offers information on oxygen consumption and delivery (Baird & Warach, 1999; Kavec et 
al, 2001), but static T2*-weighted MRI under normoxic conditions has not adequately 
delineated penumbra in ischaemic stroke patients (Tamura et al, 2002; Grohn & 
Kauppinen, 2001), possibly because deoxyhaemoglobin is not rapidly cleared in ischaemic 
conditions (Giesler et al, 2006). A new method using sequential T2*-weighted images with 
transient hyperoxia may dynamically alter the oxyhemoglobin: deoxyhaemoglobin balance 
with the aim of distinguishing tissue compartments which have different metabolic activity 
and therefore different relative concentrations of deoxyhaemoglobin. By providing the 
additional measure of the rate of contribution of deoxyhemoglobin to the measured pool, 
this may remove the potential confound observed by Geisler and colleagues. 
 
Higher BOLD signal intensities arise from increases in the concentration of oxygenated 
haemoglobin since the blood magnetic susceptibility now more closely matches the tissue 
magnetic susceptibility. The BOLD contrast changes can be either positive or negative 
depending upon the relative changes in both CBF and CMRO2. Increases in CBF that 
outstrip changes in oxygen consumption will lead to increased BOLD signal, conversely 
decreases in CBF that outstrip changes in oxygen consumption will cause decreased BOLD 
signal intensity. 
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1.3.3.9 The T2*- weighted Oxygen Challenge 
 
A new MRI technique in which oxygen is employed as a metabolic biotracer to detect 
tissue metabolism may enable a more precise definition of the penumbra.  The technique 
uses the BOLD premise that is based on the different magnetic properties of 
deoxyhaemoglobin and oxyhaemoglobin in blood. Oxygen is carried in the blood in two 
forms: when breathing air (~21% oxygen) most O2 combines with haemoglobin to generate 
oxyhaemoglobin but a very small amount dissolves in the plasma (paramagnetic free 
oxygen). By breathing normobaric hyperoxia (100% oxygen, oxygen challenge, OC), 
additional oxygen will dissolve in the plasma at a rate of 0.003 ml O2/100ml of blood 
/mmHg pO2) (Law and Bukwirwa, 1999).  
 
By detecting changes in deoxy: oxyhaemoglobin ratio during OC, T2* signal change may 
provide an index of tissue oxidative metabolism and hence viability in ischaemic brain. In 
metabolising tissue, oxyhaemoglobin gives up its oxygen to the tissue to become 
deoxyhaemoglobin. The more paramagnetic deoxyhaemoglobin present in blood, the lower 
the T2* signal from the tissue. Following stroke, penumbral oxidative metabolism 
(CMRO2) is maintained in the face of reduced cerebral perfusion pressure by increasing 
oxygen extraction fraction (OEF). During OC, additional O2 converts deoxy- to 
oxyhaemoglobin, thereby increasing T2* signal. An increase in OEF in penumbra results in 
increased conversion of deoxy- to oxyhaemoglobin in penumbra, thus resulting in an 
amplified T2* signal change. This increase in signal should reflect the amount of oxygen 
being taken up by the tissue from the blood. At the end of the OC, free unbound O2 is no 
longer present to maintain oxyhaemoglobin levels and so deoxyhaemoglobin levels will 
increase as blood flows through the tissue, and the T2* signal will return to the pre-OC 
baseline.  Therefore, the increase in T2* signal, its maintenance during the OC and its 
return back to baseline when the OC is complete, should indicate metabolism within the 
tissue.  
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Figure 1.29.  The Oxygen Challenge Paradigm 
1. O2 taken up by normal tissue for oxidative metabolism results in oxyhaemoglobin 
converting  to deoxyhaemoglobin and thus lowering the T2* value for the tissue.  With 
normobaric hyperoxia (oxygen challenge, OC), extra oxygen dissolved in plasma reduces 
deoxyhaemoglobin levels, increasing the T2* value for the tissue. 
2. With permanent MCAO, where flow is not restored to the ischaemic core, haemoglobin 
has given up its oxygen to the tissue. Switching ventilation to 100% oxygen will have 
minimal effects on T2* as this tissue is not perfused. 
3. In tissue with an increased oxygen extraction fraction, such as the penumbra, blood 
flow is restricted but the tissue is still metabolically active, resulting in higher levels of  
 
A. Normal Brain:                          
Normal flow, metabolising tissue 
B. Ischaemic Core:                            
No flow, no oxidative metabolism 
C. Ischaemic Penumbra:                       
Restricted flow, metabolising tissue 
CBF 
CBF 
CBF 
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deoxyhaemoglobin within the blood and a lower T2* signal from the tissue. Switching 
ventilation to 100% oxygen will convert this deoxyhaemoglobin back to oxyhaemoglobin, 
resulting in a greater increase in T2* than in normal metabolising tissue. (Santosh et al, 
2008) 
 
 
 
Figure 1.30 T2* percentage signal change map 1 hour following permanent MCAO. 
Penumbral tissue displays the greatest T2* percentage signal change, which is reflective of 
an increased oxygen extraction fraction. The ischaemically damaged tissue displays a 
negligible signal change, whereas the contralateral hemisphere exhibits normal 
metabolism. High signal change is evident in the large veins of the contralateral 
hemisphere and the venous sinuses seen in the midline, where more deoxyhaemoglobin 
is available for conversion 
 
T2* maps can be generated that locate and quantify the percentage change in T2* signal to 
oxygen challenge throughout the territory of the occluded artery. In addition, the 
maintenance of this increased signal during the oxygen challenge and its return back to 
baseline following OC is consistent with T2* signal change indicating oxygen consumption. 
Therefore, detecting deoxyhaemoglobin in vivo would indicate oxygen utilisation and 
therefore metabolism. This technique may therefore yield information on oxygen 
metabolism that more closely correlates with PET definitions of the penumbra 
 
If confirmed, this new non-invasive MRI technique should be able to discriminate between 
metabolically active and inactive tissues in the ischaemic brain, and enable serial imaging 
of penumbra, thereby providing an improved means of defining the ischaemic penumbra. 
 
T2
*
 percentage signal 
change map 
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1.4 Aims of the thesis 
 
1. Validation of the oxygen challenge T2* technique by confirming tissue identified as 
penumbra is viable using [14C] 2-deoxyglucose autoradiography to provide 
information on glucose metabolism in a rat model of permanent focal ischaemia 
 
2. Technique validation by confirming tissue identified as penumbra recovers with 
prompt restoration of blood flow  
 
3. Characterising the technique by serial scanning and comparison with alternative 
MRI techniques for penumbral identification (diffusion-perfusion mismatch)  
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2  
 
Materials and Methods 
 
2.1 Rodents           
 
All experiments were performed using male Sprague-Dawley rats (Harlan, Bicester UK), 
under license from the UK Home Office (Project License number: 60/3759) and were 
subject to the Animals (Scientific Procedures) Act, 1986. Water and food were available 
ad libitum to all rats, housed in a temperature (21 ± 2°C), humidity (55 ± 15%), and light 
(12/12 hour light/dark cycle) controlled environment.  
 
2.2  Surgery          
Aseptic conditions were maintained throughout all surgical procedures.  In the procedures 
that required recovery, animals were administered two 1 mL subcutaneous injections of 
sterile saline post-surgery to prevent dehydration and were given wet baby food to 
encourage eating.  
 
2.2.1 General anaesthesia        
Animals were initially anaesthetised with 5% inhaled isofluorane delivered in oxygen–
nitrous oxide (30:70) in an induction chamber at room temperature. In the experiments that 
required recovery, animals were intubated with a 16 gauge (1.3mm inner, 1.8mm outer 
diameter, and 45 mm in length) sterile plastic Anicath i.v. cannula (Millpledge Veterinary, 
Nottingham, UK) and artificially ventilated. Upon intubation, gases were changed to air to 
limit the effect of oxygen on the baseline physiology during T2* scans. Animals were given 
a subcutaneous 0.4 mL dose of atropine sulphate (Martindale Pharmaceuticals, UK) post-
intubation to prevent a build up of mucous secretions in the trachea. During surgery, 
isoflurane was maintained at ~2% anaesthetic dose, and animals were artificially ventilated 
with a 7025 rodent ventilator (Ugo Basile, Italy) with a respiratory rate of 60 breaths per 
min and a tidal volume of 3-4 mL.  
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For experiments that did not require recovery, animals underwent a surgical tracheotomy. 
Following initial anaesthetic in the induction chamber, anaesthesia was maintained with a 
face mask whilst a ventral incision was performed in the neck to expose the muscle 
surrounding the trachea. Blunt dissection of the muscle was performed to expose the 
trachea. Loose ties were placed around the trachea, an incision made, and a tracheal tube 
(13 gauge (2.5 mm) x 150 mm, Solomon Scientific, USA) was quickly inserted into the 
trachea and tied in place and connected to the ventilator. Artificial ventilation was 
maintained at a rate of 50 breaths per min with a respiratory volume of 3-4 mL. 
 
2.2.2 Cannulation of blood vessels 
Femoral artery cannulation was performed to monitor blood gases and mean arterial blood 
pressure (MABP). The femoral artery was exposed by blunt dissection and isolated with 
4.0 silk threads (United States Surgical, USA). The artery was cannulated with 1% 
heparinised (1000 units/mL, Wockhardt UK Ltd, UK) saline-filled polythene catheters 
(Portex: external diameter 0.96 mm; internal diameter 0.58 mm; 70 cm long). Femoral vein 
cannulation was performed for the study that required radioisotope administration (Chapter 
4). 
 
2.2.3 Intraluminal filament model of middle cerebral artery occlusion  
MCA occlusion  
 
Permanent middle cerebral artery occlusion (pMCAO) was induced using the intraluminal 
filament method (Figure 2.1), first described by Koizumi and colleagues in 1986. A ventral 
midline incision was made in the neck, to the left of the trachea. Blunt dissection exposed 
the underlying muscle that covers the carotid artery. The common carotid artery was 
exposed by retraction of the triumvirate of the multidirectional pretrachial strap 
musculature, the sternomastoid muscle and the mandibular gland. Just below the internal 
and external bifurcation, the common carotid was ligated using a 4-0 nylon suture. The 
external carotid artery (ECA) was then tied above the occipital branch, and the ascending 
pharyngeal and superior thyroid arteries were isolated and permanently occluded using 
diathermy forceps. Following this, the ECA was occluded by diathermy distal to the tie, 
and cut to enable introduction of the intraluminal filament for stroke inducement. The 
internal carotid artery (ICA) was also loosely tied above the occipital artery, which was 
also diathermied, and the pterygopalatine artery was isolated and tied around its bifurcation 
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from the internal carotid, preventing the filament from entering the extracranial branch 
instead of reaching the origin of the MCA. A small incision was made into the remaining 
ECA stump, and a 3-0 nylon monofilament with a bulb (0.28-0.3 mm in diameter for 300-
350 g rats) fashioned using a cauterising pen, was gently advanced through the incision in 
the ECA, through the ICA to the origin of the MCA for a distance of ~22 mm. When slight 
resistance was felt, this indicated that the origin of the MCA was reached, occluding the 
blood flow and inducing a stroke within the MCA territory.  
 
To induce transient MCAO, the filament was left in position for a specific time period, and 
then reperfusion was performed by filament withdrawal, electrocoagulation of the incision 
site on the ECA stump, and loosening of the tie around the common carotid artery and 
pterygopalatine branch to restore blood flow to MCA territory. Restoration of cerebral 
blood flow on filament withdrawal was confirmed on MRI cerebral blood flow maps. 
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          Maxillary artery 
 
 
 
Legend:  = Ligature 
                  = Diathermy occlusion  
                  = Cut  
                  = Intraluminal filament 
 
Figure 2.1.  Diagram showing the intraluminal filament method for MCAO. The following 
arteries were ligated in this order with 4-0 surgical sutures (illustrated in figure by a black 
circle): the common carotid artery (at the internal and external bifurcation), the internal 
carotid artery and the pterygopalatine artery (at its bifurcation from the internal carotid) 
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2.2.4 Testing reperfusion  
 
Laser Doppler Flowmetry (LDF) generally allows the surface monitoring of blood flow 
although flow probes can also be implanted into the brain. The principle of laser Doppler 
involves directing a monochromatic light source in the form of a laser beam at the region 
under investigation. The light is reflected from both moving red blood cells (RBC) and 
from static sources. Photons are scattered and undergo a frequency shift (known as the 
Doppler shift) according to the Doppler principle. Reflected light is then collected and 
directed to a photodetector. The electrical output of the photodetector is processed to yield 
a continuous recording proportional to the blood flow. However, the actual unit is one of 
velocity or flux and the results are usually quoted as a percentage change from baseline 
values (Dirnagl et al, 1989). 
 
To test the reperfusion technique, a laser Doppler experiment was performed on one 
animal, where LDF probes were placed on the fronto-parietal ipsilateral and contralateral 
cortices following stroke.  Probe calibration was performed using a flux agent with a pre-
determined microsphere size of 0.33 mm (Moor Instruments). The prone animal was 
immobilised in a stereotaxic frame. A midline head incision through the skin and fascia 
exposed the skull. Burr holes were drilled into the skull 5 mm lateral and 1 mm posterior to 
bregma. Care was taken to preserve a thin layer of bone to avoid injury to the cortex. Two 
DP5b stainless steel 0.8 mm diameter probes bent at a 90° angle (Moor Instruments) were 
attached to the arms of the stereotaxic frame, enabling accurate manipulation of the probes 
in the x,y and z planes. The face probes were placed perpendicular to the exposed parietal 
cortex (Figure 2.2). 
 
The animal was subjected to MCAO for 60 mins, followed by 3 hours of reperfusion. The 
filament was gently advanced until LDF indicated adequate MCA occlusion by a sharp 
decrease in ipsilateral flow (Figure 2.3).  
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Figure 2.2. Experimental setup for cerebral blood flow measurements using laser Doppler 
Flowmetry (Image from Hungerhuber (2006) 
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Figure 2.3. LDF measurements in the fronto-parietal ipsilateral and contralateral cortices 
A. Before filament insertion, B. Following filament insertion, and C. Following reperfusion. 
The blue dashed lines represent the point when filament was inserted and withdrawn, 
respectively 
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2.2.5 Physiological monitoring       
Following stroke, the animal was immediately transferred to the imaging cradle, and 
instrumented for monitoring of physiological variables such as MABP, heart rate, body 
temperature and blood gases.  Ventilation parameters were adjusted and imaging delayed 
until the animal was physiologically stable and blood gases were within a defined range 
[Mean arterial BP 80-100 mmHg, PaCO2 35-45 mmHg and PaO2 80-100 mmHg, body 
temperature 37oC].  Mean arterial blood pressure was monitored with MP150 Biopac and 
AcqKnowledge software (Linton). A rectal thermocouple (Physitemp Thermalert TH-5) 
provided continual monitoring of core body temperature which was controlled (37oC) with 
a heated lamp during surgery and with a heated water jacket during imaging. 
 
2.3 Brain tissue processing  
        
2.3.1 Perfusion fixation  
        
For assessment of ischaemic brain damage on Haematoxylin and Eosin (H&E) stained 
sections, the animals were killed by perfusion fixation with 4% paraformaldehyde in 
phosphate buffered saline (PAM).  Rats were deeply anaethetised (5% isoflurane) and 
placed in the supine position.  The chest was opened with scissors in order to expose the 
heart and a 16 gauge needle was inserted directly into the apex of the left ventricle and 
advanced into the ascending aorta for perfusion fixation. The needle position was secured 
with a clamp and heparinised saline was delivered at a pressure of ~100-150 mmHg. The 
right atrium was then cut with sharp scissors. When blood was cleared from body with 
heparinised saline (~200 ml), 4% paraformaldehyde solution (~200 ml) was perfused at the 
same pressure. Spontaneous movement on switching from saline to fixative and a lightened 
colour of the liver provided good indicators of effective perfusion fixation. 
 
2.3.2 Tissue processing         
Following perfusion fixation, animals were decapitated and the heads immersed in PAM 
for 24 hours. The brains were then removed from the skull, and post-fixed in PAM for a 
further 24 hours before being placed in a processor (Tissue-Tek VIP, Miles Scientific), 
which took them through cycles of alcohols to dehydrate the tissue and to allow clearance 
with xylene over a 59 hour period (Table 2.1). Brains were then submerged in liquid 
paraffin wax at 60oC.  
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Station Solution Temperature Time 
1 70% Alcohol 35oC 2 hours 
2 80% Alcohol 35oC 3 hours 
3 96% Alcohol 35oC 4 hours 
4 Absolute Alcohol 35oC 4 hours 
5 Absolute Alcohol 35oC 5 hours 
6 Absolute Alcohol 35oC 5 hours 
7 Absolute Alcohol 35oC 6 hours 
8 Xylene/ Abs Al 35oC 4 hours 
9 Xylene 1 35oC 5 hours 
10 Xylene 2 35oC 5 hours 
11 Paraffin wax 1 60oC 5 hours 
12 Paraffin wax 2 60oC 5 hours 
13 Paraffin wax 3 60oC 6 hours 
 
Table 2.1. The tissue processing procedure 
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2.3.3 Tissue embedding and sectioning  
      
The brains were then embedded in small containers containing liquid paraffin wax, left to 
cool, then removed and mounted onto wooden blocks. Coronal sections (6 µm) were cut 
using a microtome (Leica RM 2135), and mounted onto poly-L-lysine glass slides. 
 
2.3.4 Haematoxylin and Eosin staining  
      
Following removal of wax in 100% Histoclear for ~15 min (National Diagnostics) and 
rehydration through a series of graded alcohols (100%, 90% and 70%) and water, sections 
were placed in 100% haematoxylin (Surgipath, Peterborough) for 5 minutes and then 
washed in running water (Table 2.2). The sections were differentiated in acid alcohol and 
washed again. The sections were placed in Scots Tap Water Substitute for 2 minutes, 
washed again in running water and placed in eosin (Surgipath, Peterborough) for 3 
minutes. The tissue was then dehydrated in absolute alcohol, cleared in Histoclear for 12 
minutes and mounted using DPX mounting medium (Raymond A Lamb Laboratory 
Supplies, East Sussex).  
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Solution Time 
Histoclear 1 4-5 mins 
Histoclear 2 4-5 mins 
Histoclear 3 4-5 mins 
Absolute Alcohol 1 3 mins 
Absolute Alcohol 2 3 mins 
90% Alcohol 3 mins 
70% Alcohol 3 mins 
Wash in running water 4 mins 
Haematoxylin 4 mins 
Wash in running water 1-2 mins 
Differentiate in acid alcohol A few dips 
Wash well in running water 3 mins 
Scott's Tap Water Substitute 2 mins 
Wash in running water 2 mins 
Dehydrate in 70% Alcohol 2 mins 
Dehydrate in 90% Alcohol 2 mins 
Stain in Alcoholic Eosin (95%) 4 mins 
Dehydrate in Absolute Alcohol 1 4 mins 
Dehydrate in Absolute Alcohol 2 4 mins 
Dehydrate in Absolute Alcohol 3 4 mins 
Clear in Histoclear 1 4 mins 
Clear in Histoclear 2 4 mins 
Clear in Histoclear 3 4 mins 
 
Table 2.2. Chronological list of agents used for the staining procedure 
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2.3.5 Determination of ischaemic damage and quantification of infarct size 
 
The haematoxylin and eosin stained sections were viewed under a light microscope at a 
range of magnifications (x5, x10, x20 and x40) to accurately determine the boundary of the 
infarct.  Morphological characteristics of ischaemic neurons compared to non-ischaemic 
neurons, and pallor/vacuolisation of the neuropil were identified on stained sections to 
delineate areas of infarction. Ischaemic neurons were identified as pyknotic (shrunken and 
triangular in shape) with cellular incrustations most evident at x20 magnification. Pyknotic 
neurons also showed an eosinphilic cytoplasm and the surrounding neuropil was disrupted 
and displayed pallor. Identification of the boundaries between ischaemic core, border zone 
and normal tissue was achieved by studying the neuronal morphology combined with 
changes in the neuropil in the form of pallor of staining and microvacuolation. Regions of 
interest (ROIs) representing the ischaemic core (where the majority of cells and neuropil 
showed the irreversible features of ischaemic cell change, Figure 2.4B), border zone 
(mixed population of cells with abnormal and normal morphology, Figure 2.4C) and 
adjacent normal zone (normal cell morphology and neuropil, Figure 2.4A) are shown in 
Figure 2.4.  
 
Areas of infarct were transcribed onto line diagrams of 8 pre-determined coronal levels 
(Figure 2.5) throughout the MCA territory, and quantified using image analysis (MCID, 
Imaging Research Inc., Canada) based on the original method by Osborne and co-workers 
(1987).  
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Figure 2.4. Differentiation between the normal zone (A), ischaemic core (B) and border 
(C) zone. Histological photomicrographs of ROI in dorso-lateral cortex ipsilateral to 
permanent MCAO from a representative animal.  Pictures from haematoxylin & eosin 
stained sections have been captured at x 40 magnification: 
a) Normal Cortex. Neurons display normal morphology; 
b) Ischaemic Core. Note darkly stained triangular neurons that have the features of the 
ischaemic cell process within microvacuolated, pale stained neuropil; 
c) Border Zone. Scattered throughout the ischaemic cortex are normal neurons (circled) 
which display a normal morphology 
 
 
 
 
 
A. Normal zone  
     (x40) 
 
 
 
 
 
 
 
 
 
 
 
B. Ischaemic core  
     (x40) 
 
 
 
 
 
 
 
 
 
 
C. Border zone  
    (x40) 
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Level 1. Bregma = 3.24 mm            Level 2. Bregma = 1.68 mm 
   
Level 3. Bregma = -0.12 mm            Level 4. Bregma = -1.32 mm   
   
Level 5. Bregma = -2.40 mm                      Level 6. Bregma = -3.60 mm            
   
Level 7. Bregma = -5.20 mm                    Level 8. Bregma = -6.36 mm 
Figure 2.5.  Line diagram comprising 8 pre-determined coronal levels with the distance 
from bregma of each level adjacent to it. Brain sections were collected at these levels and 
areas of infarct (in pink) were transcribed onto the diagram (Paxinos and Watson, 2007) 
 
76 
 
The areas of ischaemic damage were measured directly from the line diagrams for each 
coronal level. The volume of damage for each brain was calculated from the integration of 
these areas using the known distance between the stereotaxic coordinates of the coronal 
levels. The integration end points of 3.24 mm anterior and -6.36 mm posterior to bregma 
were used. Provided the origin of the MCA is occluded by the filament and the 
cardiovascular and respiratory status of the animal are controlled rigorously, then a 
reproducible lesion results. This type of occlusion would be classed as a proximal MCAO 
and since the lenticulostriate branches of the MCA lie distal to the occlusion site, and the 
model produces both subcortical and cortical ischaemic damage. Distal occlusions, which 
are uniquely produced with the electrocoagulation model of ischaemia, also produce 
reproducible lesions which are limited to the cortical regions, whilst a proximal occlusion 
blocks the lenticulostriate arteries and induce a subcortical lesion. Relatively minor 
differences in operative technique affect significantly the extent of ischaemic damage and 
the stroke outcome in the rat model. It is dependent upon good microsurgical technique, 
well-controlled anaesthesia and close physiological monitoring and control within 
physiological limits (Osborne et al, 1987). 
 
2.3.6 2, 3, 5 Triphenyltetra-zolium chloride (TTC) staining    
2,3,5-triphenyltetrazolium chloride (TTC) is a colourless, water-soluble salt which is 
oxidised to a lipid soluble bright red formazan by mitochondrial enzyme systems.  In 
undamaged tissue, dehydrogenase reduces TTC to formazan which stains a deep red. The 
intensity of the stain reflects the functional activity of the mitochondria. In infarcted tissue, 
where the mitochondrial systems have been incapacitated, dehydrogenase activity is 
reduced or eliminated and so such areas remain unstained (Figure 2.6). TTC is effective in 
assessing infarct volume at 24 hours after stroke.  It is not an accurate assessment of 
infarction at 4 hours post-stroke but was used when training in stroke surgery to give a 
quick assessment of the extent of ischaemic damage. The stroke was allowed to progress 
for 4 hours, allowing evolution of ischaemic damage. The animal was then anaesthetised 
with 5% isoflurane and decapitated for brain removal. The brain was placed in a rat brain 
matrix (World Precision Instruments, Hertfordshire, UK) and chilled with ice. Continuous 
bathing with ice-cold saline prevented the brain from sticking to the matrix. Razor blades 
were placed 2 mm apart to section the brain into coronal slices. The slices were then 
incubated in 2% TTC at 37oC for 15 minutes. TTC staining after 4 hours of focal 
ischaemia displays deep red staining of normal brain tissue and white non-staining of 
ischaemically-injured tissue with a distinct border. 
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Figure 2.6.  TTC stained coronal slice of tissue from an animal 4 hours after permanent 
MCAO. The white area represents ischaemic damage 
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TTC has been validated for use 24 hours after injury (Bedersen et al, 1986), but it cannot 
accurately delineate areas of infarcted tissue as early as 4 hours after permanent MCAO. 
However, after 36 hours of ischaemia, infiltration of macrophages and microglia, 
neovasculisation and astrocytic reactions occur (Hudgins and Garcia, 1970) which can 
obscure the margin of ischaemic damage. Also, although the extent of ischaemic damage 
can be assessed using this technique, there is no differentiation of grey and white matter 
structures, or the ability to study the consequences of ischaemia on individual cells.  
 
Digital photographs of both sides of the slices were taken with a Canon Camcoder Mv750i. 
The photographs were analysed using ImageJ v1.39 (http://rsb.info.nih.gov/ij/). The entire 
contralateral hemisphere, and the stained area of the ipsilateral hemisphere, were manually 
traced and measured on two separate occasions and the mean calculated. 
 
2.4 [14C] 2-Deoxyglucose autoradiography  
    
Quantification of local glucose utilisation in the brain can be achieved with the [14C] 2-
deoxyglucose autoradiography technique ([14C] 2DG). 2DG is an analogue of glucose and 
it is unique in that it is metabolised through part of the pathway of glucose metabolism at a 
rate relative to glucose. Unlike glucose, however, its product, 2-deoxyglucose-phosphate, 
is trapped in the tissues as it is not a substrate for phosphoglucose isomerise. Therefore, 
this can provide a quantitative indication of glucose utilisation locally. The rate of glucose 
utilisation is proportional to the concentration of radioactivity ([14C]) in the tissues and this 
can be visualised in cerebral structures with autoradiographical methods.  
 
2.4.1 Theory          
 
[14C] 2DG autoradiography assumes that energy requirements of cerebral tissue are 
exclusively obtained by the aerobic catabolism of glucose (Sokoloff, 1977), and also that, 
within the CNS, functional activity is associated with local energy consumption. The 
technique is essentially measuring the rate of glucose phosphorylation within a region of 
cerebral tissue. As this is equivalent to the oxidative catabolism of glucose, it therefore 
corresponds to the generation of energy and its consumption.  
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Figure 2.7. The structural differences between glucose and 2-deoxyglucose. 
2-deoxyglucose and glucose are almost identical. The only difference is on the second 
carbon atom in which a hydroxyl group is replaced by a hydrogen atom 
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2DG and glucose can be transferred between the blood and the brain in both directions. 
Within the CNS, they become substrates for metabolism and are phosphorylated by 
hexose-6-phosphates. 2DG is phosphorylated by hexokinase to 2-deoxyglucose-6-
phosphate (2-DG-6-P). Glucose-6-phosphate is metabolised further and thus does not 
accumulate in cerebral tissue, with the final products being CO2 and water (Sokoloff, 
1981).  
 
2-DG-6-P differs from glucose-6-phosphate in that it is not a substrate for the next enzyme 
in the glycolytic cycle (isomerise), allowing the 2-DG-6-P to be trapped in the brain long 
enough to be measured (Figure 2.8). 2-DG-6-P can undergo glucose-6-phosphatase 
metabolism, although the low levels of glucose-6-phosphatase prevents it from interfering 
with the present experiment. Regions with more metabolic activity that require more 
glucose will accumulate more 2-DG-6-P (Sokoloff, 1981). 14C is isotopically labelled with 
2DG, enabling the radioactive substrate to be identified and quantified by autoradiographic 
measures.  
 
An operational equation was derived by Sokoloff and colleagues (1977) which enabled 
quantification of the rate of glucose utilisation (Figure 2.9). For the duration of the 
experiment, it exploits the rate of glucose utilisation in relation to the arterial plasma 
concentration of glucose (Cp) and [14C]-2-DG (Cp*), and the total concentration of 14C 
tracer within cerebral tissue at the end of the experiment (Ci*). 
 
The operational equation depends on the following assumptions: 
1. A steady state for glucose – the arterial plasma concentration and the rate of 
glucose consumption remain constant throughout the experimental period; 
2. Tissue is homogenous within which the concentrations of [14C] 2-deoxyglucose and 
glucose are uniform and exchange directly with the plasma, and; 
3. [14C] deoxyglucose-6-phosphate and [14C] 2-deoxyglucose are present in a tracer 
amount 
(Sokoloff, 1977) 
 
 
 
 
 
 
81 
 
 
 
 
Total Tissue 14C Concentration (CI*) = CE* + CM* 
 
Figure 2.8. Diagrammatic representation of the theoretical model that forms the basis for 
the 2-deoxyglucose method 
CI represents the total 14C concentration in a single homogenous tissue of the brain 
CP and CP* represent the concentration of glucose and [14C]-2-deoxyglucose in the arterial 
plasma 
CE and CE*represent the concentrations of glucose and [14C]-2-deoxyglucose in tissue 
pools serving as substrates for hexokinase 
CM* represents the tissue concentration of [14C]-2-deoxyglucose 
K1* is the rate constant for carrier-mediated transport of [14C]-2-DG from plasma to tissue 
K2* is the constant for carrier-mediated transport back from the tissue to plasma 
K3* is the constant for phosphorylation by hexokinase 
K1, K2, and K3 are the equivalent constants for glucose 
      Adapted from Sokoloff et al (1977) 
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Three rate constants, K1*, K2* and K3* and the lumped constant (K) were predetermined by 
Sokoloff and colleagues (1977), and, as such, they are not measured in every experiment. 
The rate constants define the distribution of tracer between plasma and brain tissue 
compartments, and the lumped constant (k) corrects for the relative preference of the 
glucose transporters and enzyme systems for glucose as opposed to 2-deoxyglucose 
(Figure 2.8). 
 
The rate of glucose consumption (Ri, Figure 2.9) is calculated in terms of the total [14C] in 
the tissue at the end of the experimental period (Ci*T) and the concentrations of [14C] 2-
deoxyglucose and glucose in the plasma (Cp* and CP, respectively). The K1*, K2* and K3* 
rate constants are for the carrier-mediated transport of [14C] 2-deoxyglucose from plasma 
to tissue and for phosphorylation by hexokinase. The lumped constant is composed of the 
ratio of the distribution space for deoxyglucose in the tissue relative to that of glucose, a 
factor which corrects for the fraction of glucose which, once phosphorylated, continues 
down the glycolytic pathway and the Michaelis-Menten kinetic constants of hexokinase for 
deoxyglucose and glucose (Sokoloff et al, 1977). 
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Figure 2.9. The operational equation of [14C]-2-deoxyglucose method 
Ri = the rate of glucose utilisation 
T = duration of the experimental period 
λ = ratio of distribution space of DG in the tissue to that of glucose 
Φ = fraction of glucose-6-phosphate, once formed, continues down glycolytic and pentose 
phosphate shunt pathways (e.g., with zero G-6-Pase activity = 1) 
Km* and Vm* are the Michaelis-Menten kinetics constants of hexokinase for DG 
Km and Vm are the equivalent kinetic constants for glucose. 
        Adapted from Sokoloff (1978) 
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2.4.2 Animal preparation for [14C] 2-deoxyglucose autoradiography  
 
Male Sprague-Dawley rats were initially anaesthetised with 5% inhaled isofluorane 
delivered in oxygen–nitrous oxide (30:70) in an induction chamber at room temperature. 
The animals were artificially ventilated following a surgical tracheotomy, with air slightly 
enriched in oxygen (30%) to maintain physiological stability under anesthesia (~2% 
isofluorane). A rectal thermocouple provided continual monitoring of core body 
temperature which was controlled (37oC) with a heated lamp. Polyethylene catheters 
(Portex: external diameter 0.96 mm; internal diameter 0.58 mm; 70 cm long) were placed 
in both femoral arteries, to continuously monitor blood pressure and conduct blood gas 
analysis, and a femoral vein for 2DG administration.  
 
Physiological parameters were maintained within the normal range under anaesthesia apart 
from increased arterial partial pressure of oxygen (PaO2) during the oxygen challenge. 
PaCO2 was maintained between 35-45 mmHg in order to minimise cerebrovascular 
reactivity. Mean arterial blood pressure was maintained between 70-90 mmHg by 
manipulating the isoflurane level.   
 
2.4.3 Experimental protocol for LCMRglc measurement  
  
Immediately after the MRI scanning session, the animal was removed from the magnet for 
LCMRglc measurement. This was initiated by the intravenous (i.v) injection of [14C] 2DG 
(125 µCi/kg in 0.6 mL heparinised saline (approximately 0.4 mL [14C] 2DG and 0.2 mL 
heparinised saline), Perkin-Elmer, Waltham, MA, USA) at a steady rate over 30 seconds. 
Over the subsequent 45 minutes of the experiment, a series of 14 blood samples, 
approximately 50 µL per sample, were collected into heparinised centrifuge tubes at pre-
determined time intervals (Table 2.3). In order to avoid hypovolaemia, each blood sample 
was replaced by a similar volume of saline. The collection of samples was timed in such a 
way as to ensure full characterisation of the peak in plasma [14C] 2DG concentration 
during the first 5 mins of the experiment and the full arterial profile of plasma [14C] 2DG 
over the course of the whole experimental period (Figure 2.10). 
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Figure 2.10. Complete plasma history profile determined in quantitative 2-deoxyglucose 
autoradiography from infusion of isotope to the terminal plasma sample at 45 min. Data 
from 6 representative animals 
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A 45 minute time course limited the influence of exponential factors in the operational 
equation, as well as making sure that there was minimal loss of  [14C]-DG-6-phosphate 
from the tissues resulting from glucose-6-phosphatase activity (Sokoloff et al, 1977). 
Samples were immediately centrifuged and aliquots of plasma removed for the 
determination of plasma glucose (Cp) and 14C concentrations (Cp*) by glucose oxidase 
assay (Beckman glucose analyser) and liquid scintillation analysis, respectively. At 45 
minutes, animals were rapidly killed by i.v injection of sodium pentobarbitone and the 
brains rapidly dissected out, frozen (isopentane, -40ºC) and processed for quantitative 
autoradiography. The brain was mounted on a microtome chuck encased in a plastic 
embedding matrix (Lipshaw). Coronal brain sections (20 µm thick) were cut on a cryostat 
maintained at -22°C. Three sections were thaw-mounted onto a glass coverslip, and then 
the coverslip was immediately placed on a hotplate (60ºC) for 5 mins. Rapid drying 
prevents diffusion of the trapped [14C] from the cells. Coverslips were glued onto card and 
apposed to x-ray film (Kodak Biomax MR film 8”x10”, Eastman Kodak Company, 
Rochester, NY, USA)  in light-tight cassettes with [14C]-labelled polymer autoradiographic 
microscales (40-1070 nCi/g, Amersham, GE healthcare) and exposed for 3 days. Films 
were then developed using a standard Kodak automatic processor.   
 
The three parameters generated from the experiment are used in the operational equation of 
the technique to determine LCMRglc; the time-course of arterial [14C] 2DG concentration; 
time-course of arterial plasma glucose concentration and; tissue concentration of [14C], as 
determined by autoradiography. LCMRglc within discrete brain regions was measured 
from local tissue calculations of [14C] (Ci*) and the plasma [14C] 2-deoxyglucose (Cp*) and 
glucose (Cp) concentrations according to the operational equation.  
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Table 2.3. Representative example of a [14C] 2-deoxyglucose data sheet displaying the 
sample times (inputted in deciminutes (1/100th of a minute) for the MCID analyser), the 
measure of radioactivity (disintegrations per minute (DPM)), plasma glucose values and 
the plasma [14C] concentrations (from a 20 µL sample) 
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2.4.4 Densitometric analysis and LCMRglc calculation   
   
Densitometric analysis of autoradiograms was performed using an MCID Basic image 
analysis system (7.0 Rev 1.0, build 207; Imaging Research Inc.).  The MCID system was 
calibrated at the start of each session to standardise the film background using the range of 
[14C] standards. The optical densities of the pre-calibrated [14C] standards were measured 
to produce a calibration curve. Measured grey level values (from 0 (black) to 255 (white)) 
within designated regions of interest (ROI) were then converted to optical density values. 
Optical density measurements were measured on the film and using the 14C standards, 
measurements were converted into 14C concentrations and measured in discrete brain 
regions by placing autoradiograms (Figure 2.11) on a light box under a closed circuit 
camera (using the same magnification and light intensity used for calibration) and 
positioning a frame over each ROI. The mean [14C] value was calculated from the average 
of the value of the ROI from 5 brain sections per rat. 
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Figure 2.11. Two separate representative autoradiograms photographed on the MCID 
analyser in animals that under went the MCAO model of ischaemia. The white region 
represents a region of critically reduced glucose use which corresponds to the ischaemic 
damage. The dark area surrounding the region of reduced glucose use represents a 
region of increased 2DG phosphorylation. White matter is notable for its reduced glucose 
utilisation compared to the grey matter, whilst the choroid plexus within the ventricle 
displays a high glucose utilisation value 
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2.5 Magnetic resonance imaging scanning  
     
2.5.1 Magnet specifications        
 
All animals were scanned in a Bruker Biospin Avance 7T (300MHz) Magnetic Resonance 
Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) system, equipped with an 
inserted gradient coil (121 mm ID, 400mT/m) and a 72 mm birdcage resonator.  
 
2.5.2 Physiological monitoring during MRI scans   
   
Following surgery to induce MCAO, animals were placed prone in a Perspex cradle, with 
the head restrained using ear and tooth bars to limit movement. A linear surface receiver 
coil (2 cm diameter) was placed above the head of the animal. The base of the cradle, and a 
cover placed over the rat’s body, contained water channels with circulating warm water 
connected to a temperature controlled combined heater and water pump. This could be pre-
set for a given temperature to maintain body temperature at 37ºC. Physiological variables 
including core body temperature, electrocardiogram (ECG) and respiration rate were 
monitored with a BioTrig system (Bruker, BioSpin) which had both a command and 
acquisition module. Physiological input was acquired by attaching electrocardiogram leads 
(3M innovation) to the rat with conductive electrode gel (Sigma) and electrode adhesive 
pads; two were attached to the animal’s chest and a third to the inner right thigh.  A rectal 
thermocouple was reinserted for continual temperature monitoring. The system was 
connected to a laptop and AcqKnowledge software used to display the cardiac and 
respiratory waveforms. Stability of physiological variables was determined from the 
waveform patterns and temperature readout, and manual control of anaesthetic levels and 
water heater temperature ensured maintenance of variables within the physiological range. 
MABP was monitored by cannulating the femoral artery and attaching the cannula to a 
blood pressure transducer, which was in turn connected to Biopac (Bruker, Biospin) 
software. 
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2.5.3 Diffusion-weighted scans       
 
Technical specifications for DWI scans 
 
Spin Echo planar (EPI) diffusion-weighted scans consisted of eight contiguous coronal 
slices of 1.5 mm thickness which were generated with an in-plane resolution of 260 µm. 
The field of view was 25 x 25 mm2 and the matrix size was 96 x 96 mm.  The gradient 
strengths (B values) were 0 and 1000 s/mm2 and gradient directions were x, y and z. The 
repetition time (TR) was 4000.3 ms and the echo time (TE) was 43 ms. A DWI scan over 
the whole brain takes approximately 3 minutes.  
 
ADC maps were generated for each of the 8 contiguous coronal slices throughout the brain 
(Figure 2.12).  Raw datasets were initially processed using Paravision v5 (Bruker Biospin). 
Subsequent analysis of ADC maps was carried out using ImageJ (http://rsb.info.nih.gov.ij) 
software.  
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Figure 2.12. A. DWI images of eight coronal slices from a rat brain 2.5 h following 
intraluminal filament model of permanent MCAO (pMCAO) and B. Equivalent ADC maps. 
The ischaemic damage appears bright on the DWI images and dark on acute ADC maps. 
ADC values expressed as x10-3 mm2/sec 
 
 
 
 
 
 
 
 
A.           B. 
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2.5.4 Arterial spin labelling        
 
Technical specifications 
 
Non-invasive quantitative CBF was carried out on coronal slices within the MCA territory 
during ischaemia, and immediately following reperfusion for Chapter 5, using a form of 
pseudo-continuous ASL based on a train of adiabatic inversion pulses (Moffat et al, 2005). 
The sequence employs a spin-echo echo-planar-imaging (EPI) imaging module (TE 20 ms, 
TR 7000 ms, matrix 96 x 96, FOV 25 x 25 mm2, slice thickness 1.5 mm, 16 averages, 4 
shots) preceded by 50 hyperbolic secant inversion pulses in a 3 second train. The time 
taken to generate data for a single slice is approximately 5 minutes. In addition to this, a 
T1-weighted image (scan time 10 minutes for the whole brain) was performed to allow 
quantification of CBF in mL per 100 g per minute. 
 
Post-processing 
 
CBF maps were generated for each of the 4 contiguous slices throughout the brain (Figure 
2.13D).  Raw datasets were processed ImageJ software.  Quantification of the CBF images 
was performed with use of methods described. The labelled CASL images were first 
subtracted from the averaged control images (subtracted CASL) (Figure 2.13A) and then 
divided by the signal intensity to generate a relative CBF map (Figure 2.13B). Fully 
quantitative CBF maps (Figure 2.13D) were generated by dividing the relative CBF map 
by the T1 values generated from the T1 map (Figure 2.13C). A perfusion deficit map can 
then be generated from the quantitative CBF map by applying a relevant threshold (e.g. 
57% reduction of the mean contralateral hemisphere excluding the ventricles (Figure 
2.13E)). 
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Figure 2.13. ASL Images and the corresponding T1 map generated from a rat 1 h 
following intraluminal filament-induced MCAO 
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2.5.5 T2-weighted scanning        
T2-weighted scans were generated for two reasons; first, sagittal T2 scans were performed 
to identify neuroanatomical landmarks and second, coronal scans were generated for final 
infarct measurements. The need for neuroanatomical landmarks was particularly important  
for the reperfusion study (Chapter 5), where the animal was removed from the magnet to 
induce reperfusion, and then placed back in to scanner (the reperfusion phase), and again at 
7 days to assess final infarct.  Using the rhinal fissure, the brain can be repositioned to 
match the initial acute scan geometry as closely as possible. During acute scanning and at 7 
days following reperfusion, a sagittal RARE (rapid acquisition with refocused echoes) T2 
scan (effective TE: 46.8 ms, TR: 5000 s; in plane resolution of 97 µm; 18 slices of 0.5 mm 
thickness) was performed, in which the rhinal fissure was used as the neuroanatomical 
landmark for the first slice position (Figure 2.14).  
 
Second, a coronal RARE T2 sequence (effective TE: 46.8 ms, TR: 5000 s; in plane 
resolution of 97 um; 16 slices of 0.75 mm thickness) enabled T2-derived final infarct 
measurements. ImageJ was used to separate the images (8 slices are displayed in Figure 
2.15) and the hyperintense region that represented the infarct was manually delineated 
using the freehand function. Measurement of individual images gave the infarct areas in 
millimetres squared, and infarct volume was calculated by adding up the 16 areas and 
multiplying by the slice thickness (0.75 mm).  
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Figure 2.14. Sagittal T2 scan of a rat brain (direction of arrow represents the rostro-caudal 
position of the brain. The dashed lines display the imaging window for which 18 slices of 
0.5 mm thickness were generated (yellow asterisk marks the rhinal fissure) 
 
 
 
 
 
 
 
 
 
 
*
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Figure 2.15. T2-weighted images of eight coronal slices (caudal to rostral) from a rat brain 
following intraluminal filament induced permanent MCAO at 24 hours post-ischaemia. 
Ischaemic damage appears bright on RARE T2 images 
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2.5.6 T2*- weighted scans        
 
The sequence used to measure T2* changes during an oxygen challenge (OC, ventilation 
changed from ~22% to 100% O2 for a short and transient period) was a single shot, 
gradient echo (echo planar imaging) sequence: TE: 20 milliseconds, TR: 10 seconds, 
matrix 96 x 96, FOV 25 x 25 mm2, eight contiguous slices of 1.5 mm thickness, two 
averages, temporal resolution 20 seconds, 75 repetitions). Two MRI slices which 
corresponded to the territory supplied by the MCA were selected for analysis (Figure 
2.16). Three paradigms were used for the generation of data during the T2*-weighted OC 
sequence:  
1) 5 minutes breathing air, followed by 5 minutes breathing 100% oxygen, and then 15 
minutes breathing air;  
2) 5 minutes breathing air followed by 5 minutes breathing 100% oxygen; or  
3) 5 minutes breathing air, followed by 5 minutes breathing 100% oxygen, and then 10 
minutes breathing air  
For the former paradigm ([14C] 2-deoxyglucose study, Chapter 4) a stack of 600 images 
were generated (75 images per slice, for a total of 8 slices). For the second paradigm, 
(Reperfusion study, Chapter 5, 240 images were generated (30 images per slice, for a total 
of 8 slices). For the latter paradigm (Serial OC study, Chapter 6) a stack of 960 images 
(120 images per slice, total of 8 slices) was generated over 10 mins.  
 
T2* image processing  
 
The time course and size of the T2* signal change during OC was analysed using the 
ImageJ percentage signal change plugin. T2* percentage signal change within selected 
regions of interest was calculated from time course graphs (Figure 2.18B), where the 
average baseline signal (over 5 minutes) was subtracted from the peak signal during OC. 
This value was then divided by the average baseline signal and multiplied by 100. T2*OC 
percentage signal change maps were then generated (Figure 2.17). 
 
T2* image analysis 
 
T2* percentage signal change within selected regions of interest were determined by first 
manually drawing round a region of interest (such as the ADC-derived ischaemic core) 
(Blue ROI on Figure 2.18A), and then generating the time course data by plotting a z-axis 
profile of the raw 75 images (Figure 2.18B) 
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Figure 2.16. Example of raw T2*-weighted images of a rostral (A) and caudal (B) slice 
within MCA territory 1 hour post-MCAO. The oxygen challenge involved 4 min air 
inhalation followed by 6 mins 100% oxygen inhalation 
  
 
 
 
 
 
 
 
 
A. Rostral slice 
 
 
 
 
 
 
 
 
 
 
 
 
B. Caudal slice 
100 
 
 
 
 
 
 
 
    
  
 
Figure 2.17.  T2* percentage signal change maps from a rat 1 hour post-pMCAO, 
generated from the time course data (corresponding maps of the rostral and caudal slices 
displayed in Figure 2.16). Note the low T2* % signal change within the ischaemic core, and 
the high signal change within the sensorimotor cortex (presumed penumbra, green arrow) 
and large veins and sinuses 
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Figure 2.18. Images and T2* data from a representative rat 1 hour after pMCAO.   A. 
Manually selected ROIs (ADC-derived ischaemic core – blue, T2*OC-defined penumbra – 
green, and contralateral cortex – red), and B. the corresponding T2* time course data for 
the selected ROIs. Y-axis scale is normalised T2* signal 
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Thresholding T2* % signal change images 
 
Penumbral tissue was defined using a threshold based on the empirical rule: the mean plus 
2 SD of the T2* value of the contralateral hemisphere, excluding the ventricles (Figure 
2.19). 
 
  
 
 
Figure 2.19. The non-thresholded (A) and thresholded (B) T2* percentage signal change 
map for a sample slice at 1 hour post-pMCAO. Scale bar in units of T2* percentage signal 
change. Presumed penumbra shown by green arrow 
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2.5.7 Co-registration of scans  
 
EPI sequences - such as the T2*OC sequence - are susceptible to high levels of artefacts 
which manifest themselves as image and signal distortion. Small magnetic field differences 
will result in spatial distortion. Regions of the brain close to the nasal sinus, such as the 
auditory meatus, frontal and temporal lobes are particularly affected. In order to compare 
data on T2* scans with ADC, T2 and ASL scans, linear coregistration was performed using 
Analyze software (AnalyzeDirect, Inc). 
 
Processed ADC maps were used as a template for co-registering the raw T2*OC stack. A 
single slice was separated from the T2*OC stack and the distorted slice was manually 
coregistered and aligned to fit the spatial location of the ADC template using the 3D voxel 
registration plugin (Figure 2.20). The coregistered matrix data was saved and 2D voxel 
registration was used to warp the remaining T2*OC stack. The coregistered matrix data was 
used to coregister raw datasets with scans performed at later time points (in Chapters 5 and 
6). 
 
Using the co-registration software (Analyze), only rotation and translation of the images 
were required to accurately co-register the data. This did not involve warping (stretching) 
the images which would cause co-registration errors (by introducing subjectivity). 
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Figure 2.20. An example ADC coronal slice (A) at 1 hour post-pMCAO, used as a 
template for co-registration with T2* scans. The unwarped OC slice (B) was manually 
warped and aligned with the ADC slice to generate a warped T2*OC slice (C).  The red line 
on the ADC map has been superimposed on the unwarped slice and the warped slice  
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       Chapter 
 
3  
 
Characterisation of the T2* Oxygen Challenge technique 
 
In this chapter data are presented to illustrate reproducibility achieved in inducing 
experimental stroke along with optimisation and characterisation of the Blood Oxygen 
Level Dependent (BOLD) MRI response to oxygen challenge (OC). The first aim was to 
achieve a reproducible volume of ischaemic damage using the intraluminal filament 
method to induce permanent MCAO in the rat and to establish methods of infarct 
quantification. Secondly, the effect of physiological variables on the BOLD signal 
response to OC was assessed. It was important to identify factors, other than tissue 
metabolism, which could influence the T2* signal change during OC.  
 
3.1 Establishing reproducibility in the MCAO model using TTC 
and H&E to quantitatively assess infarct volume 
    
3.1.1 Introduction 
 
Infarct volume is an important outcome measure for assessing irreversible ischaemic 
damage. 2,3,5-triphenyltetrazolium chloride (TTC) and haematoxylin-eosin (H&E)  
staining were used, which are commonly used to detect infarct volumes in animal models. 
Experiments were performed to assess the MCAO surgical technique with TTC staining 
initially carried out as a quick method of confirming success of MCAO surgery and for 
quantifying infarct volume reproducibility. Once proficiency in stroke surgery was 
achieved, H&E staining was used to accurately measure infarct volume.  
 
Using TTC staining, two different methods can be implemented that do not necessarily 
produce the same results (Dettmers et al, 1994). TTC can be transcardially perfused in vivo 
or incubated with brain slices ex vivo. Using the perfusion technique, in the acute phases of 
ischaemia, staining mainly reflects changes in perfusion of the stain due to altered blood 
flow rather than ischaemic (mitochondrial) damage (Liszczak et al, 1984). The latter 
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technique was used in the first in vivo experiments, as this was simpler and provided a 
crude but quick estimate of infarct. TTC does not accurately define infarct size until 24 
hours after permanent MCAO (Bedersen et al, 1986) but provides sufficient information 4-
6 hours post-MCAO to determine if the MCA has been sufficiently occluded by the 
intraluminal filament.  
 
Cerebral ischaemia causes changes to the general morphology of cells which can be 
detected with the commonly used histological stain haematoxylin and eosin (H&E). 
Specifically, haematoxylin stains basophilic structures with a blue-purple hue, and eosin is 
the counterstain which stains the eosinophilic structures, such as the cytoplasm and 
extracellular components a sharply contrasting pink.  The basophilic structures contain 
nucleic acids, such as the ribosomes and the chromatin-rich cell nucleus.  
 
3.1.2 Methods 
 
Male Sprague-Dawley rats (300-343 g, Harlan, Bicester, UK) were initially anaesthetised 
with 5% inhaled isoflurane delivered in oxygen–nitrous oxide (30:70) in an induction 
chamber at room temperature. The rats were then intubated and artificially ventilated, with 
anaesthetic maintained at ~2% isoflurane. A polyethylene catheter (Portex: external 
diameter 0.96 mm; internal diameter 0.58 mm; 70 cm long) was surgically inserted in a 
femoral artery to continuously monitor blood pressure and for sampling to conduct blood 
gas analysis. Twelve rats were used overall (6 for TTC staining and 6 for H&E histological 
assessment of infarct), and the intraluminal filament method of permanent (pMCAO) was 
performed. H&E and TTC staining were performed using the methods described in 
Chapter 2.3). Data are displayed as the mean±SD. 
 
Ischaemic damage assessed with TTC staining 
 
The MCAO surgical technique was first mastered on cadavers before progressing to in vivo   
(anaesthetised throughout) experiments with assessment 4 hours after MCAO with TTC.  
At 4 hours post-stroke, the animal was killed by anaesthetic overdose and the brain 
removed, chilled, sliced in the coronal plane on a brain matrix and slices incubated in TTC. 
The area of ischaemic damage was measured on TTC stained tissue slices (See Chapter 
2.3.6). Slice 0 to 7 refers to the most rostral to caudal slices, respectively (Figure 3.1), and 
two measurements of infarct area were made on each slice and the mean plotted. As slice 
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thickness was 2 mm, areas were converted into volumes by summing all the slice areas and 
multiplying by the slice thickness (2 mm). 
 
Ischaemic damage assessed with H&E staining  
 
Animals underwent perfusion fixation, and brains were removed for tissue processing, 
paraffin wax embedding and microtome sectioning (Chapters 2.3.2 and 2.3.3).  Following 
H&E staining (Chapter 2.3.4) sections were selected at 8 stereotaxic levels throughout the 
MCA territory and viewed by light microscopy at x20 magnification. Areas of ischaemic 
damage were transcribed onto line diagrams from the rat stereotaxic atlas. Volumetric 
measurements were calculated three times, and the three values were averaged and infarct 
volume calculated by plotting the areas against the Bregma coordinates (level 1 (3.24 mm) 
to level 8 (-6.36 mm)) and area under the curve was calculated (Figure 3.2). 
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3.1.3 Results 
 
3.1.3.1  TTC-derived ischaemic volume analysis  
 
 
Figure 3.1.  Area of ischaemic damage on TTC stained tissue slices throughout the MCA 
territory. Note that the region within end artery MCA territory (between slices 2-5) tended 
to have larger areas of ischaemic damage, whereas the slices in the more rostro-caudal 
regions with more collateral supply experienced less damage 
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3.1.3.2  H&E-derived ischaemic volume analysis 
 
Figure 3.2. Areas of ischaemic damage per stereotaxic level according to Bregma 
coordinates measured on H&E stained sections. At each level, 3 sections were each 
measured 3 times and the average value plotted 
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3.1.3.3  Ischaemic damage volume comparison     
 
The mean lesion volume using TTC staining was 308±86 mm3 and the mean lesion volume 
using H&E staining was 171±25 mm3 (Figure 3.3). The TTC method appeared to have a 
larger variation of results compared to histology which may reflect inexperience with the 
technique at this time. To determine the presence of brain swelling, the volumes of the 
ipsilateral and contralateral hemispheres for the TTC slices were compared (Figure 3.4), 
but at 4 hours post stroke there was no evidence of significant brain oedema and brain 
swelling (p=0.1427). 
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Figure 3.3. Scatterplot illustrating infarct volumes measured on TTC slices (early 
experiments) and histology at 4 hours following permanent MCAO. The horizontal line 
represents the mean 
 
 
 
 
 
 
 
 
111 
 
 
 
 
 
 
 
 
1 2 3 4 5 6
0
100
200
300
400
500
600
700
800
900
Ipsilateral hemisphere
Contralateral hemisphere
Rat
H
e
m
is
ph
e
ric
 
v
o
lu
m
e 
(m
m
3 )
 
Figure 3.4. Comparing the ipsilateral and contralateral hemisphere volumes in the TTC-
stained brains to determine presence of brain swelling at 4 hours post-stroke. With Rat 2, 
due to tissue damage to the rostral region of the brain during sectioning, only 5 slices 
were measured compared to the 6 or 7 slices measured in the other 5 animals. This 
explains the smaller measurements for total hemispheric volumes 
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3.2 Optimisation of the BOLD T2*OC technique 
 
3.2.1 Introduction 
 
Blood oxygen level dependent (BOLD) signal changes in MRI were initially reported in 
relation to cerebral blood vessels, where it was found that changes in the oxygenation of 
venous blood altered the T2* MR signal response (Ogawa et al, 1990). Acceptance and 
validation of the technique was aided by evidence of global signal changes following a 
number of respiratory challenges (Turner et al, 1991). Following on from this, human 
studies confirmed the concept - first described by PET studies - that during functional brain 
activation, the oxygen content of venous blood increases. The simple explanation for this 
phenomenon was that the increase in oxygen delivery outweighs the smaller increase in 
neuronal oxygen metabolism. The effect is that the venous blood contains less 
deoxyhaemoglobin which gives rise to a concomitant BOLD MRI signal increase produced 
by a change in T2* (Ogawa et al, 1992), which is useful in assessing cerebral function non-
invasively. The premise is similar to that for O15 PET, where the detection of brain 
activation is based on measuring rCBF by O15 water injection (Volkow, Rosen and Farde, 
1997).  
 
The emergence of functional MRI (fMRI) – which measures the haemodynamic response 
to neural activation - was an important corollary of the initial BOLD studies which 
provided additional information on function to the structural neuroimaging methods, and 
high speed acquisition of multi-shot techniques was made possible with EPI. A robust 
feature of fMRI is its ability to map signal change in real time, despite the fact that 
temporal and spatial resolution is determined by factors associated with the haemodynamic 
response (Menon et al, 1997; Menon et al, 1993). However, the BOLD response originally 
depended on a number of underlying assumptions including factors such as baseline states 
remaining uniform between subjects. We now know that there are a number of factors in 
addition to brain function that influence the magnitude of the BOLD signal change. For 
example, baseline physiological parameters, such as blood gases and haematocrit, plus 
CBF and cerebral blood volume can influence this BOLD response. Rostrup and 
colleagues (Rostrup et al, 1995; Rostrup et al, 1994) verified this in humans by varying the 
respiratory status (the partial pressure of oxygen and carbon dioxide). The baseline CBF 
was shown to be a fundamental factor influencing the BOLD response by Bandettini and 
colleagues (1997) who noted attenuation in signal intensity when baseline CBF was high. 
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The role of the baseline physiological state has been complicated by reports that functional 
BOLD response remains constant (Bandettini and Wong, 1997) or decreases (Rostrup et al, 
2005) during reduced PaO2 (hypoxia), or increases (Cohen et al, 2002) or decreases (Posse 
et al, 2001) during increased PaCO2 (hypercapnia).  
 
3.2.2 Influence of baseline physiological state and CBF on T2*OC signal 
response to OC            
 
A number of factors must be considered when interpreting alterations in T2* response. 
They may relate to the physiological responses such as vascular reactivity, in that blood 
vessels dilate or constrict in response to the amount of oxygen delivered. The factors may 
also be biophysical; venous oxygenation may change when blood flow is altered, the levels 
of deoxy- and oxyhaemoglobin in the blood, and the actual tissue requirements of oxygen 
in relation to metabolism (oxygen extraction factor, OEF), affect T2* response.  
 
In normal conditions, the T2* signal intensity following brain activation would increase in 
proportion to a decrease in deoxyhaemoglobin (Ogawa et al, 1990; Ogawa et al, 1992; Lin 
et al, 1998; Kwong et al, 1992). Introducing a hyperoxic challenge will increase the 
content of arterial oxygen by increasing the oxygen saturation of haemoglobin and the 
levels of O2 dissolved in the plasma. Therefore, increasing arterial O2 content will decrease 
the amount of venous deoxyhaemoglobin, and thus increase the BOLD signal (Rostrup et 
al, 1995). Also, fluctuations in CBF, without an accompanying increase in CMRO2 has the 
effect of changing the amount of deoxyhaemoglobin in the blood, which therefore alters 
the local magnetic susceptibility and affects the T2* response. 
 
3.2.2.1  Aims 
The aim was to identify the factors that could influence the T2* response and magnitude to 
oxygen challenge.  Changes in CBF, CBV, tissue oxygenation, and oxidative metabolism 
can all influence the T2* signal (Ramsay et al, 1993; Corfield et al, 2001), so it was 
important to discount the possibility that factors other than tissue metabolism were 
influencing the signal change during OC. To develop and validate OC as an accurate 
penumbral marker, the relationship between T2*, baseline physiological state and CBF was 
tested since changes in these parameters may contribute to the T2* response. To assess the 
magnitude of the CBF component, correlations between T2* and CBF were assessed. Since 
T2* is sensitive to changes in oxy:deoxyhaemoglobin ratios, the influence of baseline 
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arterial partial pressure of oxygen (PaO2) on T2* response was tested. Lastly, since baseline 
oxygen saturation (the percentage of haemoglobin binding sites in the blood occupied by 
oxygen) may give an indication of the extent to which deoxyhaemoglobin can be converted 
to oxyhaemoglobin following OC, the effect of oxygen saturation was assessed, in which 
the percentage change in oxygen saturation (from post-OC to during-OC) and T2* 
percentage signal change in ROIs were correlated. 
 
3.2.2.2  Methods         
Animal preparation 
 
Male Sprague Dawley rats were anaesthetised (2% isoflurane), ventilated (air), the middle 
cerebral artery occluded by an intraluminal filament, and MR imaging was performed 
throughout MCA territory. A polyethylene catheter (Portex: external diameter 0.96 mm; 
internal diameter 0.58 mm; 70 cm long) was placed in a femoral artery  to continuously 
monitor blood pressure and collect blood samples for blood gas analysis. Using arterial 
blood gas sampling, baseline PaO2 (n=35) and the percentage change in oxygen saturation 
from baseline to during OC was measured (n=27).  
 
Magnetic resonance imaging scanning 
 
Magnetic resonance imaging data were acquired on the scanner described in Chapter 2.5.1. 
After stroke surgery, animals were placed prone in a rat cradle, with the head restrained 
using ear and tooth bars to limit movement, and a linear surface receiver coil (2 cm 
diameter) placed above the head of the animal. 
 
T2* scanning 
 
The sequence used to measure T2* changes during OC is described in Chapter 2.5.6. One 
coronal MRI slice (slice 5, Figure 3.5) within core middle cerebral artery territory was 
selected for analysis.  The paradigm for the T2* weighted OC sequence was 4 minutes 
ventilation on air, followed by 6 minutes ventilation on 100% oxygen. The T2* % signal 
change was calculated and correlated with the baseline (pre-OC) PaO2 (n=35) to identify 
the extent to which PaO2 modulates BOLD response. 
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Diffusion-weighted imaging 
 
DWI was performed to identify ischaemically injured tissue, using the sequence described 
in Chapter 2.5.3.  
 
Arterial Spin Labelling 
 
Perfusion-weighted imaging (PWI, by continuous arterial spin labelling) was used to 
generate quantitative CBF maps (n=17). Non-invasive quantitative CBF was carried out on 
1 of the 8 coronal slices (slice 5, Figure 3.5) within the MCA territory using a form of 
pseudo-continuous ASL based on a train of adiabatic inversion pulses (Moffat et al, 2005). 
The sequence is described in Chapter 2.5.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
116 
 
   
   
   
   
                                     
   
   
   
Figure 3.5. T2*OC (shown as % signal change) maps and equivalent ADC (in x10-
3mm2/sec) maps across the 8 caudal-to-rostral extent (slice 1-8), including the CBF 
(ml/100g/min) map at slice 5. Image analysis was performed on slice 5. Note region of 
increased T2* % signal change on right hemisphere identified as penumbra, situated out 
with the ADC lesion (expressed as the dark region on the ADC maps in the regions within 
MCA territory) 
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ROI analysis 
 
CBF and T2* % signal change values were analysed from MRI-defined regions of interest 
(ROI) (Figure 3.6): Ischaemic core was defined as the ADC lesion (with a threshold set at 
an 16.5% reduction of the mean contralateral ADC value excluding the ventricles), OC-
defined penumbra (thresholded using the empirical rule – the mean plus 2SD) and mirror 
regions in contralateral caudate and cortex. T2* percentage signal change was calculated 
from time course graphs, where the average baseline signal over 4 minutes was subtracted 
from the peak signal during oxygen challenge. This value was then divided by the average 
baseline signal and multiplied by 100. The relationship between the different variables (T2* 
percentage signal change with PaO2, oxygen saturation and CBF) was assessed using the 
Pearson r correlation test.  
 
3.2.2.3  Results 
 
Baseline CBF and T2*OC 
 
In the four regions of interest, there was no correlation between T2* percentage signal 
change to OC and CBF, suggesting that baseline CBF is not implicated as a factor 
influencing T2* response (within T2*OC defined penumbra r2=0.08579, p=0.2539; ADC-
derived ischaemic core r2=0.00003, p=0.98; Contralateral cortex r2=0.0005, p=0.93; 
Contralateral caudate r2=0.024, p=0.56; Figure 3.7). T2* signal change was not higher when 
lower CBF values were recorded in any of the regions analysed and vice versa.  
 
PaO2 
 
In penumbra (r2=0.1935, p=0.0092) and in tissue unaffected by ischaemia (r2=0.5197, 
p<0.0001 in contralateral cortex and r2=0.5395, p<0.0001 in contralateral caudate), the 
magnitude of the T2* response is influenced by the baseline PaO2, whereas baseline PaO2 
does not influence the T2* response in the ischaemic core caudate (r2=0.0455, p=0.2186). 
Lower baseline PaO2 gives rise to greater T2* signal responses and vice versa in ROIs still 
metabolically active (Figure 3.8). 
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Oxygen saturation 
 
In the ischaemic core (r2=0.00006, p=0.49), the percentage change in O2 saturation from 
baseline to during OC did not affect the T2* response, whereas in tissue regarded as normal 
(contralateral cortex r2=0.43, p=0.0002 and contralateral caudate r2=0.45, p=0.0001 in 
contralateral caudate), and in penumbra (r2=0.6525, p=0.0001), the magnitude of the T2* 
response is influenced by the change in O2 saturation. Lower percentage change in O2 
saturation gives rise to a lower T2* signal response and vice versa in ROIs on the 
contralateral hemisphere (Figure 3.9). 
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Figure 3.6. MRI scans used for data analysis. Regions of interest (shown in D) selected 
from a single MRI slice, where green ROI represents the T2*OC defined penumbra (from 
T2* % signal change map (A), the yellow ROI is the ADC-derived ischaemic core (from the 
ADC map), and the red and sky blue ROIs are the contralateral cortex and caudate, 
respectively. Penumbra defined from diffusion-perfusion mismatch is included for 
comparison (B) 
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CBF 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Correlation analysis between baseline CBF and T2* percentage signal change 
in; A. T2*OC defined penumbra, B. ADC-derived ischaemic core, C. Contralateral cortex 
and D. Contralateral caudate nucleus. n= 17. No significant correlations were found in the 
ipsilateral or contralateral cortex ROIs 
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Baseline PaO2 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Correlation between baseline PaO2 and T2* percentage signal change in; A. 
T2*OC defined penumbra, B. ADC-derived ischaemic core, C. contralateral cortex and D. 
contralateral caudate nucleus. The accompanying T2* % signal change maps show the 
regions of interest selected for analysis, n=35. A significant correlation was found in the 
penumbra and both contralateral ROIs, whereas no significant correlation was found in 
the ischaemic core 
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Oxygen Saturation 
 
 
 
 
 
 
 
 
 
Figure 3.9. Correlation analysis between the percentage change in O2 saturation from 
pre- to during-OC and T2* percentage signal change in; A. T2*OC defined penumbra, B. 
ADC-derived ischaemic core, C. Contralateral cortex and D. Contralateral caudate 
nucleus, n=25. A significant correlation was found in the contralateral ROIs, whereas no 
significant correlation was found in the ipsilateral ROIs 
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3.3 Discussion 
3.3.1 Establishing reproducibility in the MCAO model using TTC and H&E to 
quantitatively assess infarct volume       
The aim of the study was to achieve proficiency in the MCAO surgical technique and to 
successfully induce reproducible ischaemic lesions. The TTC immersion technique was 
performed to demonstrate the ability to occlude the middle cerebral artery using the 
intraluminal filament method, and to rapidly assess ischaemic damage. It was shown by the 
subsequent H&E dataset that reproducibility improved with practice, in that there was less 
variation in ischaemic lesion volume in these experiments.  
 
The pilot study also allowed the comparison of two currently used methods to determine 
ischaemic damage, and to assess the merits and disadvantages of each. The main finding of 
this study was that the quantification of the infarct volume using TTC and histology 
differed. The result of the current study was in agreement with those found by Park and 
colleagues (1988), in which the TTC-measured ischaemic volume was significantly larger 
than the volumes measured histologically. There are considerable differences in the 
volumes of ischaemic damage determined by TTC and H&E histology due to the fact that 
histology involves the dehydration of the brain tissue which causes significant tissue 
shrinkage. Conversely, TTC immersed tissue slices retain their original size, and thus the 
TTC-stained tissue is larger than the histology-analysed tissue. This explains why the 
ischaemic volumes of the histological samples were consistently smaller than the TTC 
samples. Also, quantifying the infarct is subjective at the 4 hour mark, and tends to be 
based on individual interpretation when there is no sufficient, sharp demarcation between 
normal and infarcted tissue (Gerriets et al, 2004).  The sharp gradient is more evident in 
TTC staining 24 hours post-stroke compared to 4 hours post stroke (Figure 3.10) 
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Figure 3.10. Comparison of TTC staining carried out at 4 hours and 24 hours post-stroke. 
Ischaemic damage is represented by paler or white tissue.  Although the boundary of 
ischaemic damage is not clearly defined at 4 hours post-stroke, the staining is sufficient to 
determine if the MCA has been successfully occluded and damages both subcortical and 
cortical tissues 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 h post-stroke 
 
 
 
 
 
 
24 h post-stroke 
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Benedek and colleagues (2006) noted that TTC staining can both under- and overestimate 
infarct volume due to marked metabolic changes over the course of evolution of brain 
infarction. Due to the fragile nature of brain tissue, there is a danger of the samples 
becoming damaged when sliced with the rat brain matrix. This introduces non-uniformity, 
in which the infarcted zone may become fragmented. 
 
TTC immersion 
 
TTC immersion is often preferred to H&E staining as it is inexpensive, technically simple, 
reliable and quicker. TTC has been validated for use 24 hours after injury (Bedersen et al, 
1986). However, after 36 hours of ischaemia, infiltration of macrophages and microglia, 
neovascularisation and astrocytic reactions occur (Hudgins and Garcia, 1970) which can 
obscure the margin of ischaemia. However, according to Okuno and colleagues (2001), it 
should be generally accepted that the TTC immersion method requires a longer period than 
4 hours of ischaemia for valid determination of infarcts. Bederson and colleagues (1986) 
compared the TTC immersion method and H&E staining in a rat MCA occlusion model 
over various periods of ischaemia. For accurate quantification of the infarct area, the 
ischaemia had to have lasted for at least 5–6 hours. Hatfeld and colleagues (1991) 
demonstrated that the TTC immersion method could not accurately determine rat brain 
ischaemic injury lasting 4 hours or less and they indicated that TTC immersion staining 
should only be used as a reliable marker of cerebral ischaemia damage with post-occlusion 
survival periods of 24 hours. Also, although the size of infarction can be measured using 
this technique, there can be no visualisation of the microscopic grey and white matter 
structures or individual cells.  
 
H&E staining 
 
In sections stained by H&E, the border between ischaemic damage and intact brain at 4 
hours post-stroke was somewhat unclear, and was frequently designated by a zone, rather 
than a line, making the results for infarct size equivocal. Additionally, the transcribing onto 
line diagrams for quantification of ischaemic damage is difficult and subjective. This may 
give rise to slight errors in defining the zone of ischaemic damage.   
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3.3.2 Influence of baseline physiological state and CBF on T2*OC signal 
response to oxygen challenge 
 
CBF 
 
The data have shown that baseline CBF value did not influence T2* % signal change to OC. 
Further analysis of CBF during an OC protocol was performed by colleagues from our 
department (Baskerville et al, 2011) and this is presented in Chapter 7.  
 
PaO2 
 
This study highlights the influence arterial oxygen levels have on the size of the T2* signal 
change to OC, with lower baseline PaO2 levels amplifying T2* signal response and vice 
versa in ROIs still metabolically active, implying that control of physiological variables 
may optimise the T2*OC technique. The implications were that, for the subsequent studies, 
ventilation parameters were adjusted and OC imaging delayed until the animal was 
physiologically stable and blood gases were within a defined range [PaCO2 35-45 mmHg 
and PaO2 80-100 mmHg]. Specifically, as T2* response was augmented at lower PaO2 
levels, ventilation parameters were adjusted to ensure that baseline PaO2 was at the lower 
end of the normal range (~80 mmHg).  This was particularly important for the serial 
scanning study (Chapter 6), in which signal responses were assessed at pre-determined 
time points and the effect of baseline physiology had to be minimised.  
 
Oxygen saturation 
 
It has been shown that the total deoxyhaemoglobin content and oxygen saturation has an 
effect on the BOLD response (Ogawa et al, 1992; Ogawa et al, 1993). The current study 
has shown that an increase in the percentage change in oxygen saturation following OC 
causes an increase in the T2* % signal change and vice versa, suggesting that the BOLD 
response is affected by baseline oxygen saturation. The  signals within the blood vessels 
vary linearly with the venous concentration of deoxyhaemoglobin (Li et al, 1998), whereas 
extra-vascular signals depend on the total deoxyhaemoglobin content within a voxel,  
which becomes a larger component of the BOLD signal as field strengths increase (Obata 
et al, 2004). Thus, the BOLD signal would be expected to vary as a function of both 
oxygen saturation and blood volume (Huppert et al, 2006; Ogawa et al, 1993; Buxton et al, 
1998).  
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In the current study, the baseline oxygen saturation often varied from 96-98% and went up 
to approximately 99% on OC. This may be more varied than what would be expected in 
human clinical presentation because of the effect of the rat’s anaesthesia and artificial 
ventilation. If the baseline oxygen saturation could be fixed (using a pulse oximeter to 
measure oxygen saturation) throughout the experiments, it may be possible to standardise 
the technique.  
 
3.4 Summary 
Proficiency in inducement of middle cerebral artery occlusion using the intraluminal 
filament was achieved, and the effect of various parameters on the extent of the T2* 
response to OC was examined. It was found that both PaO2 and oxygen saturation have 
significant influences on T2* signal change in metabolising tissue – within the contralateral 
hemisphere and in tissue identified as penumbra.  With this in mind, these parameters were 
monitored and controlled in subsequent studies to limit variability in the T2* response.  
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 Chapter 
4  
Validating T2*OC using [14C] 2-Deoxyglucose 
Autoradiography 
4.1 Introduction 
The gold standard physiologic imaging technique used to identify penumbral tissue is PET, 
which measures both metabolic activity and perfusion (Marchal et al, 1993). PET can 
identify that penumbral oxidative metabolism (CMRO2) is maintained in the face of 
reduced cerebral perfusion pressure by increasing oxygen extraction fraction (Powers, 
1991; Baron, 1999; Marchal et al, 1993). This, in turn, increases the deoxy: 
oxyhaemoglobin ratio in the vasculature, resulting in a decreased T2* signal within 
penumbra. Increased oxygen delivery during OC will convert deoxyhaemoglobin back to 
oxyhaemoglobin with a resultant increase in T2* signal - the magnitude of which should be 
greatest in regions with greatest oxygen extraction fraction (OEF).  
 
Whilst the OC predicates that CMRO2 and OEF are the components responsible for the 
elevated T2* signal response in the penumbra, they cannot be directly measured with MRI. 
However, indirect measurements of metabolism can be employed to confirm the viability 
of discrete brain regions, including [14C] 2-deoxyglucose (2DG) autoradiography. Glucose 
plays a fundamental role in the mammalian brain, in that it is - along with oxygen - a 
principle fuel for energy metabolism, and it is the only substrate able to completely sustain 
neural activity (Siesjo, 1978).  In the basal and activated state, cerebral glucose utilisation 
fuels neuronal activity via oxidative metabolism. Since cerebral blood flow is intricately 
linked to the cerebral metabolic rate of oxygen, CMRO2, there is a coupling of flow and 
metabolism under normal conditions (Roy and Sherrington, 1890; Sokoloff, 1976; 
Sokoloff et al, 1977). There are comparable functional increases in blood flow and 2DG 
uptake which in turn is directly related to neuronal activity (Magistretti, 2006).  
 
In a previous study (Santosh et al, 2008), the OC technique applied to a rodent MCAO 
model defined an inner boundary between metabolically inactive ischaemic core (no T2* 
signal increase to OC) and metabolically active penumbra (T2* signal increase to OC), 
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which overlapped approximately with DWI/PWI mismatch, and correlated with 
histological evidence for neuronal integrity. The differences in magnitude of T2* signal in 
ischaemic core, penumbra and normal cortex during OC may differentiate between core, 
hypoperfused penumbra and benign oligaemic tissue on the basis of differences in 
CMRO2, thereby providing a means of defining the boundaries of the penumbra. 
 
The aim of this study was to provide further validation for the T2*OC MRI technique, first 
by determining the viability of tissue within regions defined as penumbra using OC. This 
was achieved by co-registering T2*OC maps with corresponding [14C] 2-deoxyglucose 
autoradiograms, which provide information on local cerebral glucose utilisation 
(LCMRglc) as a quantitative representation of metabolic activity. Second, regions of 
interest (ROIs) identified on 2DG autoradiograms and MRI scans were investigated to 
determine the LCMRglc and MRI signatures of different tissue compartments in the 
ischaemic hemisphere. 
 
4.2 Materials and methods 
 
4.2.1 Rodent MCAO Surgery 
 
Experiments were performed under license from the UK Home Office and were subject to 
the Animals (Scientific Procedures) Act, 1986. Male Sprague Dawley rats (289±13 g, n=6, 
Harlan, Bicester, UK), fasted overnight, were initially anaesthetised with 5% inhaled 
isoflurane in an induction chamber at room temperature. Following a surgical tracheotomy, 
animals were artificially ventilated with 2% isoflurane delivered in air, slightly enriched 
with oxygen (30%) to maintain physiological stability throughout the experiment. Blood 
gases were sampled at baseline in the 5 min before the start of OC, and half way through 
100% O2 inhalation. Blood gases were maintained within the normal physiological range 
apart from increased PaO2 during the oxygen challenge. PaCO2 was maintained between 
35 - 45 mm Hg to minimise cerebrovascular reactivity (Table 4.1). A rectal thermocouple 
provided continual monitoring of core body temperature which was maintained at 
37±0.5oC. 
 
Polyethylene catheters (Portex: external diameter 0.96 mm; internal diameter 0.58 mm; 70 
cm long) were placed in both femoral arteries, to continuously monitor blood pressure and 
conduct blood gas analysis, and the femoral vein was cannulated for [14C] 2-deoxyglucose 
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administration. Middle cerebral artery occlusion was achieved by the intraluminal filament 
technique (Longa et al, 1989), where a 3-0 nylon monofilament with a bulbed tip was 
introduced through the internal carotid artery and advanced to block the origin of the 
middle cerebral artery (described in  Chapter 2.2.3).   
 
4.2.2 Magnetic Resonance Imaging scanning 
Magnetic resonance imaging data were acquired on the system as described in Chapter 
2.5.1.  
 
T2 scanning 
 
A RARE T2 provided the neuroanatomical template for co-registration of T2* scans with 
DWI and PWI scans and 2DG autoradiograms (Figure 4.1A & B).  
 
T2* scanning 
 
The sequence used to measure T2* changes during OC is described in Chapter 2.5.6. Two 
coronal MRI slices which corresponded to territory supplied by the middle cerebral artery 
were selected for analysis.  The paradigm for the T2* weighted oxygen challenge sequence 
was 5 minutes ventilation on air, followed by 5 minutes ventilation on 100% oxygen, and 
then 15 minutes ventilation on air. 
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Figure 4.1. RARE T2 neuroanatomical templates for caudal (A) and rostral (B) middle 
cerebral artery territory coronal slices of interest. Corresponding coregistered perfusion-
weighted imaging (PWI) and diffusion-weighted imaging (DWI) thresholded images 
displaying DWI lesion (white) superimposed on perfusion deficit (red), revealing DWI/PWI 
mismatch areas for caudal (C) and rostral (D) slices. ASL scans were thresholded using a 
57% reduction in the mean contralateral values (Meng et al, 2004); whereas the ADC 
maps were thresholded using a 16.5% reduction in the mean contralateral values (Lo et 
al, 1997) 
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Figure 4.2. Time line of experimental protocol. Following stroke, the animals were placed 
in the magnet and a DWI scan was performed to identify ischaemic damage. An ASL scan 
was then performed to generate fully quantitative CBF maps and mismatch images were 
generated using these data. A second DWI scan allowed the evolution of ischaemic 
damage to be assessed. OC scanning was then performed to derive T2* percentage signal 
change maps, and finally, [14C] 2DG autoradiography produced glucose utilisation images 
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Diffusion-weighted imaging 
 
DWI was performed using the sequence described in Chapter 2.5.3 to identify 
ischaemically injured tissue.  
 
Arterial Spin Labelling 
 
Non-invasive quantitative CBF was carried out on 2 of the 8 coronal slices (slices 5 & 6, 
moving rostro-caudally) within the MCA territory as described in Chapter 2.5.4. 
 
4.2.3 [14C] 2-deoxyglucose autoradiography 
 
[14C] 2-deoxyglucose autoradiography was performed according to Chapter 2.4. 
Quantitative optical density measurements were taken from five ROIs (defined in detail in 
section 4.2.4 and in the legend for Figure 4.3): (1) ischaemic core; (2) penumbra; (3) an 
intermediate region of increased 2DG phosphorylation within the boundary of the 
ischaemic core (see Figure 4.32C); (4) and (5) contralateral regions homotopic to the 
penumbra and ischaemic core, respectively. Optical density values were converted into 14C 
tissue concentrations using the calibration curve derived from the set of 14C standards. The 
14C tissue concentrations along with the plasma glucose and 14C plasma concentrations 
were used to calculate LCMRglc (µmol per 100g per minute) in ROIs using the operational 
equation of Sokoloff et al (1977) (Figure 2.9). 
 
Glucose utilisation for each ROI was generated from 10 autoradiographic images covering 
the rostro-caudal extent of each MRI slice (1.5 mm) to accurately equate T2* signal change 
maps with glucose utilisation. 
 
[14C] 2-deoxyglucose autoradiography in conscious rats 
 
LCMRglc values generated in our study were considerably lower than values documented 
in the literature, which are almost exclusively from conscious animal experiments. 
Anaesthetic presence and duration (approximately 6 hours) is the most likely explanation 
for the lower values as it is known to significantly inhibit metabolism. Consequently, [14C] 
2-deoxyglucose autoradiography was carried out on a conscious naive rat and conscious 
stroke rat in order to confirm this point. Rats were anaesthetised for approximately 45 
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minutes during surgery and given 2 hours to recover from anaesthesia before beginning the 
2DG experiment. 
 
4.2.4 Regions of interest analysis 
 
Circular ROIs were selected according to specific features on the images (Figure 4.3). To 
ensure placement solely within the areas of interest and uniformity in ROI size, ROIs were 
chosen manually (spanning 80 pixels). During ROI placement, I was blinded to the 
autoradiography data and vice versa. MRI-based ROIs were defined and placed within (1) 
ischaemic core in caudate nucleus within the thresholded ADC lesion (Figure 4.3E, red); 
(2) its mirror contralateral region (sky blue), manually designated; (3) penumbra as defined 
by thresholded T2* percentage signal change (Figure 4.3B, green); (4) equivalent 
contralateral cortex (white), and (5) a cortical region of increased 2DG phosphorylation 
selected from the 2DG autoradiogram (Figure 4.3C, yellow). 
 
Coregistration and regions of interest analysis 
 
The processed data from the T2*OC, 2DG, thresholded ADC and CBF maps, were 
coregistered to: (1) generate ROI data and; (2) identify the location of the DWI/PWI 
mismatch (Figures 4.3C and D). Linear coregistration was first performed using Analyze 
(AnalyzeDirect, Inc. Overland Park, KS, USA) and then DWI, ASL, T2*- and 2DG images 
were warped to their corresponding RARE T2 slices using AIR 5.2.6 (Automated Image 
Registration (Woods et al, 1998). 
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Figure 4.3. Representative MRI maps and 2DG autoradiograms from a rostral slice (slice 
6 moving rostro-caudally) in a stroke rat; (A) T2* oxygen challenge (OC) percentage signal 
change map; (B) Thresholded T2*OC map; (C) [14C] 2DG autoradiogram; (D) CBF map in 
mL/100g/min; (E) ADC map (x10-3 mm2/sec) and; (F)  DWI/PWI overlay (mismatch tissue 
is shown in red). ROIs were defined as follows: Green ROI: penumbra—the thresholded 
region displaying the greatest T2* percentage signal change excluding veins and ventricles 
(B). Yellow ROI: region of increased 2DG phosphorylation—identified by the dark band 
within the ipsilateral cortex on the 2DG autoradiogram (C). Red ROI: ischaemic core—
within the ADC-derived lesion in the caudate nucleus (E). White ROI: contralateral 
cortex—homotopic to the penumbra ROI. Sky Blue ROI: contralateral caudate nucleus—
homotopic to the ischaemic core ROI 
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4.2.5 Defining the ischaemic penumbra with T2*OC 
 
The time course and size of the T2* signal change was analysed within ROIs (Chapter 
2.5.6). T2* percentage signal change was calculated from time course graphs, where the 
average baseline signal during the first 3 min of the MRI scanning was subtracted from the 
peak signal during OC. This value was then divided by the average baseline signal and 
multiplied by 100 to generate a percentage signal change. T2*OC percentage signal change 
maps were generated using Image J software. Penumbral tissue was defined on T2* maps 
using a threshold based on the empirical rule: the mean plus 2 SD of the T2* value of the 
contralateral hemisphere, excluding the ventricles (see Figure 4.3B). 
 
4.2.6 Defining the ischaemic penumbra with DWI/PWI Mismatch 
 
DWI and PWI (using ASL) were used to define mismatch, before the T2*OC data were 
analysed, on two selected coronal slices within the MCA territory (Figure 4.1). The 
DWI/PWI mismatch method was included as an alternative indirect technique currently 
used to identify penumbra. It was used to compare the location of presumed penumbra 
between the two techniques. However, there are a number of limitations to the mismatch 
technique, which will be discussed further in Chapter 6. Quantitative ADC maps, in units 
of square millimeters per second, were calculated using the Stejskal–Tanner equation 
(Stejskal and Tanner, 1965). ADC and CBF maps were generated using ImageJ software. 
A 16.5% reduction of mean contralateral ADC was used to determine ischaemic lesion 
volume, which has been shown to match closely the final infarct size following permanent 
MCAO in Sprague-Dawley rats (Lo et al, 1997). Perfusion-weighted imaging was 
performed on the fifth and sixth coronal slices within core MCA territory and the perfusion 
deficit area was calculated based on a 57% reduction of mean contralateral CBF (Meng et 
al, 2004). ADC and CBF maps were overlaid to identify the DWI/PWI mismatch area 
defined as the difference between the perfusion deficit and the ADC lesion area on the 
corresponding slice. For analysis, the data for the rostral and caudal slices were combined. 
 
4.2.7 Volumetric analysis of penumbra, hypo- and hyperglycaemic tissues 
 
Volumetric analysis of penumbra (from DWI/PWI mismatch and the T2*OC), ADC-
defined lesion, perfusion deficit and hypo- and hyperglycaemic tissue on 2-deoxyglucose 
autoradiograms were performed and data expressed as the mean volume over the rostro-
caudal extent of the ASL scans. For 2DG autoradiograms, images were analysed to cover 
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the same rostro-caudal extent as the MR images, and were thresholded to determine the 
region of severely reduced glucose use (glucose values below 10 µmol per 100g per 
minute) and the region of increased 2DG phosphorylation (tissue with glucose values 
above 60 µmol per 100g per minute).  The thresholds were determined by retrospectively 
analysing the glucose utilisation data points (Figure 4.6), and it found that all regions 
regarded as normal in the contralateral hemisphere had glucose values above 10 µmol per 
100g per minute. Similar thresholding was used for the region of increased 2DG 
phosphorylation, in which all values in this rim had glucose values above 60 µmol per 
100g per minute, and the values in the contralateral and penumbra did not exceed this.    
 
4.2.8 Statistical analysis 
 
All data are presented as mean±SD. All data were tested to confirm normal distribution 
using the D'Agostino and Pearson normality test. Data were found to be normally 
distributed, and as such, physiological variables at baseline (pre-OC) and during OC were 
analysed by Student's paired t-test. T2* signal, ADC, CBF, and LCMRglc values in 
different ROIs were analysed by one-way analysis of variance followed by Student's paired 
t-test with a Bonferroni correction for multiple comparisons. A paired t-test was used to 
analyse the temporal evolution of the ADC-derived lesion volume.  
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4.3 Results  
 
4.3.1 Physiological variables 
 
Mean time to commence OC was 147±32 minutes after MCAO. Physiological variables 
were recorded immediately before and during OC (Table 4.1). PaO2 increased significantly 
(262%, p<0.0001) as expected during OC, PaCO2 did not change significantly and mean 
arterial blood pressure increased significantly (11%, p<0.05). The mean plasma glucose 
before scanning was 9.8±2.7 mmol/L. 
 
4.3.2 T2* percentage signal change to OC 
 
T2* percentage signal change during OC was measured over two coronal slices. 
Thresholded T2* maps revealed a region of increased signal, which corresponded 
approximately with the DWI/PWI mismatch (Figures 4.3B & F, respectively). Examining 
the individual T2* time course data (Figure 4.4), T2* signal increase in this penumbral ROI 
was 9.2±3.9%, significantly greater than in the contralateral ROI (2.76±0.3%, p<0.001; 
Figure 4.5). In ischaemic core, mean T2* signal during OC was reduced (−0.49±1.6%) 
compared with the contralateral caudate nucleus ROI (3.56±0.94%, p<0.01). In the ROI 
with increased 2DG phosphorylation, there was a small T2* signal increase of 1.4±0.6%, 
significantly smaller than the response in the contralateral cortex (p<0.05) and penumbral 
ROIs (p<0.001). 
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Physiological Data (n=6) 
 Baseline During OC 
MABP (mmHg) 82.4±7 91.4±6.7* 
PaCO2 (mmHg) 34.8±7 36.3±8.5 
PaO2 (mmHg) 85.8±7.4 310.6±84.1** 
Blood pH 7.32±0.04 7.32±0.04 
 
Table 4.1. Physiological variables at baseline (the 5 min of air inhalation immediately 
before OC) and during oxygen challenge. Data expressed as mean±SD, * p<0.05 and ** 
p<0.0001, Student’s paired t-test 
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Figure 4.4. EPI T2* oxygen challenge (OC) signal time course: time course showing T2* 
signal change during OC in: ADC-derived ischaemic core (red circle); cortical region of 
increased 2DG phosphorylation from 2DG autoradiogram (yellow circle); a region 
corresponding to the greatest T2* percentage signal change increase adjacent to region of 
increased 2DG phosphorylation (green circle); corresponding regions on the contralateral 
cortex (black circle) and caudate nucleus (sky blue circle). Each line represents data from 
a single animal. Within each animal, all data were normalised to the average signal over 
the 5-minute before OC. Blue box represents the period of 100% oxygen inhalation  
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Figure 4.5. T2* percentage signal change from baseline in ROIs. These are individual 
animal data with horizontal lines representing means. ***p<0.001 and *p<0.05 relative to 
contralateral cortex ROI. ## p<0.01 relative to contralateral caudate nucleus. Contra = 
contralateral 
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4.3.3 Glucose use values in ROIs 
 
[14C] 2-deoxyglucose autoradiography revealed at least three different glucose use values 
in the ischaemic hemisphere; the ischaemic core registered severely reduced glucose 
values, a region of increased 2DG phosphorylation on the periphery of the ischaemic core, 
and an adjacent region which displayed glucose utilisation values equivalent to the 
contralateral values. The contralateral hemisphere displayed relatively heterogeneous 
glucose utilisation apart from the white matter, which registered low glucose utilisation 
values. [14C] 2-deoxyglucose autoradiography confirmed glucose use within the T2*OC-
defined penumbra, which was not significantly different from the contralateral ROI 
(22.67±2.1 µmol per 100g per minute compared with 20.1±2.3 µmol per 100g per minute; 
Figure 4.6). Glucose use was below the limit of detection in ischaemic core (Figures 4.3C 
and 4.6) and it was markedly increased in the region of increased 2DG phosphorylation 
(79.7±12 µmol per 100g per minute, compared with contralateral cortex 20.1±2.3 µmol per 
100g per minute, p<0.001). The region of increased 2DG phosphorylation (279% increase 
in LCMRglc compared to the contralateral cortex) was located within the boundary of the 
ADC lesion. It displayed a small increase in T2* signal to OC, which was significantly 
smaller (p<0.05) than the T2* increase observed in the contralateral cortex (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
143 
 
 
 
 
 
 
Figure 4.6. Local cerebral glucose utilisation (LCMRglc) in ROIs. These are individual 
animal data with horizontal lines representing means. ***p<0.001 relative to contralateral 
cortex. ### p<0.001 relative to contralateral caudate nucleus 
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Absolute glucose utilisation values in the hemisphere contralateral to the stroke were low 
compared with most values from the literature, which are generated from conscious 
animals. To confirm the validity of our 2DG technique, in an additional animal, anesthesia 
was withdrawn following MRI scanning and 2DG autoradiography performed 2 hours later 
when the animal was fully conscious (Figure 4.7). Glucose use values were similar to 
reported values and proportionally higher in each ROI when compared with anesthetised 
animals (Table 4.2). The contralateral cortex and caudate registered an LCMRglc value of 
41.67 and 46.7 µmol per 100g per minute and penumbral and region of increased 2DG 
phosphorylation LCMRglc values displayed a 66% and 118% increase relative to 
contralateral cortex, respectively. Conversely, the ischaemic core had a 97% decrease in 
LCMRglc relative to contralateral caudate nucleus. Therefore, the low glucose utilisation 
values in the MRI study were most likely due to the level and duration of anesthesia  
To dismiss the possibility that the presence of the region of increased 2DG 
phosphorylation may be a confound of O2 administration, an additional rat underwent 
MCAO, and when fully conscious, 2DG autoradiography was performed without OC 
(Figure 4.8). The region of increased 2DG phosphorylation was present, suggesting the OC 
per se was not responsible for generating increased 2DG phosphorylation. 
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Figure 4.7. Example 2DG autoradiograms from animals that did not undergo MCAO. A (i) 
A normal conscious rat and accompanying [14C] calibration standards (A (ii)). B (i) A 
normal anaethetised rat (RHS), and the accompanying [14C] calibration standards (B (ii)).  
LCMRglc values generated from the conscious animal were similar to values in the 
literature 
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A (ii)      B (ii) 
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Figure 4.8. Example 2DG autoradiograms from animals that underwent MCAO. A (i) 
Conscious rat and accompanying [14C] calibration standards (A (ii)). B (i) An 
anaesthetised rat with accompanying [14C] calibration standards (B (ii)).  The dark region 
of increased 2DG phosphorylation adjacent to the region of critically reduced glucose use 
which corresponds to the ischaemic damage 
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A. 
  
  
Glucose Utilisation Values  
(µmol/100g/min) 
  
Region of Interest 
  
Conscious Normal Rat 
  
Left Cortex 45.1 
Left Caudate Nucleus 48 
Right Cortex 42.6 
Right Caudate Nucleus 50.3 
 
B. 
 
Table 4.2. Glucose utilisation values (µmol/100g/min) for A. a fully conscious control rat 
and B. a fully conscious rat 1 hour after MCAO 
 
 
 
 
 
 
  
  
Glucose Utilisation Values  
(µmol/100g/min) 
  
Region of Interest 
  
Conscious Stroke Rat 
  
T2*OC defined penumbra 69 
Contralateral Cortex 41.7 
Contralateral Caudate Nucleus 46.7 
Increased 2DG phosphorylation region 91 
Ischaemic Core 1.43 
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4.3.4 Severity of Ischaemia and tissue viability 
On quantitative CBF maps (Figure 4.3D), contralateral cortex and caudate nucleus ROIs 
had mean CBF values of 185±45 and 165±31 mL per 100g per minute, respectively. In the 
ipsilateral hemisphere, there was severe or critically reduced CBF within MCA territory 
that matched spatially with the ADC-derived ischaemic core, and there were incremental 
gradations in CBF from the MCA territory outward.  Cerebral blood flow within ischaemic 
core, region of increased 2DG phosphorylation and penumbra ROIs was significantly 
reduced (7.9±4.7, 21±0.2 and 37±66 mL per 100g per minute, respectively, all p<0.001) 
relative to the equivalent contralateral ROI (Figure 4.9A). 
 
On ADC maps (Figure 4.3E), ROIs in contralateral cortex and caudate nucleus had a mean 
ADC of 0.73±0.06 and 0.74±0.02 x10−3mm2/s, respectively (Figure 4.9B). Apparent 
diffusion coefficient values were significantly reduced in ischaemic core and region of 
increased 2DG phosphorylation ROIs (0.47±0.04 and 0.51±0.08 ×10−3mm2/s, respectively, 
p<0.001), while in the T2*OC-defined penumbral ROI, mean ADC value (0.71±0.04 
x10−3mm2/s) was not significantly reduced compared with contralateral cortex (p>0.05; 
Figure 4.9B). 
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Figure 4.9. CBF (A) and ADC (B) in ROIs. Individual animal data with horizontal lines 
representing means. ***, ### (p<0.001) relative to contralateral cortex and contralateral 
caudate nucleus, respectively 
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4.3.5 Volumetric analysis of penumbra, hypo- and hyperglycaemic tissues 
 
For comparison, penumbra as defined by DWI/PWI mismatch, was mapped over two 
coronal slices from the coregistered ADC and ASL scans (Figures 4.3C & D and 4.3F). 
The volume of perfusion deficit determined at 76.4±13.2 minutes after stroke, was 
103.1±21 mm3, the ADC lesion volume, determined at 106±8 minutes after stroke was 
80.7±30 mm3, generating a DWI/PWI mismatch volume of 22.3±19 mm3. The thresholded 
T2*OC-defined penumbra, determined at 147±32 minutes, was 15±9 mm3. Mismatch- and 
T2*OC-defined penumbral volumes were ~28% and 19% of the volume of the ADC-
defined ischaemic core, respectively. The volume of tissue with severely reduced glucose 
use in ischaemic core was 52.8±18 mm3 and the volume of the region of increased 2DG 
phosphorylation was 21.1±16 mm3. 
 
4.3.6 Evolution of ADC-derived lesion volume 
 
Diffusion-weighted imaging scans generated at the start and conclusion of the MRI 
scanning session (Figure 4.2) provided information on the evolution of ischaemic injury 
over time. A significant increase in the ADC-derived lesion volume (106±66 mm3 at 
52±11 minutes compared with 185±130 mm3 at 106±8 minutes after stroke, p<0.05) 
highlighted the progression of damage in the acute stroke period and the concomitant loss 
of penumbral tissue (Figures 4.10 and 4.11). 
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Figure 4.10. ADC maps from one animal at A. 47 min and B. 107 min to illustrate the 
neuroanatomical location and evolution of the ischaemic damage over time. Absolute 
ADC values measured in x10-3 mm2/sec 
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Figure 4.11. Evolution of the ADC-derived lesion volume. Lesion volumes at the two time 
points in individual animals are displayed, *p<0.05 
 
 
 
 
 
 
 
 
 
 
* 
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4.4 Discussion 
 
Information on metabolic state should improve penumbral definition. BOLD MRI offers 
information on oxygen consumption and delivery (Baird and Warach, 1999; Kavec et al, 
2001), but static T2*-weighted MRI under normoxic conditions has not adequately 
delineated penumbra in ischaemic stroke patients (Tamura et al, 2002; Grohn and 
Kauppinen, 2001); possibly because deoxyhaemoglobin is not rapidly cleared in ischaemic 
conditions (Giesler et al, 2006). However, mapping dynamic changes in T2* in response to 
an oxygen challenge may improve discrimination between penumbra and surrounding 
tissue compartments (Santosh et al, 2008). 
 
The T2*OC MRI technique for detection of the ischaemic penumbra was originally 
described and data generated in a permanent focal cerebral ischaemia model. Validation 
was based on comparison with DWI/PWI mismatch and histologically defined neuronal 
morphology (Santosh et al, 2008), and the feasibility of translation of the technique for 
clinical use in acute stroke has subsequently been demonstrated (Dani et al, 2010). The 
current study provides more direct validation for the technique, with evidence of ongoing 
glucose metabolism within the normal range in T2*OC-defined penumbra.  In addition, 
coregistration of 2DG autoradiography with MRI has provided detailed information on the 
adjacent tissue compartments within the ischaemic hemisphere, which show markedly 
different levels of glucose metabolism. The hypothesis is that the T2*OC technique 
indirectly identifies penumbra from its higher oxygen extraction fraction, which influences 
deoxy: oxyhaemoglobin ratios and consequently T2* signal.  
 
4.4.1 Limitations of the 2DG technique 
 
The [14C] 2DG method may not have accurately defined LCMRglc because the increase in 
radioactivity registered may either be a result of real glucose consumption or a 
methodological artefact from an increase in the lumped constant. In normal conditions, the 
lumped constant used for the 2DG technique is stable over a large spectrum of plasma 
glucose concentrations (Sokoloff et al, 1977). With reduced glucose supply - such as 
during ischaemia - the lumped constant may increase considerably (Suda et al, 1990; 
Vannucci et al, 1989; Gilland and Hagberg, 1996). As there is reduced glucose availability, 
the glucose distribution volume decreases and the lumped constant increases because 2DG 
is the preferred sugar for phosphorylation by hexokinase. As such, local values of the 
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lumped constant should be estimated, which may be derived by measuring the brain uptake 
of methlyglucose (Dienel et al, 1991; Gjedde et al, 1985). Another limitation is the lack of 
a gold standard or independent identification method for penumbra to compare T2*OC 
with. The previous preclinical and human studies by Santosh and colleagues (2008) and 
Dani and colleagues (2010), respectively, implicate CMRO2 and OEF as the components 
responsible for T2*OC penumbral identification, but these cannot be directly measured with 
the imaging modalities used. Ultimately, microPET co-registered with MRI would provide 
a more definitive assessment of the metabolism – compared to 2DG – in the tissue defined 
by T2*OC as penumbra.  
 
4.4.2 Glucose utilisation profiles in the ischaemic brain 
 
Under ischaemic conditions, the coupling of blood flow and metabolism is compromised in 
some regions. Following focal ischaemia, regions of severely reduced blood flow exhibit 
markedly reduced glucose utilisation, whereas a consistent pattern of hypermetabolism is 
evident in the hypoperfused periphery using the 2DG autoradiography technique 
(Nedergaard et al, 1986; Shigeno et al, 1983; Tanaka et al, 1985). This suggests a 
metabolism-flow uncoupling in tissue adjacent to the ischaemic core, in which the 
uncoupling is considered a contributing factor to the evolution of ischaemic damage.  This 
may occur because neural tissue appears to be more sensitive to reductions in oxygen than 
glucose (Astrup et al, 1981; Cox et al, 1983). 
 
The contralateral hemisphere 
 
A smaller T2* signal increase to OC in normal metabolising tissue compared with 
penumbral tissue would be expected (Santosh et al, 2008), and in all six animals, the 
hemisphere contralateral to MCAO showed measurable increases in T2* signal intensity 
during OC (Figures 4.4 and 4.5). By co-registering thresholded T2* maps with glucose use 
autoradiograms, a metabolic signature of normal tissue was generated to allow comparison 
with the ischaemic hemisphere.  
 
The ischaemic core 
 
The MR findings were consistent with the previous study (Santosh et al, 2008), in which 
the ischaemic core, defined by ADC, was notable as a region with negligible T2* signal 
change. It registered undetectable glucose use values, thus confirming metabolic inactivity 
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in this tissue compartment where CMRO2 and oxygen extraction fraction would be 
expected to be markedly reduced or absent. 
 
The ischaemic penumbra 
 
The results show a region of significant T2* increase during OC localised to a cortical 
boundary zone between the MCA and anterior cerebral artery territories, which is 
hypoperfused and overlaps with the DWI/PWI mismatch area. This region displayed 
metabolism on co-registered autoradiograms not significantly different from contralateral 
normal tissue, and significantly greater than infarct core, which is consistent with previous 
2DG studies in acute focal ischaemia (Belayev et al, 1997; Tohyama et al, 1998). Previous 
2DG studies suggest penumbra metabolism within the normal range at 2 hours after stroke, 
with loci of hypermetabolism evident on autoradiograms (Belayev et al, 1997; Tohyama et 
al, 1998).  
 
The region of increased 2DG phosphorylation  
 
An intermediate tissue compartment, identified as a region of increased 2DG 
phosphorylation on autoradiograms (terminology discussed with Professor Guenter Mies, 
Max-Planck-Institute for Neurological Research, Germany) , displayed a small (sub-
threshold) T2* signal change and lay inside the boundary of the ADC abnormality (Figures 
4.3C and 4.4). This may point to residual oxygen utilisation on the border of the ADC 
abnormality in tissue with ADC and CBF values intermediate between the ischaemic core 
and T2*-defined penumbra (Figure 4.9). The presence of the region of increased 2DG 
phosphorylation within the ADC lesion suggests the tissue is still metabolically active, and 
may not be irreversibly injured at this time point, but could be critically injured and 
employing anaerobic glycolysis (Nedergaard and Astrup, 1986), which cannot sustain 
viability. As some oxygen is still being extracted from the blood, this suggests that some 
oxidative metabolism persists but it may indicate tissue destined for rapid, irreversible 
damage. This supports recent blood oxygen level-dependent MR studies proposing that the 
ADC lesion may not only incorporate tissue that is destined to die, but also severely 
injured, still viable tissue (Kidwell et al, 2002), and validates a number of previous studies 
that have reported reversibility of the ADC lesion following reperfusion (Mintorovitch et 
al, 1994; Minematsu et al, 1992; Kidwell et al, 2000). Hypermetabolic tissue displaying a 
small T2* percentage signal change may therefore indicate an intermediate compartment of 
the ischaemic penumbra situated within both the ADC abnormality and the perfusion 
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deficit, whose fate may be being determined by secondary insults after stroke, such as pre-
terminal spreading depolarisations (Back et al, 1996), which may exhaust ATP levels in 
vulnerable cells. 
 
4.4.3 Fate of the hypermetabolic region 
 
The enhanced glucose metabolism after cerebral ischaemia has been ascribed to anaerobic 
glycolysis with lactate production contributing to irreversible damage to the tissue 
(Ginsberg et al 1977). From a number of studies, the ischaemic core has always been 
shown to be hypometabolic and always shows evidence of infarction (Nedergaard et al, 
1988; Prado et al, 1988). There is also a suggestion that the region displaying low glucose 
utilisation may have little or no blood flow, and therefore little or no [14C] 2DG can be 
delivered to the tissue. This study has shown that the ischaemic core is hypoperfused with 
evidence of very restricted but measureable CBF, and that some tracer must gain access to 
this region. Thus, it seems apparent that the hypometabolism is real, and a result of 
compromised cell activity, and not simply the failure to deliver the radioisotope. 
Specifically, the data have shown that the region of increased 2DG phosphorylation is 
situated between the ischaemic core and the region of significantly increased T2* signal 
change (the penumbra displaying glucose metabolism). This region has a negligible T2* 
signal change, suggesting that the region has switched to anaerobic glycolysis, which 
cannot sustain viability. During aerobic respiration, there is a yield of 36 ATP molecules 
per glucose molecule as opposed to only 2 ATP molecules per glucose for anaerobic 
glycolysis. This shows that there is very little ATP generated to sustain the cell in 
anaerobic conditions. The fate of the tissue may also be determined by secondary 
mechanisms post-stroke, including spreading depolarisations. 
 
4.4.4 Spreading depolarisations as a contributor to increased glucose 
phosphorylation 
 
This study has shown the flow-metabolism uncoupling phenomenon in which perfusion in 
the region of increased 2DG phosphorylation is critically reduced whilst glucose use is 
markedly increased (Figure 4.6). Many studies have shown increased glucose 
phosphorylation with 2DG autoradiography immediately peripheral to the infarct border 
(Nedergaard et al, 1986; Shigeno et al, 1983). Notable explanations for this phenomenon 
are that hypermetabolism occurs in this region, which requires increased glucose utilisation 
due to lack of oxygen, and also that anaerobic glycolysis is the predominant mechanism for 
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maintenance of brain metabolism due to the hypoperfused state of the tissue (Nedergaard, 
1986).  
 
There is a theory implicating metabolic stress as a determinant of the fate of the ischaemic 
penumbra. This stress is induced by cortical spreading depolarisations (CSDs) that stem 
from ischaemic depolarisations.  These SD waves have been shown to originate from the 
boundary of the infarct core and traverse through the cortical penumbra (Mayevsky and 
Weiss, 1991; Iijima et al, 1992). Ischaemic depolarisations seem to induce cell damage due 
to the fact that, in ischaemic conditions, CBF in ischaemic tissue is unable to increase in 
response to heightened metabolic demand, and as a consequence, tissue oxygen tension 
decreases (Back et al, 1994) and high energy stores may become depleted (Takeda et al, 
1993). 
 
In experimental focal cerebral ischaemia, CSD incidence correlates with infarct size 
(Dijkhuizen et al, 1999). In the injured penumbra, where blood supply is compromised, 
CSD waves cause further reduction in tissue PO2 and exacerbate metabolic stress–failure 
(Back et al, 1994; Somjen, 2001). Peri-infarct depolarisations (PIDs) in the initial hours 
after injury have been shown to cause a step-wise increase in the ischaemic tissue volume 
(Busch et al, 1996; Takano et al, 1996). Recurrent waves of depolarisation have been 
shown to extend from the ischaemic core to the penumbral region and beyond. CSD cause 
cells to depolarise and they require ATP to restore membrane potentials and ion 
concentration gradients, and peri-infarct depolarisations have been shown to recruit 
penumbral tissue into the ischaemic core (Hartings et al, 2003). The region of increased 
2DG phosphorylation may represent the wave of spreading depolarisations and account for 
the progression of damage in the acute stroke period shown by the evolution of the ADC-
derived lesion volume (Figure 4.11). Nedergaard and Astrup (1986) found that direct 
current (DC) potential was correlated to 2DG phosphorylation in this region. The 200% 
increase in glucose utilisation at the cortical infarct rim was associated with spontaneously 
recurring increases of extracellular potassium detected as DC potential deflections. This 
was in agreement with Branston and colleagues (1977) and Harris (1981), who also noted 
transient increases in extracellular potassium, which linearly correlated with clearance of 
potassium and blood flow. The transformation from aerobic to anaerobic glycolysis in the 
peri-infarct zone has gained credence because of repeated transient elevations of 
extracellular potassium detected in this region of increased 2DG phosphorylation 
(Branston et al, 1977). The increase in extracellular potassium affects the efficiency of the 
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ion transport, which in turn increases the metabolic rate (Shinohara, 1979), and as such, 
this displays the markedly high rate of glucose phosphorylation on the infarct rim. 
 
In the intact brain, increased energy demand is coupled by an increase in cerebral blood 
flow, which allows equilibrium in energy state. In the periphery of brain infarcts, there is 
an uncoupling of flow and metabolism due to the restriction of blood flow. Thus, the peri-
infarct depolarisations may compromise ion homeostasis which is detrimental to the brain 
tissue. For example, Ca2+ influx induced by PID in the peri-infarct region, will contribute 
to the downstream mechanisms in the ischaemic cascade resulting in cell injury that 
accompanies PIDs in the penumbra (Siesjo, 1992). Strong and colleagues (1983) found 
transient increases of potassium activity in the peri-infarct zone, and the frequency of these 
spreading depolarisations correlated with elevated glucose phosphorylation (Shinohara et 
al, 1979), as ATP-dependent ion pumps were overworked to sustain viability.  
 
Tanaka and colleagues (1985) showed that, in the infarct rim, some regions displayed 
preserved flow-metabolism coupling, in that both local CBF (LCBF) and LCMRglc 
decreased proportionally. In this region, there was no evidence of histological damage. In 
contrast, regions having similar degree of flow reduction but increased 2DG accumulation 
displayed mild ischaemic damage. From this, they concluded that the flow-metabolism 
uncoupling contributes to infarct evolution.  
 
Shiraishi and colleagues (1989) suggested that, during MCAO, high concentrations of 
excitatory amino acids may act on postsynaptic receptors which will continuously 
depolarise cells, without the cell actually firing. This causes glial metabolism to increase to 
metabolise the excitatory amino acids. Also, the increase in glucose uptake may be due to a 
shift toward anaerobic metabolism. As oxygen is limited around the rim of the infarct, 
glucose becomes the main nutrient for metabolism, although without oxygen, the Krebs 
cycle efficiency is limited. Lactate is therefore produced, and the amount of ATP 
molecules generated from each glucose molecule is significantly reduced. As a result, more 
glucose is taken up to compensate.  
 
MR lactate spectroscopy co-registered with [14C] 2DG would be one way in which to 
determine anaerobic glycolysis within the ischaemic hemisphere. In the current study, the 
region of increased 2DG phosphorylation, which we assume is metabolising anaerobically, 
has a negligible T2* signal (indicating a low oxygen extraction fraction and oxygen 
metabolism), but it has elevated glucose utilisation. This phenomenon has been shown to 
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disappear 6 hours after stroke (Nedergaard et al 1986). Since this is very inefficient method 
of metabolism, the tissue cannot maintain viability for an extended length of time with 
purely anaerobic respiration. Coregistration shows that the region of increased 2DG 
phosphorylation is on the boundary of the ADC lesion, implying severely injured tissue 
that will rapidly become incorporated into the irreversibly damaged region.    
 
It has been shown that within a few minutes of severe ischaemia, there is a loss of 
electrical activity and disruption of ion homeostasis.  This results in a significant increase 
in extracellular potassium concentrations with a concomitant increase in intracellular 
sodium and calcium concentrations (Hansen, 1981). The rise in intracellular calcium is 
responsible for the irreversible cell damage to mitochondrial function, the powerhouse for 
ATP production. At a later time point, as energy stores are affected, a depletion of 
phosphocreatine is also evident. Following the anaerobic metabolism of glucose in 
ischaemic brain tissue, excessive lactic acid is also produced which induces cellular 
acidosis (Raichle, 1983). Therefore, the decrease in oxygen delivery or other restrictions in 
mitochondrial activity, rather than glucose availability, are probably responsible for 
limiting oxidative metabolism (Sims and Anderson, 2002). This means that the decrease in 
oxygen delivery or impaired mitochondrial activity may be responsible for restricting 
oxidative metabolism, rather than glucose availability. There is a small positive change in 
T2* signal change to OC in the region of increased 2DG phosphorylation, suggesting that 
the tissue is still removing some oxygen from the blood, but a minority of intact 
mitochondria may allow oxidative metabolism to account for the slight increase in signal 
change.  
 
Summary 
 
The current study provides evidence of ongoing glucose metabolism in T2*OC-defined 
penumbra which was not significantly different from contralateral tissue, and significantly 
greater than infarct core. In addition, co-registration of 2DG autoradiography with MRI has 
provided detailed information on the adjacent tissue compartments within the ischaemic 
hemisphere, which show markedly different levels of glucose metabolism. 
 
When compared to the conventional mismatch method, the Oxygen Challenge has 
introduced an additional parameter to improve the delineation of the ischaemic penumbra 
and provided further information on the metabolic characteristics of the tissue. 
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 Chapter 
 
5  
Validation of T2*OC Based on Consequences of 
Reperfusion 
5.1 Introduction 
The mechanical or drug-induced restoration of blood flow represents the most effective 
intervention for acute ischaemic stroke that is ever likely to be discovered (Molina and 
Saver, 2005). In 1996, thrombolysis with recombinant tissue plasminogen activator was 
approved by the US Food and Drug Administration for acute ischaemic stroke of <3 hours 
duration. In May 2009, the American Heart Association/American Stroke Association 
recommended an extension of the window for acute ischaemic stroke, approving 
recombinant tissue plasminogen activator (alteplase) as a treatment up to 4.5 hours after 
symptom onset. The decision was primarily based on the findings from the third European 
Cooperative Acute Stroke Study trial (ECASS III), which confirmed a significant reduction 
in disability at the 90-day time period after recombinant tissue plasminogen activator 
treatment between 3 and 4.5 hours (Hacke et al, 2008). More recently, a time profile of 
benefit and harm for alteplase in a pooled analysis of eight randomized trials concluded 
that one in three patients had improved outcomes when treated between 1 and 3 hours from 
symptom onset, while one in six benefitted in the 3- to 4.5-hour time window. 
Significantly, risk may outweigh benefit beyond the 4.5-hour time point (Lees et al, 2010), 
and this was supported by a previous Cochrane meta-analysis (Wardlaw et al, 2009).  
 
However, patient ineligibility means that fewer than 10% of all stroke patients can be 
thrombolysed (Cocho et al, 2005; Molina and Saver, 2005). There is no current MRI 
technique that accurately detects tissue viability and which could be used in routine clinical 
practice to identify patients likely to benefit from therapy such as thrombolysis, flow 
enhancement, or neuroprotection. The ability to determine a full index of tissue viability 
and haemodynamic status following stroke would significantly improve therapeutic 
intervention strategies for acute ischaemic stroke (Hacke et al, 1998). Alternative 
techniques that could determine tissue metabolic status would represent an advance on 
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current clinical imaging of the penumbra, establishing patient selection criteria for 
therapeutic strategies out-with current rigid time windows.  
 
The previous chapter confirmed that T2*OC identified a compartment with a unique 
profile, defined by a significantly increased T2* percentage signal change. If this region is 
penumbra, the tissue should be capable of recovery if blood flow is restored, and this can 
be achieved by reversing the ischaemic insult by reperfusion. The aim of the current study 
was to test the validity of the T2*OC MRI technique based on the consequences of 
reperfusion. Our stated hypotheses were that T2*OC-defined penumbra should show signs 
of recovery following early restoration of flow and that the T2* response to OC following 
reperfusion should change to resemble the signal change in normal, non-ischaemic tissue. 
This was tested acutely after reperfusion and again at day 7. Evidence of tissue recovery in 
T2*OC-defined penumbra was determined from changes in CBF and ADC acutely 
following reperfusion. T2*OC maps during ischaemia were also coregistered with T2-
defined final infarct to determine whether tissue identified as penumbra had or had not 
become incorporated into final infarct. 
 
5.2 Materials and methods 
 
5.2.1 Rodent MCAO surgery 
 
Male Sprague-Dawley rats (306±12g, n=8, Harlan, Bicester, UK) were initially 
anesthetised with 5% inhaled isoflurane in an induction chamber at room temperature. 
Following intubation, animals were artificially ventilated with 2% isoflurane delivered in 
air, slightly enriched with oxygen (30%) to maintain physiological stability throughout the 
experiment. Blood gases were maintained within the normal physiological range apart 
from increased PaO2 during the OC. PaCO2 was maintained between 35 and 45 mmHg to 
minimise cerebrovascular reactivity (Table 5.1). A rectal thermocouple provided continual 
monitoring of core body temperature that was maintained at 37°C±0.5°C. 
 
Polyethylene catheters (Portex: external diameter 0.96mm; internal diameter 0.58mm; 
70cm long) were placed in femoral arteries, to continuously monitor blood pressure and 
conduct blood gas analysis. MCAO was achieved by the intraluminal filament model, as 
described in Chapter 2.2.3. Ischaemia was induced for 109±20 minutes, which reflected the 
time taken to transfer the animal to the scanner and run the ischaemia scan series. The 
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monofilament was then removed. To ensure complete reperfusion, the ties around the 
common carotid and pterygopalatine branch were loosened to restore blood flow to MCA 
territory. 
 
5.2.2  MRI scanning  
 
Magnetic resonance imaging data were acquired on the system as described in Chapter 
2.5.1.  
 
Protocol 
 
At ~1 hour after stroke, animals underwent MRI scanning that comprised DWI to detect 
ischaemic injury, T2*OC to detect penumbra, and ASL to provide CBF maps of ischaemia. 
Animals were removed from the magnet, and reperfusion was induced by withdrawal of 
the intraluminal filament. The scanning sequence was then repeated to confirm reperfusion 
and to study the consequences of reperfusion on the tissue defined as penumbra from the 
earlier DWI, T2*OC and ASL scans. 
 
Ischaemia-induced damage will continue to evolve following reperfusion in this model and 
consequently histology or MRI at 24 hours will not predict final infarct size. Therefore, 
rats were recovered and rescanned at day 7 to define the final infarct. Choosing this late 
time point also avoids the confounding effects of brain swelling, which is present during 
the first days after stroke but has resolved by 7 days. This improves coregistration of final 
T2 scans with acute scans. The animals also underwent T2*OC at this time point (Figure 
5.1). 
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Figure 5.1 Time line of experimental protocol. Following stroke, the animals were placed 
in the magnet and a DWI scan was performed to identify ischaemic damage, ASL to 
generate fully quantitative blood flow maps and DWI/PWI mismatch images were 
produced for comparison. T2*OC was also performed during this period of ischaemia to 
derive T2* percentage signal change maps. Following MR scanning, the animals were 
removed from the magnet and reperfusion was performed by withdrawal of the 
intraluminal filament. The animals were then placed back in the magnet and the scanning 
sequence was repeated to identify the effect of reperfusion on the ischaemic brain. 
Following the reperfusion scanning series, the animals were removed from the magnet 
and recovered for 7 days post stroke when a T2*OC and a RARE T2 was performed 
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Diffusion-weighted imaging and perfusion-weighted imaging 
 
Diffusion-weighted and perfusion-weighted imaging was performed as described in 
Chapter 2.5.3 and 2.5.4. DW- and PW-imaging were also used to define penumbra from 
DWI/PWI mismatch (Figure 5.3A(vi)) and data were analysed on two selected coronal 
slices within the MCA territory. For analysis, the data for the rostral and caudal slices were 
combined. Arterial spin labelling scans were generated at 44±11 and 59±15 minutes after 
stroke for caudal and rostral slices, respectively. The scanning time for a single ASL slice 
was ~6 minutes and two slices were scanned throughout the MCA territory. Additionally, a 
T1-weighted image (scan time 10 minutes) was performed to allow quantification of CBF 
in mL per 100g per minute. 
 
T2*-weighted imaging 
 
T2*-weighted imaging was performed as described in Chapter 2.5.6. Two coronal MRI 
slices (identified as rostral and caudal slices), which corresponded to territory supplied by 
the MCA, were selected for analysis. The paradigm for the T2*-weighted OC sequence was 
4 minutes breathing air, followed by 6 minutes breathing 100% oxygen. This sequence was 
repeated at day 7 after stroke. 
 
T2-weighted imaging 
 
During acute scanning and at 7 days following reperfusion, a sagittal RARE T2 scan (as 
described in Chapter 2.5.5) was performed, in which the rhinal fissure was used as a 
neuroanatomical landmark to match the geometry as closely as possible with the acute 
scans (Figure 5.2A). A coronal RARE T2 sequence was performed as described in Chapter 
2.5.5 which enabled T2-derived final infarct measurements (Figure 5.2B). 
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Figure 5.2. RARE T2 scans performed in the sagittal plane (A) where the slices were 
aligned with the rhinal fissure (green line), and in the coronal plane (B), which enabled 
final infarct calculations. Ischaemic damage appears hyperintense in this scan sequence. 
There is also evidence of haemorrhage within the infarct, which appears as dark spots in 
the caudate nucleus and the cortex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.          B. 
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5.2.3 MRI Data Analysis 
 
Defining the ischaemic penumbra with DWI/PWI mismatch 
  
Quantitative average ADC maps were generated as described in Chapter 2.5.3. A 16.5% 
reduction of mean contralateral ADC was used to determine the volume of ischaemic 
damage, which has been shown to match closely the final infarct size following permanent 
MCAO in Sprague-Dawley rats (Lo et al, 1997). Perfusion-weighted imaging was 
performed on caudal and rostral coronal slices within core MCA territory and the perfusion 
deficit area was calculated based on a 57% reduction of mean contralateral CBF (Meng et 
al, 2004). ADC and CBF maps were overlaid to identify the DWI/PWI mismatch area. 
Diffusion–perfusion mismatch was calculated as the difference between the perfusion 
deficit and the ADC lesion area on the corresponding slice. Volumes of DWI/PWI 
mismatch and thresholded T2*OC-defined penumbra were generated from the data from 
two coronal slices and the neuroanatomical location compared between the two techniques. 
 
T2* oxygen challenge time course data and defining the ischaemic penumbra 
  
The time course of the T2* signal change was analysed from ROIs (Figure 5.3A (iv)). T2* 
percentage signal change was calculated from time course graphs (Figure 5.4), where the 
average baseline signal was subtracted from the peak signal during OC. This value was 
then divided by the average baseline signal and multiplied by 100. T2* percentage signal 
change maps were generated using ImageJ software. The boundaries of penumbral tissue 
were defined using a threshold based on the empirical rule: the mean plus 2 SD of the T2* 
value of the contralateral hemisphere, excluding the ventricles (Figure 5.3A (iii). 
 
Volumetric analysis of penumbra 
 
Volumetric analysis of the perfusion deficit, ADC lesion, DWI/PWI mismatch, and T2*OC-
defined penumbra was performed over the rostro-caudal extent of the ASL scans. 
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5.2.4 Regions of interest 
 
During ROI placement on the ischaemia scans, I was blinded to the acute reperfusion and 
day 7 data and vice versa. ROIs were selected according to specific features on the images 
(Figure 5.3): (1) ischaemic core in caudate nucleus from the thresholded ADC lesion 
(Figure 5.3A (iv), red); (2) the contralateral caudate nucleus (excluding veins and 
ventricles) (pink), which was manually designated; (3) penumbra as defined by thresholded 
T2* percentage signal change (green); (4) equivalent contralateral cortex (sky blue); and (5) 
DWI/PWI mismatch (dark blue). 
 
For the 7-day data, MRI-defined ROIs were defined and placed within; the final infarct 
according to the RARE T2 scan; the thresholded T2*OC-defined penumbra identified from 
the acute ischaemic scan series; and two equivalent contralateral ROIs. 
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Figure 5.3 (A) Ischaemia scan series and (B) post-reperfusion scan series, with ROIs 
superimposed on the ADC maps (images Aiv and Biv); (ii) T2* oxygen challenge 
percentage signal change map, (iii) thresholded T2*OC map, (v) CBF map (mL per 100g 
per minute), and (vi) DWI/PWI overlay (mismatch tissue shown in red). ROIs were defined 
as follows: 
Green ROI - the penumbra was defined by applying a threshold to display the greatest T2* 
percentage signal change excluding veins and ventricles (iii). 
Red ROI - ischaemic core within the caudate nucleus, derived from the ADC lesion (i). 
Sky blue ROI - the contralateral cortex, equivalent to OC-defined penumbra. 
Cerise ROI - the contralateral caudate nucleus, equivalent to the ADC-derived lesion. 
Dark blue ROI— DWI/PWI mismatch (vi) derived from the thresholded ADC (i) and CBF 
maps (v) 
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Coregistration 
 
To coregister the acute and 7-day scans, linear coregistration was performed using Analyze 
(AnalyzeDirect, Inc. Overland Park, KS, USA). To align the data, ischaemia ASL and T2* 
images were warped to their corresponding DWI slices, and the reperfusion scan series and 
7-day scans were warped to the same DWI slice as the ischaemic scan series. The 
processed data from the T2*OC and thresholded ADC and CBF maps were coregistered to 
(1) define ROIs and (2) identify the T2*OC-defined penumbral tissue. To correlate the T2-
defined infarct with the acute data, the data set at day 7 were also coregistered to the DWI 
scans generated from the ischaemic scan series. 
 
5.2.5 Statistical analysis 
 
All data are presented as mean±SD and were tested to confirm normal distribution using 
the D’Agostino and Pearson normality test. Data were normally distributed and as such, 
mean arterial blood pressure before and during OC was analysed by Student's paired t-test. 
T2* signal, ADC, and CBF values in different ROIs were analysed by one-way analysis of 
variance (ANOVA) followed by Student's paired t-test with a Bonferroni correction for 
multiple comparisons. A paired t-test was performed to compare changes in T2* signal, 
ADC, and CBF at the ischaemia and post-reperfusion time points. 
 
5.3 Results 
 
5.3.1 Acute data  
 
5.3.1.1 Physiological variables 
 
Oxygen challenge was performed twice during the acute scanning session. The mean time 
to commence OC was 78±15 minutes after MCAO for the scans performed during 
ischaemia and 180±31 minutes for the set of scans performed following reperfusion. 
Physiological variables were monitored throughout the experiment. Blood pressure and 
blood gases recorded immediately before OC for both the ischaemia and reperfusion scan 
series were within normal physiological levels (Table 5.1). 
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PHYSIOLOGICAL  
           DATA  
 
 
 
Values during          
ischaemia scans 
 
Values for                
reperfusion scans 
 
 
BASELINE 
 
DURING OC 
 
BASELINE 
 
DURING OC 
 
 
MABP 
 
 
89.4±9 
 
98.3±6* 
 
86.9±9 
 
93.5±10** 
 
 
PaCO2 (mmHg) 
 
41.8±8 
 
42.8±7 
 
 
PaO2 (mmHg) 
 
90±13 
 
89.5±9 
 
 
Blood pH 
 
7.324±0.05 
 
 
7.302±0.03 
 
 
 
Table 5.1. Baseline physiological variables for the ischaemia scan series and the 
reperfusion scan series. MABP, mean arterial blood pressure. Data are expressed as 
mean±SD.  * p<0.05 and ** p<0.001, Student's paired t-test 
 
 
 
 
 
 
 
 
 
 
 
 
171 
 
5.3.1.2 Acute T2* percentage signal change to OC 
 
During MCAO (ischaemia scans), the T2* signal change during OC varied in magnitude 
across the hemisphere ipsilateral to the stroke (Figure 5.4A & C), with the smallest change 
in ischaemic core and the largest in the dorsolateral cortex (OC-defined penumbra). T2* 
signal increase in the penumbra ROI was significantly greater than in the contralateral 
cortical ROI (p<0.01; Figure 5.4C). In ischaemic core within the caudate nucleus, mean 
T2* signal during OC was significantly reduced compared with the contralateral caudate 
nucleus ROI (p<0.05). 
 
Following reperfusion (mean OC scan time = 180±31 minutes following stroke onset and 
71 minutes from initiation of reperfusion), T2* signal increase in the penumbral ROI 
reduced significantly from 8.4±4.1% to 3.25±0.81% (p<0.001, Figure 5.4B & D). In the 
DWI/PWI mismatch ROI, T2* percentage signal changed from 5.48±2.8% during 
ischaemia to 2.49±1.04% following reperfusion (Figure 5.4D). There were no significant 
T2* percentage signal changes from ischaemia to reperfusion in any of the other ROIs; T2* 
percentage signal change in ischaemic core caudate nucleus changed from 0.39±0.47% 
during ischaemia to 0.83±1.7% following reperfusion, contralateral cortex changed from 
2.97±1.8% to 2.61±1.1%, and contralateral caudate nucleus changed from 3.35±2% to 
2.59±1.3%. 
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Figure 5.4. Mean T2* signal time course during ischaemia (A), and following reperfusion 
(B), mean T2* percentage signal change from baseline for ROIs during ischaemia (C) and 
following reperfusion (D) (n=8). (A, B) Positive T2* signal changes were recorded during 
oxygen challenge (OC) in contralateral caudate nucleus and cortex, the DWI/PWI 
mismatch, and the T2*OC-defined penumbra. All data were normalised to the average 
signal over the 4 minutes before OC from eight animals. The blue box represents the 
period of 100% oxygen inhalation (OC). (C, D) Horizontal lines represent means. ** 
p<0.01, relative to contralateral cortex ROI. # p<0.05, relative to contralateral caudate 
nucleus 
 
 
 
 
A.           B. 
C.         D. 
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5.3.1.3 Severity of ischaemia and tissue viability 
 
During ischaemia, blood flow in the T2*OC-defined penumbra, DWI/PWI mismatch, and 
ischaemic core caudate nucleus were significantly reduced compared with the equivalent 
contralateral ROIs (p<0.001, Figure 5.5A). Cerebral blood flow values in the OC-defined 
penumbra were significantly higher than the DWI/PWI mismatch-defined penumbra 
(p<0.05). On reperfusion, mean CBF in ischaemic core caudate nucleus increased from 
4.3±5.3 to 31±74 mL per 100g per minute, but remained significantly reduced compared 
with the equivalent contralateral ROI (p<0.001, Figure 5.5B). Mean CBF in the T2*OC-
defined penumbra increased significantly from 41.94±13 to 116.5±25mL per 100g per 
minute (p<0.001, 5.5B). Mean CBF in DWI/PWI mismatch also increased significantly 
from 16.8±14 to 104.4±50mL per 100g per minute (p<0.001). Blood flow in contralateral 
caudate nucleus and cortex did not change significantly following reperfusion; 143±20 to 
121±14 and 161±24 to 127±36 mL per 100g per minute, respectively. 
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Figure 5.5. Mean CBF in selected ROIs during ischaemia (A) and following reperfusion 
(B). Horizontal lines represent means. *** p<0.001 relative to contralateral cortex ROI.       
# # # p<0.001 relative to contralateral caudate nucleus ROI. $ p<0.05 
 
 
A. 
 
B. 
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Figure 5.6. Mean ADC in selected ROIs during ischaemia (A) and following reperfusion 
(B). Horizontal lines represent means. ***  p<0.001, ** p<0.01, * p<0.05 relative to 
contralateral cortex ROI. ###  p<0.001, relative to contralateral caudate nucleus ROI 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
* 
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During ischaemia, ADC values (mean scan time was 72±8 minutes after stroke) in the 
T2*OC-defined penumbra, ischaemic core caudate nucleus and DWI/PWI mismatch were 
significantly reduced compared with the equivalent contralateral ROIs (Figures 5.3A(i) and 
5.6A; p<0.001, p<0.001, and p<0.01, respectively).  Following reperfusion, ADC values in 
the DWI/PWI mismatch and ischaemic core caudate nucleus ROIs remained significantly 
reduced when compared to equivalent contralateral ROIs following reperfusion. However, 
the ADC values in T2*OC-defined penumbra were not significantly different than the 
contralateral cortex ROI following reperfusion (Figure 5.6). 
 
5.3.2 Day 7 data  
 
5.3.2.1 T2-defined infarct volume and T2*OC percentage signal change 
 
In the surviving animals, infarcts were predominantly located sub-cortically with minimal 
cortical damage. The surviving animals (n=4, Figure 5.7B) tended to have a smaller ADC 
lesion volume during acute imaging than the animals that died prematurely (n=4) (Figure 
5.7A). The animals that died prematurely did not survive beyond the 24 hour time point, 
suggesting that acute brain swelling was the most likely cause of death. Both ipsilateral 
and contralateral hemispheric volumes were calculated to show that there was no 
significant residual brain swelling at day 7 (622±27 and 624±30 mm3 for the ipsilateral and 
contralateral hemispheric volumes, respectively). 
 
T2* percentage signal change on day 7 in the OC-defined penumbra ROI (1.69±0.6%) was 
not significantly different from data for the equivalent contralateral cortex (1.72±0.6%; 
Figure 5.8B). The T2* signal change in the T2-defined final infarct ROI was significantly 
reduced – displaying a negative signal (−0.88±0.6%) - compared with the equivalent 
contralateral caudate nucleus (1.72±0.6%) (p<0.01; Figure 5.8B). Figure 5.9 shows ADC 
maps and equivalent T2* percentage signal change maps from three slices within MCA 
territory during ischaemia, following reperfusion and at day 7.  Figure 5.11 shows the 
effect of reperfusion on the ADC lesion over 3 slices in representative animal, as well as 
allowing comparison of the initial ADC lesion with the RARE T2-derived final infarct. 
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Figure 5.7. Illustrative ADC maps (slice 5) during the acute ischaemia scanning series of 
A. Animals that died before day 7 and B. Animals that survived up to day 7. The animals 
that survived up to day 7 tended to initially have smaller acute ADC lesions with less 
cortical damage. ADC scale bars in units of x10-3mm2. ADC lesions were derived using a 
16.5% reduction in the mean contralateral ADC values excluding the ventricles (outlined in 
red) 
 
 
 
Non-surviving animals Surviving animals A.          B. 
Rat ID. REP6 Rat ID. REP2 
Rat ID. REP8 Rat ID. REP5 
Rat ID. REP7 Rat ID. REP11 
Rat ID. REP12 Rat ID. REP9 
ADC map ADC map 
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Figure 5.8. T2* percentage signal change at day 1 and day 7 in selected ROIs. 
(A) MRI ROIs derived from (i) acute T2*OC percentage signal change maps during 
ischaemia (ipsilateral cortex penumbra - green); (ii) RARE T2 scans at day 7 after stroke 
(infarct ROI-yellow); and (iii) T2* percentage signal change maps at day 7 (contralateral 
cortex and caudate nucleus - sky blue and red, respectively). ROIs were superimposed 
onto day 7 T2* percentage signal change maps generated 7 days after stroke to generate 
T2* signal time course graphs (B). T2* time course graphs represent the mean normalised 
signal from four animals. All data were normalised to the average signal over the 4 
minutes before oxygen challenge. Blue box represents the period of 100% oxygen 
inhalation 
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     Slice 4  Slice 5   Slice 6 
 Ischaemia          
                            
 Reperfusion       
                 
   Day 7                 
     
Figure 5.9.  ADC maps and equivalent T2* percentage signal change maps from three 
slices within MCA territory during ischaemia (top), following reperfusion (middle) and at 
day 7 (bottom).  ADC lesions were derived using a 16.5% reduction in the mean 
contralateral ADC values excluding the ventricles (outlined in red) 
 
 
ADC map 
ADC map 
ADC map 
T2*% change map 
T2*% change map 
T2*% change map 
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5.3.2.2 Evidence of penumbral salvage 
 
Coregistration of the T2*OC-defined penumbra ROI (derived from the T2* percentage map 
during ischaemia) onto the RARE T2 scan at day 7 (Figure 5.10), revealed that this region 
was not incorporated into the final infarct in any animal, providing evidence that T2*OC-
defined penumbra had been salvaged by reperfusion. 
 
5.3.2.3 Volumetric analysis of perfusion deficit, ADC lesion and penumbra 
 
The volume of perfusion deficit, determined at 52.8±14.2 minutes after stroke, was 110±25 
mm
3
 and the ADC lesion volume determined at 72±8 minutes after stroke was 91.6±33 
mm
3
, generating a DWI/PWI mismatch volume of 20.2±15 mm3. The thresholded T2*OC-
defined penumbral volume, determined at 78±15 minutes was 17.3±9 mm3. The mismatch- 
and T2*OC-defined penumbral volumes were ~22% and 19% of the volume of the ADC-
defined ischaemic core, respectively. Although the volume of penumbral tissue was similar 
for the two methods, there were spatial differences with regards to the physical location 
(Figure 5.10(iv)). 
 
The perfusion deficit volume in the four animals that survived to day 7 was 110.3±6 mm3 
determined at 53.5±12 minutes after stroke, and the ADC lesion volume was 88.6±21 mm3 
determined at 68.3±8.4 minutes after stroke. The DWI/PWI mismatch volume was 
25.7±14 mm3 and the thresholded T2*OC-defined penumbra, determined at 82.5±15 
minutes was 18.9±8 mm3. The mismatch- and T2*OC-defined penumbral volumes were 
~29% and 22% of the volume of the ADC-defined ischaemic core, respectively. The T2-
defined final infarct volume at 7 days following MCAO was 71.7±22 mm3.  
 
5.3.2.4 Reperfusion reduces ADC-defined ischaemic damage 
 
When comparing final infarct at 7 days with the ADC-derived lesion during ischaemia, 
ischaemic damage reduced from 116±64 mm3 during ischaemia to 107±68 mm3 at day 7 
(Figure 5.11 and 5.12). This confirms the presence of penumbral tissue within the ADC 
defined lesion. 
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Figure 5.10. Comparison of neuroanatomical location of thresholded OC-defined 
penumbra in relation to T2-defined final infarct and DWI/PWI mismatch. Acute T2* 
percentage signal change map (i) was thresholded to identify penumbra (ii) and 
superimposed upon the day 7 RARE T2 (iii)—penumbra outlined in green. The final infarct 
is outlined in yellow. The T2*OC penumbra region of interest (ROI) was superimposed 
upon the DWI/PWI mismatch (iv) to compare the difference in the spatial locations of the 
mismatch and the T2*OC defined penumbra 
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  Ischaemia  Reperfusion       Day 7 
     
     
     
     
     
     
     
     
Figure 5.11. Ischaemic damage during ischaemia, post-reperfusion and at day 7 from a 
representative animal. ADC lesions were derived using the 16.5% reduction threshold 
(drawn in red), whereas the hyperintense region on the RARE T2 scans were manually 
transcribed. ADC lesion volume decreased following reperfusion and final infarct was 
slightly reduced at day 7 compared to the ADC lesion post-reperfusion (Animal ID REP5, 
lesion volume shown in Figure 5.12)  
ADC map   ADC map RARE T2 map 
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Figure 5.12. ADC lesion volume during ischaemia, following reperfusion and final infarct 
volume at day 7. Data with red lines represent the animals that survived up to day 7. Note 
that the lesion volume tended to either decrease or remain relatively static following 
reperfusion, and the injury did not expand between time of reperfusion and day 7. Data 
with black lines represent the animals that died before day 7 scans could be performed.  
Note that initial lesion volume in the animals that died tended to be greater than in the 
surviving animals, and that lesion volume continued to evolve despite reperfusion in two of 
the animals 
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5.4 Discussion 
 
Depending on the duration and severity of the ischaemic insult, at least some of the tissue 
regarded as penumbra may recover if blood supply is promptly restored. If blood supply is 
restored and the tissue recovers, it should no longer demonstrate an increased OEF and its 
response to OC should be similar to non-ischaemic tissue. The validity of T2*OC by timely 
restoration of CBF and final infarct measurement to determine tissue salvage was 
evaluated. 
 
The aim of this study was to test the validity of the technique by examining the fate of 
T2*OC-defined penumbra by timely restoration of CBF and final infarct measurement. 
Repeat T2*OC MRI sequences should reflect changes in the penumbra associated with 
restoration of flow and normalisation of T2* signal change consistent with tissue salvage. 
Evidence of recovery in the OC-defined penumbra was evaluated acutely by assessing 
changes in CBF and ADC following reperfusion and in the longer term on T2-derived final 
infarct volume after 7 days.  
 
There are varying definitions of penumbra, which have been devised using different 
techniques. The penumbra can be described as a region of decreased cerebral protein 
synthesis and preserved tissue ATP levels (Hossmann, 1993), unlike the ischaemic core, 
which experiences reductions in both protein synthesis and ATP.  Following the 
progressive reduction in blood flow, decreased protein synthesis is one of the first 
biochemical or molecular changes that can be identified (Dienel et al, 1980; Bergstedt et al, 
1993), declining when flow reduces below 50% (Mies et al, 1990). While this method may 
more accurately delineate penumbra, it requires a terminal autoradiographical technique, 
which cannot be used in recovery models of stroke. As such, the current definition of 
penumbra used for the study was tissue with reduced flow which has the capacity to 
recover when flow is promptly restored and this was evaluated from final infarct displayed 
on T2 scans at 7 days post-stroke. Additionally, the pathophysiological mechanisms of 
ischaemic damage differ between permanent and transient MCAO. In permanent MCAO, 
peri-infarct depolarisations in oligaemic tissue are implicated in the evolution of penumbra 
into the infarct core, whereas in transient MCAO delayed secondary energy failure is 
responsible for evolution of damage (Olah et al, 2001). 
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5.4.1 Acute data 
 
As expected, during ischaemia, the tissue demonstrating the greatest T2* increase to OC 
was localised to a cortical boundary zone between the MCA and anterior cerebral artery 
territories, which overlapped the DWI/PWI mismatch area. A smaller T2* response was 
recorded in non-ischaemic tissue, with negligible response within ischaemic core. These 
MR findings were consistent with our previous studies (Santosh et al, 2008; Robertson et 
al, 2011; Chapter 4 of the current thesis). 
 
Restoration of blood flow to penumbral tissue will restore arterial oxygen levels back to 
normal with a resultant decrease in the OEF. The reduction in T2* signal change in T2*OC-
defined penumbra following reperfusion is consistent with our stated hypothesis and 
provides evidence that the tissue is metabolising aerobically (Figure 5.4B). The extent of 
reperfusion was apparent on CBF maps, which demonstrated that blood flow in penumbral 
tissue attained levels similar to the contralateral cortex (Figure 5.5B). However, 
withdrawal of the intraluminal filament did not universally lead to complete reperfusion, as 
flow was still compromised in the ADC-defined ischaemic core (31.74±38 mL per 100g 
per minute, Figure 5.5B). Tissue recovery following reperfusion was evident in the OC-
defined penumbra, in which the ADC values were above the ADC threshold of 
abnormality (0.63±0.06 x 10−3mm2/s). In addition, reperfusion increased the ADC value of 
some tissue within the ischaemic core to above the predefined viability threshold (shown 
by change in lesion size following reperfusion) (Figure 5.3A(i) and B(i), and Figure 5.6). 
 
5.4.2 Day 7 Data 
 
T2*OC-defined penumbra 
  
Our hypothesis stated that reperfused penumbral tissue should exhibit a normal T2* 
response to OC and this was confirmed on the day 7 T2* response (Figure 5.8B). There is 
evidence to suggest that the T2*OC technique is detecting true penumbral tissue. Penumbra 
must fulfil the fundamental criteria of being functionally reversible and responsive to 
therapeutic intervention. The region of tissue that displayed an increased T2* response 
(penumbra) in the acute scanning series, whose signal response then attenuated to a level 
similar to normal tissue following reperfusion,  was shown to fully recover in that it did not 
become incorporated into the final infarct (Figure 5.10). During ischaemia, penumbra is 
capable of metabolising oxygen and extracting oxygen in the blood, aided by an increased 
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OEF.  As such, during ischaemia, the oxyhaemoglobin: deoxyhaemoglobin ratio would 
alter in response to OC, in that high baseline deoxyhaemoglobin levels in penumbra 
convert to oxyhaemoglobin. This, in turn, increases the T2* signal response. Following 
reperfusion, blood flow and concomitant oxygen in the viable penumbral tissue is restored, 
which reduces the OEF and mirrors the T2* response seen in normal tissue. At day 7, this 
previously penumbral tissue remains out with the final infarct and has a similar T2* 
response to the contralateral hemisphere following OC (Figure 5.10 and 5.8B). As such, 
the reversibility of penumbra to normal tissue is detected by the T2*OC technique and 
confirmed by T2-weighted scans.  
 
Ischaemic core 
 
Following reperfusion, irreversibly injured (ischaemic core) tissue should no longer 
metabolise oxygen or extract oxygen from the blood. Oxyhaemoglobin: deoxyhaemoglobin 
ratios would therefore be expected to remain static during OC. Within the T2-defined 
infarct on day 7 after stroke, a negligible negative T2* signal change was observed during 
OC. The negative signal change recorded may be due to the presence of paramagnetic free 
oxygen dissolved within the plasma flowing through non-metabolising irreversibly 
damaged tissue, which will result in a reduction in T2* signal. Therefore, after 7 days, 
T2*OC enabled reperfused, non-metabolic tissue to be differentiated from metabolic tissue. 
Four out of the eight animals died before day 7.  The high mortality appears to be most 
likely due to raised intracranial pressure associated with brain swelling as in these 4 
animals the ADC lesion during ischaemia was larger than those animals that survived and 
the lesion continued to evolve following reperfusion.  
 
5.4.3 Deleterious reperfusion events 
 
In the hyperacute stage of stroke, a region of tissue normally supplied by the occluded 
artery cannot maintain normal oxygen metabolism when blood flow is reduced. This 
region is characterised by a decrease in CBF, with partially preserved CMRO2 and 
LCMRglc. This is the early penumbral stage – often called misery perfusion – in which 
there is inadequate blood supply relative to metabolic demand (Baron et al, 1981). This 
phenomenon describes the state in which the tissue cannot receive adequate nutritive 
delivery whilst its energy reserves are rapidly becoming exhausted. The inadequacy to 
nourish the still-viable tissue outlines the in limbo nature of the ischaemic penumbra, in 
which full recovery of this tissue is still possible. According to PET studies, misery 
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perfusion is evident in 45-57% of patients studied within 4 days onset of acute stroke 
(Figure 5.13) (Baron et al, 1987). 
 
On blood vessel recanalisation, misery perfusion in the ischaemic brain is followed by 
luxury perfusion which tends to be present during early reperfusion but is not maintained. 
Luxury perfusion is characterised by an oxygen supply in excess of demand, and its 
hallmark is a focal reduction of the OEF. It indicates full or partial re-establishment of 
perfusion within injured or already irreversibly damaged tissue. In luxury perfusion, the 
CBF may be increased (hyperperfusion), normal, or even decreased (relative to normal 
perfusion), although by definition in excess of what is required for prevailing CMRO2, 
which itself may be normal, increased, or reduced. Hyperperfusion may compound the 
original insult by exacerbating cerebral oedema or by causing intraparenchymal 
haemorrhage. Therefore, despite a good likelihood of an excellent neurological outcome, 
reperfusion may paradoxically induce a series of pathophysiological responses which result 
in potentially fatal outcomes, including cerebral oedema or intracranial haemorrhage (The 
National Institute of Neurological Disorders and Stroke rT-PA Stroke Study Group (1997). 
Haemorrhagic transformations 24-36 hours following stroke are more frequent after 
reperfusion, regardless of the modality used (such as anti-thrombotics, mechanical 
recanalisation and intravenous lytics) (Khatri et al, 2007). Regarding animal models, 
reperfusion following a long period of ischaemia may actually increase final infarct size, 
compared to permanent blood vessel occlusion models (Aronowski et al, 1997; Yang and 
Betz, 1994). As such, thrombolytic therapy can potentially exacerbate ischaemic injury for 
certain patients, whilst dramatically improving clinical outcomes in others. The 
pathological cascade resulting from delayed reperfusion is often termed ‘reperfusion 
injury’.  
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Figure 5.13.  Evidence of misery perfusion in the acute stage (day 1), where there is 
impaired CBF and a preservation of oxygen metabolism (misery perfusion and increased 
oxygen extraction fraction) throughout whole MCA territory. After two weeks, CBF and 
CMRO2 are proportionally decreased in this region, suggesting incorporation of penumbra 
into infarct (Adapted from Heiss and Herholz, 1994) 
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Reperfusion injury induces a cascade of harmful mechanisms that both introduce cellular 
dysfunction and increase cell death in tissues compromised by ischaemia. Reintroduction 
of oxygenated blood to the ischaemic region initiates the generation of oxygen free radicals 
and infiltration of neutrophils which, in addition to direct neuronal damage, may injure the 
endothelium and lead to subsequent haemorrhage (Fisher et al, 1990; Matsuo et al, 1995; 
Iadecola et al, 1996). Additionally, MCAO rat data have shown that inflammatory cells 
also contribute to increased apoptotic neuronal cell death (Chopp et al, 1996). An 
inflammatory response is known to originate from biochemical and cellular changes that 
cause oxidant production and complement activation (Jean et al, 1998). There are systemic 
and local responses to the onset of inflammation. This secondary brain damage arising 
from the acute inflammatory reaction may be due to cytokine production and molecular 
adhesive events. Leukocytes are recruited to the reperfused tissue which may induce 
microvessel occlusion and thus initiate a no-reflow phenomenon. So, following 
reperfusion, recirculation is inefficient (Ames et al, 1968) and likelihood of salvage is 
reduced.  
 
Some subjects may have a more rapid recruitment of ischaemic tissue before reperfusion is 
performed, thereby leading to non-nutritional reperfusion, which may be due to the actual 
severity of the ischaemia.  There is also a danger of pathophysiological effects following 
reperfusion, such as blood brain barrier disruption which leads to haemorrhagic 
transformation, or brain oedema (Molina and Alvarez-Sabin, 2009). However, the extent of 
reperfusion is now used as a surrogate marker for treatment efficacy, particularly with 
regards to thrombolytic therapy (Arnold et al, 2005). 
 
5.4.4 Limitations of the study 
 
Time to reperfusion varied slightly between rats due to the time taken to carry out the MRI 
scanning protocol during ischaemia. The duration of ischaemia was worth examining to 
note its contribution to mortality and explain why in some rats little or no tissue salvage 
was seen following reperfusion. The non-surviving animals had a mean reperfusion time of 
113±25 min, whereas the surviving animals had a mean reperfusion time of 107±22 min. 
This non-significant difference suggests that duration of ischaemia was not the 
contributing factor. Reperfusion is associated with considerable brain swelling at the 24- to 
48-hour time point. For this reason, only four of the 8 animals survived out to 7 days. This 
is a drawback of the intraluminal filament model, where the intact skull means there is no 
control of intracranial pressure. Also, the presence of iron-rich haemorrhages at day 7 may 
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undermine the T2*OC technique for identifying metabolic tissue following stroke at later 
time points.  
 
Summary 
 
An attenuation of the T2* percentage signal change to OC, following restoration of CBF, 
was consistent with tissue salvage in the T2*OC-defined cortical penumbra. Therefore, 
cortical tissue identified as penumbra using the OC technique is capable of recovery when 
blood flow is restored, which provides further evidence for the utility of T2*OC MRI for 
acute stroke management. 
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Chapter 
6  
Spatiotemporal mapping of the T2*OC- and DWI-PWI 
mismatch-defined penumbra 
6.1 Introduction  
When DWI/PWI mismatch was used to select patients for thrombolysis, it identified 
patterns that may define treatment responsiveness (DEFUSE study, Albers, Thijs & 
Wechsler et al, 2006) and it has been used to select patients for investigating an extended 
time window for thrombolytic therapy (Hacke, 2005).  However, the technique has not 
been validated clinically and has a number of limitations.  No DWI or ADC threshold has 
been determined which can differentiate between irreversibly damaged and potentially 
recoverable tissue (Guadagno et al, 2004) and when DWI/ADC thresholds are applied, the 
lesions identified can be fully or partially reversed by reperfusion in animal models and 
man (Kidwell et al, 2000). Interestingly, after reversal of the DWI lesion in humans 
following thrombolysis, secondary injuries may result in the return of the DWI lesion 
(Kidwell et al, 2000).  As a consequence, thrombolysis may also benefit patients with no 
evidence of mismatch, since DWI lesions can potentially reverse. Also, defining a 
threshold for the perfusion deficit is equally difficult and may include benign oligaemic 
tissue which is not at risk (Butcher et al, 2005; Takasawa et al, 2008).    
 
In animal stroke models, the amount of mismatch tissue has been shown to be very 
variable, and dependent upon the thresholds applied to ADC and CBF. Mismatch evolution 
varies between animal strains (Bardutzky et al, 2005) and the techniques applied to induce 
stroke (Henninger et al, 2006). These are crucial factors, as embolic MCAO models show 
the presence of penumbra for a long period of time compared to the intraluminal filament 
model (Zhang et al, 2001; Wang et al, 2001), suggesting that therapeutic time windows 
may be subjective. 
 
Selection of patients for thrombolysis using DWI/PWI has been attempted (DEFUSE) and 
the phase II Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) suggested that 
patients with large mismatch may have improved clinical outcomes following 
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thrombolysis, although the DIAS-2 study indicated otherwise (Donnan et al, 2009; Albers 
et al, 2006; Hacke et al, 2009; Davis et al, 2008). DIAS-2 defined the PWI perfusion 
deficit as >20% of the DWI lesion volume when presenting within 3-9 hours of symptom 
onset, whereas the DEFUSE and EPITHET volumetric measurements of mismatch were 
generated at a later time point. This highlighted the problem of quantifying CBF and 
mismatch, as there is no consensus over the thresholds to define the terms. Thresholds 
often tend to be generated from in-house measurements, and the introduction of 
standardised parameters may simplify findings between groups and studies.  
 
The penumbra per se is defined not only as a region of perfusion deficit but also of some 
remaining metabolic activity. The absence of a marker of tissue metabolism for penumbral 
definition in current MRI paradigms renders comparability with standard PET findings 
difficult and leaves interpretation susceptible to the varied approaches used to define the 
perfusion deficit. As such, technological advancements are in place which introduce a 
measurement of metabolic activity to mismatch estimation, including MRI assessments of 
CMRO2 (Xu et al, 2009) and MR-PET technology (Beyer and Pichler, 2009). 
 
Aims 
 
The previous studies have applied one T2*OC to identify penumbra and tested if this tissue 
compartment demonstrated the characteristics of penumbral tissue, i.e., ongoing glucose 
metabolism, and recovery on early reperfusion.  Penumbral tissue would be expected to 
deteriorate and become incorporated into the irreversibly damaged ischaemic core over 
time if blood supply is not restored.  In this study, I investigated how the T2*OC defined 
penumbra changed over time and then compared this with identification of penumbra as 
defined by PWI/DWI mismatch. 
 
The main goals were:  
 
(1) To map the temporal and spatial dynamics of tissue compartments in the ischaemic 
brain by applying thresholds according to its ADC, CBF and T2* status. Specifically, tissue 
compartments were defined by generating images using ADC and CBF criteria, CBF and 
T2* criteria, and ADC and T2* criteria.   
 
(2) Identify and quantify the normal, ischaemic core and penumbral tissue compartments 
as defined by the aforementioned criteria over the first 4 hours following stroke. 
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6.2 Materials and methods 
6.2.1 Rodent MCAO surgery 
Male Sprague-Dawley rats (328±22g, n=6, Harlan, Bicester, UK) were initially 
anesthetized with 5% inhaled isoflurane in an induction chamber at room temperature. 
Following intubation, animals were artificially ventilated with 2% isoflurane delivered in 
air, slightly enriched with oxygen (30%) to maintain physiological stability throughout the 
experiment. Blood gases were maintained within the normal physiological range apart 
from increased arterial partial pressure of oxygen (PaO2) during the OC. PaCO2 was 
maintained between 35 and 45 mmHg to minimise cerebrovascular reactivity (Table 6.1). 
A rectal thermocouple provided continual monitoring of core body temperature that was 
maintained at 37°C±0.5°C. A polyethylene catheter (Portex: external diameter 0.96mm; 
internal diameter 0.58mm; 70cm long) was placed in the femoral artery, to continuously 
monitor blood pressure and conduct blood gas analysis. Middle cerebral artery occlusion 
(MCAO) was achieved by the intraluminal filament model, as described in Chapter 2.2.3.   
 
6.2.2 MRI scanning 
Scanning Protocol 
 
Scanning was performed at three time points acutely (Figure 6.1) and once at the 24 hour 
time point. Firstly, at approximately 1 hour after stroke, animals underwent MRI scanning 
that comprised DWI to detect ischaemic injury, T2*OC to detect penumbra, and ASL to 
provide CBF maps of ischaemia. This scanning sequence was then repeated again at 2.5- 
and 4- hours following stroke. Rats were then recovered and rescanned at 24 hours post-
stroke where RARE T2-weighted imaging was performed to define the final infarct. The 
animals also underwent T2*OC and ASL at this time point. 
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Figure 6.1 Time line of experimental protocol. Following stroke, the animals were placed 
in the magnet and a DWI scan was performed to identify ischaemic damage, ASL to 
generate fully quantitative blood flow maps and mismatch images were produced. T2*OC 
was also performed during this period of ischaemia to derive T2* percentage signal change 
maps. The scanning sequence was repeated twice, to allow T2*OC scanning at 2.5 hours 
and 4 hours post-MCAO. The animals were removed from the magnet and recovered up 
to 24 hours, and T2*OC and a RARE T2 was performed 
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Diffusion-weighted imaging and perfusion-weighted imaging 
 
Diffusion-weighted and perfusion-weighted imaging was performed as described in 
Chapter 2.5.3 and 2.5.4. DW- and PW-weighted imaging was used to define penumbra 
from DWI/PWI mismatch and data were analysed on four selected coronal slices within 
the MCA territory. The scanning time for a single ASL slice was ~6 minutes and four 
slices were scanned throughout the MCA territory. Additionally, a T1-weighted image 
(scan time 10 minutes) was performed to allow quantification of CBF in mL per 100g per 
minute. 
 
T2*-weighted imaging 
 
T2*-weighted imaging was performed as described in Chapter 2.5.6. The same four coronal 
MRI slices throughout MCA territory used to generate CBF and ADC maps were selected 
for analysis. These slices were carefully selected to minimise the effect of susceptibility 
distortion around the ear canals. The paradigm for the T2*-weighted OC sequence was 5 
minutes breathing air, followed by 5 minutes breathing 100% oxygen, and then 10 minutes 
breathing air. This sequence was repeated 24 hours after stroke. 
 
T2-weighted imaging 
 
A coronal RARE T2 sequence was performed as described in Chapter 2.5.5 which enabled 
T2-derived final infarct measurements 
 
6.2.3 MRI data analysis 
T2* oxygen challenge time course data and defining the ischaemic penumbra 
  
T2* percentage signal change was calculated from time course graphs, where the average 
baseline signal was subtracted from the peak signal during OC. This value was then 
divided by the average baseline signal and multiplied by 100. T2* percentage signal change 
maps were generated using ImageJ software. The boundaries of penumbral tissue were 
defined using a threshold based on the empirical rule: the mean plus 2 SD of the T2* value 
of the contralateral hemisphere, excluding the ventricles. 
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Defining the ischaemic penumbra with DWI/PWI mismatch 
  
Quantitative ADC maps, in units of square millimetres per second, were calculated using 
the Stejskal–Tanner equation (Stejskal and Tanner, 1965). Apparent diffusion coefficient 
maps and CBF maps were generated using ImageJ and the ADC lesion and perfusion 
deficit, respectively, were thresholded using the empirical rule. Perfusion deficit area was 
calculated on each of the four PWI slices.  Apparent diffusion coefficient and CBF maps 
were overlaid to identify the DWI/PWI mismatch area. DWI/PWI mismatch was calculated 
as the difference between the perfusion deficit and the ADC lesion area on the 
corresponding slice. Volumes of DWI/PWI mismatch and thresholded T2*OC-defined 
penumbra were generated from the data and the neuroanatomical location compared 
between the two techniques. 
 
Coregistration 
 
To coregister the T2*OC scans with the ADC and CBF scans at the three time points, linear 
coregistration was performed using Analyze. To align the data, T2* images were co-
registered to their corresponding ADC slices, which allowed accurate pixel-by-pixel 
analysis. 
 
Volumetric Analysis of Penumbra 
 
The thresholds for ADC, CBF and T2* are defined as: 
ADC – Mean contralateral hemisphere ADC values (excluding ventricles) minus 2SD 
CBF – Mean contralateral hemisphere CBF values (excluding ventricles) minus 2SD 
T2* - Mean contralateral hemisphere T2* (excluding large veins and ventricles) plus 2SD 
 
Note that no lower limit of T2* was defined, and as such, normal tissue may have a T2* 
value above or below the T2* threshold, providing the region has normal ADC and CBF 
values (i.e., values above the ADC and CBF thresholds). 
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6.2.4 Pixel-by-pixel analysis 
Pixel-by-pixel analysis provides an unbiased means of investigating the spatial and 
volumetric dynamic evolution of brain damage.  Pixel-by-pixel analysis was generated 
using codes written in Matlab (MathWorks, Natick, MA, U.S.A.). Temporal changes in 
pixel distribution were analysed using pixel-by-pixel scatterplots and colour-coded images 
(such as in Figure 6.5) were derived to identify specific tissue compartments based on the 
ADC, CBF and T2* thresholds. Pixel-by-pixel analysis was performed to identify tissue 
regions based on ADC and CBF values (which are traditionally used to define DWI/PWI 
mismatch), the T2* and CBF values, and the T2* and ADC values.  
 
Rat brain tissue was segmented into different compartments using an automated MatLab 
program written specially for this purpose by Dr Maria del Rosario Lopez-Gonzalez. The 
program inputs are the prepared images (i.e. cropped, and background values adjusted to     
-90 in the case of the CBF maps, 0 for the ADC maps and -1 for the T2*% signal change 
maps), and the threshold values of ADC, CBF and T2*. The program classifies the tissue 
using these threshold values for the 4 selected slices. 
  
The program runs using interactive inputs from users during execution and runs by typing 
‘t2’ in the command line; the program then asks the user for the input values/files, for 
example: 
 
 
 
 
 
 
 
 
 
After execution, the program produces scatter plots of ADC vs CBF, T2* vs ADC and T2* 
vs CBF, colour coded maps of the segmented tissue, and histograms of ADC, CBF and T2* 
signal intensities. Additionally, the program gives the number of pixels per tissue 
compartment using ADC vs CBF, T2* vs ADC and T2* vs CBF maps which allows 
derivation of volumetric tissue compartment measurements. 
 
>> t2 
Enter 1 or 2, for single or double threshold values: 1 
Enter name of DWI map: DWI1.tif 
Enter name of CBF map: CBF1.tif 
Enter name of T2* map: PctChg.tif 
Enter adc threshold value: 0.5 
Enter cbf threshold value: 60 
Enter T2* threshold value: 1 
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For the ADC v CBF images, the four compartments were operationally defined as:  
1. The ‘normal’ region where both ADC and CBF values were above the thresholds;  
2. The ‘core’ region where both ADC and CBF values were below the thresholds; 
3. The ‘mismatch’ (or penumbral) region where the ADC value was above the threshold 
and the CBF value was below the threshold, and; 
4. The ‘negative mismatch’ region where the ADC value was below the threshold and 
CBF value was above the threshold (Figures 6.5 and 6.6) 
 
For the T2* signal change to OC (T2*OC) v CBF images the four compartments were 
defined as: 
1. The ‘normal’ region where T2* signal change was below and CBF was above the 
thresholds; 
2. A second ‘normal’ region where both T2* signal change and CBF were above the 
thresholds;  
3. The ‘T2*OC defined penumbra’ region where the T2* signal change was above the 
threshold and the CBF value was below the threshold, and; 
4. The ‘core’ region where T2* signal change was below the threshold and CBF was below 
the threshold (Figures 6.7 and 6.8) 
 
For the T2* signal change to OC v ADC images the four compartments were defined as: 
1. The ‘normal’ region where both T2* signal change and the ADC value were above the 
thresholds;  
2. A second ‘normal’ region where T2* signal change was below and ADC was above the 
thresholds; 
3. The ‘T2*OC defined penumbra’ region where the T2* signal change was above the 
threshold and ADC was below the threshold, and; 
4. The ‘core’ region where the T2* signal change was below the threshold and ADC was 
below the threshold (Figures 6.9 and 6.10) 
 
It is important to note that it was not possible to exclude the ventricles and large veins prior 
to pixel-by-pixel analysis, and as such, these structures are included in the data. 
 
Pixel-by-pixel tissue compartment volumetric analysis 
 
For each acute time point, the tissue volume and mean±SD was calculated for each 
compartment for the three methods of tissue identification.  The Matlab program also 
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quantifies the number of pixels within each tissue compartment, and so tissue area was 
calculated by the multiplying the number of pixels in a tissue compartment by the area of a 
pixel (0.0678 mm2). Tissue volume was then generated by multiplying the areas by the 
tissue thickness (1.5 mm) (Figures 6.11, 6.12 and 6.13) 
 
6.2.5 Quantifying final infarct at 24 hours 
Infarct volume was calculated using ipsilateral brain swelling and contralateral 
compression corrections first described by Swanson and colleagues (1994) and Gerriets 
and colleagues (2004), respectively. Eight coronal RARE T2 slices which matched the 
eight 4-hour acute ADC slices were selected, and the ipsilateral and contralateral 
hemisphere areas, as well as the final infarct area, were calculated by manual tracing using 
ImageJ. Infarct volumes were identified as regions of hyperintensity on the RARE T2 
scans. The volumes of the ipsilateral and contralateral hemispheres (HVi and HVc, 
respectively) and the lesion (LV) were calculated by summing the individual areas and the 
multiplying by slice thickness (1.5mm). 
 
To correct for brain oedema and swelling, Swanson correction (Swanson et al, 1994) for 
lesion volume is as follows; 
 
Swanson’s correction for lesion volume = (HVc) – (HVi-LV) 
 
However, this correction factor does not account for contralateral compression, and so 
Gerriets’ correction for compression was applied to calculate the lesion volume as a 
percentage of the ipsilateral hemisphere; 
 
Corrected %HLV = ((HVc - HVi + LV) / HVc)) x 100 
 
A further compression correction factor to calculate the hemispheric lesion volume 
(Gerriets et al, 2004) was used; 
 
Gerriets compression correction factor = (HVi + HVc) / (2 x HVc) 
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Therefore, to calculate the corrected lesion volume (cLV) that corrects for ipsilateral 
swelling (using the Swanson equation) and contralateral compression (using Gerriets’ 
compression factor), the following equation was used; 
 
cLV = Swanson lesion volume x Gerriets compression correction factor 
 
6.2.6 Statistical analysis 
All data are presented as mean±SD. A one-way analysis of variance followed by Student's 
paired t-test with a Bonferroni correction for multiple comparisons was used to analyse the 
temporal evolution of the ADC-derived lesion volume. Comparison of physiological 
variables (pH, PaCO2 and PaO2) and the tissue volumes at the three time points were 
analysed using one-way analysis of variance followed by Student's paired t-test with a 
Bonferroni correction for multiple comparisons. 
 
6.3 Results 
 
6.3.1 Physiological variables 
 
For the first scan series, the mean time to commence OC was 62±2.6 minutes after MCAO, 
and 150±1.7 minutes and 242±14 minutes post-MCAO for the 2.5 and 4 hour scan series, 
respectively. Physiological variables were recorded immediately before OC (Table 6.1). 
There were no significant differences in both PaCO2 and PaO2 at the three time points. A 
small but statistically significant (p<0.0001) increase in blood pH was recorded at 4 hours 
compared to the pH at the 1 hour and 2.5 hour time points but this had no physiological 
significance.  
 
6.3.2 Evolution of ischaemic damage and concomitant loss of penumbra 
By identifying the extent and change of ischaemic damage and penumbra over the 4 hours 
post-stroke, it was clear that the dynamic evolution of brain damage was not similar for all 
animals. From observation, for four out of the six animals, the ADC-derived ischaemic 
damage on the 4 selected coronal slices did not evolve markedly and the areas of penumbra 
did not measurably decrease over the time course of scanning (a sample animal is shown in 
Figure 6.2).  An animal that did experience a dynamic increase in ADC-derived ischaemic 
damage with a concomitant loss of penumbral tissue is shown in Figure 6.3. 
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  1 hour scan series 2.5 hour scan series 4 hour scan series 
pH 7.34±0.04 7.34±0.05 7.36±0.04*** 
pCO2 44.5±5.7 45.33±10 42.42±5.7 
pO2 93.62±11 93.42±12 95.68±15 
 
Table 6.1. Physiological variables in arterial blood samples at the three time points. Data 
expressed as mean±SD, *** p<0.0001, one-way analysis of variance followed by 
Student's paired t-test with a Bonferroni correction for multiple comparisons. 
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Time post-stroke 
(mins) when scans 
were run   
DWI 
scan 
Slice 4 
ASL 
Slice 5 
ASL 
Slice 6 
ASL 
Slice 7 
ASL 
OC scan 
1 hr scan series 57±4.6 45.7±7.6 66±20 94±10 103±8 62±2.6 
2.5 hr scan series 133±24 110±14 122±10 149±22 169±20 150±1.7 
4 hr scan series 247±26 200±45 214±55 227±43 233±44 242±14 
 
Table 6.2. Mean scan times (n=8) for the DWI, ASL and OC scans at the three scanning 
time points. Data expressed as mean minutes post-ischaemia±SD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
203 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. An example of an animal where the ADC lesion (drawn in yellow on slice 2 at 
each time point) and the T2*OC-defined penumbral tissue (drawn in green on slice 2 at 
each time point) did not increase and decrease significantly over time, respectively. ADC 
maps measured in x10-3mm2/sec and T2*OC maps scaled in units of percentage signal 
change 
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Figure 6.3. An example of an animal where the ADC lesion (drawn in yellow on slice 2 at 
each time point) and the T2*OC-defined penumbral tissue (drawn in green on slice 2 at 
each time point) increased and decreased over time, respectively. ADC maps measured 
in x10-3mm2/sec and T2*OC maps scaled in units of percentage signal change 
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6.3.3 Volumetric analysis of the thresholded T2*% signal change region 
For comparative purposes, penumbra was firstly calculated using only the thresholded T2* 
percentage signal change region (Figure 6.4, and green line on Figure 6.13). At the one 
hour time point, the volume of tissue defined as penumbra was 45.9±31.2 mm3, which 
reduced to 37.2±25 mm3 at 2.5 hours and reduced again to 32.9.1±25 mm3 at 4 hours post 
stroke. However this was not statistically significant, and there was no significant 
difference between the volumes at the 1 and 4 hour time points. This highlights that 
penumbral volume tended to remain relatively static over the course of the 4 hours in four 
of the animals, whereas decrease in penumbral volume occurred in two animals (animal 
IDs; Serial OC 7 and 10 on Figure 6.4). 
 
 
 
Figure 6.4. Penumbra calculated by measuring the volume of the thresholded T2*% signal 
change region for each animal (n=6). Penumbral volume remained relatively static over 
the 4 hour time point 
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6.3.4 Pixel-by-pixel analysis 
ADC v CBF 
The dynamics of ischaemic evolution was analysed on a pixel-by-pixel basis using the 
three methods of analysis. Figures 6.5 and 6.6 show representative ADC v CBF 
scatterplots and colour-coded maps of 4 slices from one animal at the three time points, 
with data subdivided into four quadrants which were defined by ADC and CBF thresholds. 
In the scatterplots, there were large clusters residing in the region defined as normal tissue 
(Region 3), the ischaemic core (Region 1) and penumbra (Region 4), with a small number 
of pixels residing in the tissue defined as negative mismatch (Region 2). The large pixel 
populations did not appear to evolve dynamically over time. 
 
T2* v CBF 
In the scatterplots (Figures 6.7 and 6.8), there were large clusters residing in the two 
regions defined as normal (Region 3 and 4) and the ischaemic core compartment (Region 
1), with a smaller cluster in the region defined as penumbra (Region 2). The large pixel 
populations did not significantly evolve dynamically over time. 
  
T2* v ADC 
In the scatterplots (Figures 6.9 and 6.10), there were large clusters residing in the two 
regions defined as normal (Region 3 and 4) and the ischaemic core compartment (Region 
1), with a smaller cluster in the region defined as penumbra (Region 2). The large pixel 
populations did not significantly evolve dynamically over time. 
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Figure 6.5. Pixel-by-pixel scatterplots and colour-coded maps of ADC v CBF in one 
animal for A. Slice 4 and B. Slice 5 at 1-, 2.5- and 4-hours post-pMCAO.                 
On scatterplots:  Region 1: Ischaemic core Region 2: Negative mismatch 
    Region 3: Normal  Region 4: Penumbra 
On colour-coded maps: 
 
Negative mismatch is evident on slice 4 due to a ghosting artefact on the ADC scans 
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A.     Slice 6 
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B.     Slice 7 
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Figure 6.6. Pixel-by-pixel scatterplots and colour-coded maps of ADC v CBF in one 
animal for A. Slice 6 and B. Slice 7 at 1-, 2.5- and 4-hours post-pMCAO.                         
On scatterplots: Region 1: Ischaemic core Region 2: Negative mismatch 
Region 3: Normal  Region 4: Penumbra 
On colour-coded maps: 
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Figure 6.7. Pixel-by-pixel scatterplots and colour-coded maps of T2* v CBF in one animal 
for A. Slice 4 and B. Slice 5 at 1-, 2.5- and 4-hours post-pMCAO.                                   
On scatterplots:  Region 1: Ischaemic core  Region 2: Penumbra 
Region 3: Normal with    T2*  Region 4: Normal 
On colour-coded maps: 
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Figure 6.8. Pixel-by-pixel scatterplots and colour-coded maps of T2* v CBF in one animal 
for A. Slice 4 and B. Slice 5 at 1-, 2.5- and 4-hours post-pMCAO.                                   
On scatterplots:  Region 1: Ischaemic core  Region 2: Penumbra 
Region 3: Normal with    T2*  Region 4: Normal 
On colour-coded maps: 
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Figure 6.9.  Pixel-by-pixel scatterplots and colour-coded maps of T2* v ADC in one animal 
for A. Slice 4 and B. Slice 5 at 1-, 2.5- and 4-hours post-pMCAO.                                    
On scatterplots:  Region 1: Ischaemic core   Region 2: Penumbra 
Region 3: Normal with    T2*  Region 4: Normal 
On colour-coded maps: 
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Figure 6.10.  Pixel-by-pixel scatterplots and colour-coded maps of T2* v ADC in one 
animal for A. Slice 6 and B. Slice 7 at 1-, 2.5- and 4-hours post-pMCAO.                                    
On scatterplots:  Region 1: Ischaemic core   Region 2: Penumbra 
Region 3: Normal with    T2*  Region 4: Normal 
On colour-coded maps: 
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6.3.5 Pixel-by-pixel tissue compartment volumetric analysis 
ADC v CBF 
Ischaemic core pixels 
Using ADC v CBF pixel-by-pixel analysis, at the 1 hour time point, the volume of tissue 
identified as ischaemic core was 163.8±45 mm3, which non-significantly increased to 
186.6±31 mm3 at 2.5 hours and then non-significantly reduced to 175±55 mm3 at 4 hours 
(Figure 6.11).  
Normal pixels 
At the one hour time point, the volume of tissue identified as normal was 365±53 mm3, 
which non-significantly increased to 372±37 mm3 and then 397±45 mm3 at the 2.5 hour 
and 4 hour time point, respectively (Figure 6.12). 
Ischaemic penumbra 
At the one hour time point, the volume of tissue defined as penumbra was 104±39 mm3 
which non-significantly decreased to 68±38 mm3 and then 51±19 mm3 at the 2.5 hour and 
4 hour time point, respectively (Figure 6.13). There was a significant decrease in 
penumbral volume from the 1- to 4- hour time point (p<0.05) 
 
T2* v CBF 
Ischaemic core pixels 
Using T2* v CBF pixel-by-pixel analysis, at the 1 hour time point, the volume of tissue 
identified as ischaemic core was 210±45 mm3, which non-significantly increased to 
213±42 mm3 at 2.5 hours and then non-significantly reduced to 183±47 mm3 at 4 hours 
(Figure 6.11). 
Normal pixels 
At the one hour time point, the volume of tissue identified as normal was 364±51 mm3, 
which non-significantly reduced to 363±35 mm3 and then non-significantly increased 
393±43 mm3 at the 2.5 hour and 4 hour time point, respectively (Figure 6.12). 
Ischaemic penumbra 
At the one hour time point, the volume of tissue defined as penumbra was 57±24 mm3 
which non-significantly decreased to 41±31 mm3 and then non-significantly decreased to 
37±12 mm3 at the 2.5 hour and 4 hour time point, respectively (Figure 6.13). 
 
 
 
 
214 
 
T2* v ADC 
Ischaemic core pixels 
Using T2* v ADC pixel-by-pixel analysis, at the 1 hour time point, the volume of tissue 
identified as ischaemic core was 174±45 mm3, which non-significantly increased to 
203±33 mm3 at 2.5 hours and then non-significantly reduced to 199±37 mm3 at 4 hours 
(Figure 6.11). 
Normal pixels 
At the one hour time point, the volume of tissue identified as normal was 439±45 mm3, 
which non-significantly reduced to 389±38 mm3 and then non-significantly reduced to 
384±35 mm3 at the 2.5 hour and 4 hour time point, respectively (Figure 6.12). 
Ischaemic penumbra 
At the one hour time point, the volume of tissue defined as penumbra was 20±6 mm3 
which non-significantly increased to 26±18 mm3 and then 36±10 mm3 at the 2.5 hour and 4 
hour time point, respectively (Figure 6.13). 
 
Overall, as time evolved, the ischaemic core volume non-significantly increased from 1 to 
4 hours using the ADC v CBF and T2* v CBF methods, and it non-significantly decreased 
with the T2* v ADC method. In the penumbral compartment, penumbral volume decreased 
over time using all three methods (significantly for the ADC v CBF, and non-significantly 
for the two T2* methods). The dynamic evolution of the normal tissue volume was well-
matched (non-significant increase) when comparing the ADC v CBF and the T2* v CBF 
methods, whilst the evolution in the T2* v ADC method non-significantly decreased. 
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Figure 6.11.  Volume of ischaemic core as defined by the three methods: 
Blue – traditional mismatch method where ADC and CBF values of pixels are below 
defined thresholds. Black – T2* v CBF criteria where T2* and ADC values are below pre-
defined thresholds. Red – T2* v ADC criteria where T2* and CBF values are below 
thresholds. Data (n=6) expressed as mean±SD 
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Figure 6.12. Volume of normal tissue across the two hemispheres as defined by the three 
methods: 
Blue – traditional mismatch method with ADC and CBF above defined thresholds 
Black –T2* v CBF criteria where CBF values are above pre-defined thresholds, whereas 
T2* may be above or below the set upper limit threshold. 
Red – ADC values above pre-defined thresholds, whereas T2* is above and below the 
upper limit threshold. As such, this region also incorporates the perfusion deficit which 
may explain why it is larger initially. Data expressed as mean±SD 
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Figure 6.13. Volume of penumbral tissue is defined by three methods: 
Blue – traditional mismatch method where tissue has low CBF but ADC values above the 
ADC lesion threshold. Penumbral volume significantly decreased from the 1- to 4-hour 
time point (p<0.05). Black – T2* v CBF criteria where T2* is high and CBF is within the 
perfusion deficit. Red – T2* v ADC criteria where there is high T2* and ADC is low – 
evidence of penumbra within ADC lesion. Green – Penumbra calculated by measuring the 
volume of the thresholded T2*% signal change region. Data expressed as mean±SD 
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6.3.6 Evolution of ischaemic damage beyond 4 hours 
There was evidence of increased T2* signal change to OC at the 4 hour time point, 
indicative of remaining penumbra (Figure 6.14), which suggests the potential progression 
of the ischaemic damage beyond 4 hours. This was was also supported by the DWI/PWI 
mismatch data.  By analysing all 8 ADC slices at 4 hours and RARE T2 slices at 24 hours 
(Figure 6.15), there was a significant progression in ischaemic damage beyond 4 hours, in 
which the mean ADC-derived volume of ischaemic damage at 4 hours was 267±55 mm3, 
and the T2-derived final infarct was 342±35 mm3 (p=0.0278, Figure 6.16). 
 
A second graph was generated showing the evolution of ischaemic damage for the 4 slices 
analysed in the pixel-by pixel analysis. This is because the 4 slices selected represent tissue 
that is almost fully supported by MCA territory, whereas the slices at the more rostro-
caudal extent have better collateral supply and may initially have more penumbra that will 
ultimately become incorporated into the ischaemic core.  There was a non-significant 
progression in ischaemic damage beyond 4 hours, in which the mean ADC-derived volume 
of ischaemic damage at 4 hours was 208±34 mm3, and the T2-derived final infarct was 
228±33 mm3 (Figure 6.17). 
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Figure 6.14. Evidence of T2*OC-defined penumbra at 4 hours post-pMCAO over 8 caudal-
to-rostral slices with accompanying ADC maps, and RARE T2 scans at 24h.  Note larger 
areas of penumbra – displayed as high percentage signal change – in the rostral and 
caudal poles (slices 1-8). There is evidence of lesion expansion between 4h and 24h 
when observing ADC and RARE T2 maps. T2* maps measured in units of percentage 
signal change. ADC maps measured in x10-3mm2/sec 
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Figure 6.15. Representative rat showing four hour ADC (Left column) and 24 hour RARE 
T2 (Right column) images across 8 coronal slices. ADC maps measured in x10-3mm2/sec 
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Figure 6.16.  Evolution of ADC-derived and RARE T2-derived ischaemic damage in the 5 
surviving animals at 4 hours and 24 hours, respectively (* p<0.05) in all 8 coronal slices 
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Figure 6.17. Evolution of ADC-derived and RARE T2-derived ischaemic damage in the 4 
selected central coronal slices for the 5 surviving animals at 4 hours and 24 hours, 
respectively. There was a negligible change in lesion volume, suggesting the damage 
progresses at the rostral and caudal poles where penumbra is more evident 
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6.4 Discussion 
Quantitative evaluation of tissue volumes was achieved using pixel-by-pixel analysis, in 
which four pixel populations were defined using thresholds for ADC, CBF and T2*. From 
this, colour-coded images could be generated which enabled spatiotemporal mapping of 
ischaemic progression.  
 
Pixel-by-pixel analysis 
 
With pixel-by-pixel analysis, T2* as a parameter for penumbral identification identifies 
tissue that closely matches the region identified by mismatch. When the ADC lesion 
expands, the volume of penumbra decreases, whereas when the ADC lesion remains static, 
the T2*OC-defined penumbra remains static. T2*OC identified potential penumbra at the 4 
hour time point, suggesting that the 4 hour time point does not represent maximal 
ischaemic damage. Volumetric comparison of the ADC lesion at 4 hours with the RARE 
T2 final infarct at 24 hours showed that T2*OC did identify true penumbra at the 4 hour 
time point because the extent of damage increased at the 24h time point. 
 
ADC v CBF 
Using ADC and CBF parameters, it was shown that mismatch-derived penumbra was 
larger than penumbra defined using the two T2* methods (Figure 6.13). This may be 
because mismatch tissue also includes the ventricles on the contralateral and ipsilateral 
hemispheres, which show low values of CBF on the ASL sequences.   
 
T2*OC V ADC 
Since there was no lower limit threshold of T2* defined, it was possible to identify the 
penumbral tissue within the ADC lesion, which explains why this method displays the 
smallest volume of penumbra. However, this is an important finding, as it may reinforce 
the notion that the ADC lesion is not a true marker of irreversibly damaged tissue - it 
incorporates a region which is still metabolically active. Consequently, this explains why 
the tissue volume regarded as normal (Figure 6.12) is the largest using this criteria.  
 
T2* v CBF 
Using the T2* and CBF criterion may be the closest technique that we have to the PET 
criterion, which identifies tissue with reduced CBF, preserved oxygen consumption and 
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with increased OEF. This is a similar definition to the T2* v CBF criteria, which we believe 
identifies tissue with increased OEF and reduced CBF.  
 
A limitation encountered in the current study is with the thresholds used for ADC, CBF 
and T2*. As there is no established T2*OC threshold, the empirical rule was used. Although 
this rule has no biological importance, it is a standard mathematical threshold used to 
identify values with statistical significance which states that, for normally distributed 
values, approximately 95% of the values lie within 2 standard deviations of the mean. This 
technique was also applied to the ADC and CBF images, partly because the established 
thresholds are known to be imprecise and inaccurate, and partly to fairly compare the three 
criteria used.   
 
Limitations of DWI/PWI mismatch  
 
Despite its limitations, the DWI/PWI mismatch model provides information on location 
and severity of ischaemia (derived from PWI), tissue viability status (ADC values derived 
from DWI), and therefore approximate location and size of penumbra. Perfusion-weighted 
imaging and DWI scans were therefore included in the scanning routine for comparison 
with T2*OC identification of penumbra. A number of studies have shown that 
differentiation between viable and nonviable tissue is difficult, using the diffusion 
abnormality (Kidwell et al, 2000; Fiehler et al, 2002), which correlates poorly with final 
infarct (Li et al, 1999). DWI lesions may be recoverable following prompt reperfusion in 
animal models and humans, and may not be destined for infarction (Schlaug et al, 1997; 
Mintorovitch et al, 1994; Kidwell et al, 2000). However, this tissue may become 
incorporated into the final infarct due to late secondary insults following reperfusion 
(Kidwell et al, 2002). This suggests that some patients with no evidence of mismatch may 
benefit from reperfusion therapies. Additionally, the perfusion deficit may incorporate 
tissue with benign oligaemia (destined to survive) even when optimal MRI thresholds 
(themselves as yet incompletely defined) are applied (Butcher et al, 2005). As such, the 
inner and outer margins of the penumbra may not be adequately delineated using the 
mismatch technique, which has been shown to frequently overestimate the final lesion size 
(Kucinski et al, 2005). By examining the evolution of the diffusion lesion and the perfusion 
deficit in patients left untreated, research has focussed on applying a multitude of ADC and 
perfusion thresholds which may enable delineation between tissue destined to die and 
tissue expected to survive (Kidwell et al, 2003).  
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MRI-defined DWI–PWI mismatch identifies penumbra in a similar, but not exact, 
neuroanatomical location. However, there are issues with the accuracy of this indirect 
technique which assumes that the DWI and ADC lesion signify irreversible damage and 
that tissue within perfusion deficit is ultimately destined to die.  These underlying 
assumptions are undermined by reversibility of the DWI lesion with reperfusion, 
uncertainty over relevant perfusion thresholds and the inclusion of benign oligaemia within 
the perfusion deficit, and the variable metabolic state of DWI lesion voxels. 
 
DWI and PWI thresholding 
 
Many papers are based on the underlying assumption that maximal ischaemic damage in 
Sprague-Dawley rats occurs at three or four hours post stroke. Indeed, the 57% reduction 
for the CBF threshold of abnormality were derived by adjusting the respective threshold 
values so that the CBF-derived lesion volumes at 3 hours were equal to the 2,3,4-
triphenyltetrazolium chloride (TTC) infarct volume at 24 hours (Meng et al, 2004). This 3 
hour time point was also used by Lo and colleagues (1997) and Bardutzky et al (2005) as a 
means of establishing ADC thresholds. In-house observations by Dr. Tracey Baskerville 
has questioned this premise, and she found evidence of penumbral tissue at the 4 hour time 
point in both male and female rats (Figure 6.18) using the same pMCAO filament model. 
The current study has also reinforced the idea that penumbra exists beyond the 4 hour time 
point (Figures 6.14 and 6.15), and this questions the validity and accuracy of studies that 
rely on this thresholding technique.   
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Figure 6.18. Volume of penumbra (PWI/DWI mismatch) in males and females at 1-4hrs 
after stroke onset.  (ADC thresholds applied were 0.60 and 0.55 x10-3mm2/s for males and 
females, respectively and a CBF threshold of 35 ml/100g/min for both sexes) (*P<0.05, 
**P<0.01, Two-way ANOVA with Bonferroni post-tests) 
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Evidence of ischaemic damage beyond 4 hours 
 
The progression of ischaemic damage may be due to secondary insults that occur following 
the return to consciousness, when animals are allowed a period of recovery prior to final 
infarct scanning. Firstly, when anaesthetic is removed, the animals could experience 
hypotensive or respiratory episodes which may compromise CBF and blood oxygen levels. 
This may therefore induce ischaemia and hypoxia, and increase waves of spreading 
depolarisation which thereby exacerbate ischaemic damage. Secondly, autoregulation 
would be expected to be impaired by stroke but physiological variables are carefully 
controlled under anaesthetic. Once consciousness returns, the autoregulatory state of the 
collateral pial vessels may lead to increased blood flow and oxygen to the injured 
penumbra which may cause secondary insults caused by increased free radical generation 
and oxidative stress. 
 
Summary 
 
The spatiotemporal behaviour of the T2*OC-defined penumbra was consistent with the 
pattern of progression shown by the established DWI/PWI mismatch technique. The 
animals that showed an increase in ischaemic damage and concomitant loss of mismatch 
over time displayed similar changes using the T2* criterion. Interestingly, mismatch 
volume that remained static over time also remained static in the T2*OC definitions. The 
current study validates the utility of T2*OC in its mapping of the spatiotemporal changes 
associated with penumbra, and suggests that mismatch overestimates penumbra and is 
unable to identify penumbra within the ADC lesion. Secondly, the current study also 
questions the accuracy and validity of studies that rely on ADC and CBF thresholds which 
assume maximal ischaemic damage at 3- or 4-hours post-stroke.  
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 Chapter 
7  
General Discussion 
Current flow restoration strategies for salvaging the ischaemic penumbra employ time 
from stroke onset, rather than positive identification of penumbra.  It is clear that existing 
prerequisites for patient selection must be improved – the time of stroke onset is not 
always known, penumbra may not exist beyond 3 hours, or patients may present with 
penumbral tissue for up to 48 hours post-onset (Heiss, 1992). Despite the extension of the 
time window threshold for rT-PA thrombolysis from 3 to 4.5 hours post-symptom onset 
(Hacke et al, 2008), significant technological advances in neuroimaging have not 
successfully translated to the clinic since the seminal NINDS trial (1995). The advent of 
DWI/PWI mismatch (Schlaug et al, 1997) was initially promising in identifying ischaemic 
damage and penumbral tissue based on indirect diffusion and perfusion measures, but their 
employment in clinical trials have been unable to improve upon the time window for 
thrombolysis. The problem may arise from the fact that current PET-derived gold standard 
definitions of penumbra use metabolic indices such as OEF and CMRO2, which are not 
fully incorporated into MR definitions. With this in mind, a paradigm shift in penumbral 
imaging is currently underway, in which MRI techniques based on a metabolic parameter 
are being developed for patient selection. The impracticalities of PET in the acute setting 
mean that MR techniques that incorporate PET definitions may introduce more accurate 
MR definitions and ultimately improve patient selection for clinical trials. Until an 
accurate means of quantifying the penumbra is available, the ability of clinical trials to 
identify effective therapies is not going to improve.  
 
7.1 T2* Oxygen Challenge 
 
The data provided in this thesis suggest that T2*OC provides information on metabolic 
state that could improve penumbral definition. It has been shown that BOLD MRI using 
T2* offers information on oxygen consumption and delivery (Baird & Warach, 1999; Kavec 
et al, 2001), but static T2*-weighted MRI under normoxic conditions has not adequately 
delineated penumbra in ischaemic stroke patients (Tamura et al, 2002; Grohn & 
Kauppinen, 2001), possibly because deoxyhaemoglobin is not rapidly cleared in ischaemic 
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conditions (Giesler, et al, 2006). Our new method using sequential T2*-weighted images 
with transient hyperoxia may dynamically alter the oxyhaemoglobin: deoxyhaemoglobin 
balance with the aim of distinguishing tissue compartments which have different metabolic 
activities and therefore different relative concentrations of deoxyhaemoglobin. By 
providing the additional measure of the rate of contribution of deoxyhaemoglobin to the 
measured pool, this may remove the potential confound observed by Geisler and 
colleagues. 
 
The first validation study in this thesis used [14C] 2-deoxyglucose autoradiography to 
determine the metabolic status of the tissue compartment identified as penumbra by the 
T2*OC MRI technique. The results indicated that glucose metabolism in the T2*OC-defined 
penumbra was comparable to contralateral values, whereas markedly different levels of 
glucose metabolism were evident in the ADC-derived ischaemic core and an adjacent 
region of increased 2DG phosphorylation. From this, it was concluded that metabolic 
information could be yielded from the ischaemic brain that may improve delineation of 
penumbral tissue which has its own unique metabolic profile. Secondly, as penumbral 
tissue must fulfil the fundamental criteria of being potentially salvageable and responsive 
to therapy, the consequences of reperfusion on the T2*OC-defined penumbra were tested. 
This confirmed that tissue identified as penumbra by T2*OC did not progress to infarction 
with prompt restoration of blood flow. Thirdly, the spatiotemporal characteristics of the 
T2*OC-defined penumbra were investigated and compared with the DWI/PWI mismatch 
definition of penumbra.  This demonstrated that penumbra defined by T2*OC behaved in a 
similar manner to the penumbra defined by traditional mismatch criterion. As mismatch 
tissue volume reduced over time, T2*OC penumbra followed the same pattern, and 
conversely it remained static when mismatch remained static over time. Additionally, an 
interesting finding arose in the latter study which showed that ischaemic damage continues 
to progress beyond 4 hours following permanent MCAO, which may be relevant to the 
calculation of ADC and CBF thresholds. 
 
From this thesis, it is clear that acute transient O2 inhalation and sequential T2* weighted 
imaging delineates a region of tissue demonstrating the  characteristics of penumbra which 
we believe is based on the OEF of the tissue and the change in deoxyhaemoglobin levels 
associated with OC. However, since neither OEF nor oxy:deoxyhaemoglobin ratios were 
measured in the studies we must also consider the contribution of additional components 
known to modulate the BOLD signal. 
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7.2 Components that may affect the T2* response 
 
It is important to consider whether or not T2*-weighted signal changes to oxygen challenge 
reflect processes other than the change in tissue venous deoxyhaemoglobin concentration 
as a consequence of metabolism and OEF. The partial pressure of oxygen PaO2 in the 
blood clearly influences the magnitude of the T2* response to hyperoxia (Chapter 3, Figure 
3.8), while other factors sure as CBF, CBV and/or OEF may contribute to differentiating 
the ischaemic penumbra from surrounding tissue (Santosh et al, 2008; Robertson et al, 
2011a and b). 
 
7.2.1 Cerebral blood flow  
 
Following ischaemia, one would expect a change in cerebral blood flow due to loss of 
autoregulation. It is well established that changes in CBF influence T2*-weighted signal 
intensity (Ogawa et al, 1990); this is the fundamental principle of functional MRI. It was 
not possible to examine real-time CBF changes in response to the hyperoxic challenge in 
the current studies, and as such, since only the baseline CBF was measured, the possibility 
that the T2*-weighted signal intensity changes reflect a change in CBF cannot be dismissed. 
The original OC paper (Santosh et al, 2008) used a pulsed ASL sequence on a single slice 
to investigate temporal changes in CBF during the OC (Figure 7.1). Oxygen challenge did 
not significantly influence relative CBF in the presumed penumbral zone, but it did induce 
a small decrease in CBF in the contralateral cortex in the rodent pMCAO model.  In this 
thesis, correlation analysis for baseline CBF and T2* signals in 17 animals was performed, 
within T2*OC-defined penumbra, contralateral caudate nucleus, contralateral cortex and the 
ischaemic core (Figure 3.7). No correlation was found between T2* signal change and CBF 
in any of the regions of interest, reinforcing the view that T2* signal is not an indirect 
measure of CBF.  
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Figure 7.1. OC did not significantly influence CBF in the ipsilateral border zone (-0.008, 
95% CI -0.066 to 0.081, p=0.78, red line) but induced a small decrease in CBF in the 
contralateral cortex (-0.10, 95% CI -0.199 to -0.001, P=0.048, blue line) following OC 
(shaded box) 
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In a subsequent (non-MRI) study from our department (Baskerville et al, 2011) CBF was 
measured during an OC protocol with intracerebral laser Doppler flowmetry probes 
(OxyFlo/Lite system) implanted into the ipsilateral (presumed penumbra) and contralateral 
cortex of rats exposed to pMCAO.  These data have been superimposed alongside the T2* 
signal response (Figure 7.2).  OC induced a small transient increase in CBF in coincident 
with a transient increase (from 83.28±4.99 to 98 ±8.78 mm Hg, p<0.05) in mean arterial 
blood pressure lasting ~2-3min.  In comparison, the T2* signal increase to OC was 
maintained during the period of hyperoxia (5 mins) and returned back to baseline when 
hyperoxia was switched off.  Therefore, the time course of this CBF response did not 
match the T2* signal response seen during OC, suggesting that the T2* signal change is not 
due simply to changes in CBF. In addition, it is known from hypercapnia studies that 
hypercapnia-induced CBF increases of 25-40% influence BOLD signal by as little as 2-3% 
(Rostrup et al, 2000; Rostrup et al, 2005). It is therefore unlikely that OC-induced changes 
in CBF had a significant influence on the BOLD T2* response.  Although baseline CBF 
does not appear to influence the T2* response to OC, simultaneous measurement of CBF 
during T2* changes to OC would be required to fully clarify the effect of tissue perfusion 
on the T2* response to OC (see Chapter 7.3.2 section on NIRS). 
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Figure 7.2. Representative traces of T2* and rCBF in presumed penumbra (ipsilateral) and 
contralateral cortex pO2 and rCBF from a middle cerebral artery occlusion (MCAO) rat 
during oxygen challenge (OC) (Baskerville et al, 2011) 
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7.2.2 Cerebral blood volume 
Buxton and colleagues (1998) proposed a model of the BOLD signal implicating the role 
of cerebral blood volume on the BOLD response. It showed that an increase in the BOLD 
signal can be caused both by a decrease in deoxyhaemoglobin content and by an increase 
in regional CBV (rCBV). It has been shown that the visual cortex and the cerebellum 
display high BOLD signal changes following hypercapnia, and these are regions which 
have high capillary densities and high basal CBV values (Kastrup et al, 1999). Resting 
state blood volume is one of the strongest determinants of the fMRI signal change 
magnitude, other than activation-induced oxygenation changes. Bandettini and Wong 
(1997) found that with oxygenation changes following activation, a voxel in the brain with 
a high blood volume will display a larger signal change than a voxel with a lower blood 
volume if all other circumstances were identical. Also, Bandettini and Wong (1995) 
showed an intricate link between CBV and oxygen saturation, in that increased blood 
volume with reduced blood oxygenation saturation causes the greatest BOLD signal 
magnitude, using a biophysical simulation (Figure 7.3). 
 
Davis and colleagues (1998) examined baseline tissue deoxyhaemoglobin (dHb) content to 
determine its effect on the BOLD signal change to hypercapnia and to photic stimulation. 
In single slice experiments, the largest signal change values (up to 16%) were found in 
visual cortex, with smaller signal change (3–5%) in surrounding parietal and occipital 
cortex. This was thought to be due to the disproportionate concentration of venules in the 
visual cortex which would therefore have increased levels of deoxyhaemoglobin. They 
concluded that the changes in blood flow and oxidative metabolism were secondary to the 
baseline deoxyhaemoglobin levels with regards to BOLD sensitivity.                  
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Figure 7.3. The relationship between signal change (∆R2*s-1) and oxygen saturation 
(%HbO2) under different blood volumes (Taken from Bandettini and Wong, 1995) 
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Contradictory explanations have also been proposed which suggest a negligible CBV 
influence on the BOLD response. Kennan and colleagues (1997) isolated the contribution 
of blood volume changes to the BOLD signal by separating blood volume and magnetic 
susceptibility effects in response to respiratory challenges such as hypoxia and hyperoxia. 
A rat model was used to identify the source of signal variation when changing from 100% 
oxygen to 10% oxygen/90% nitrogen ventilation. They found that the change in blood 
magnetic susceptibility (i.e., the change from deoxy- to oxyhaemoglobin which has a large 
observed magnetic susceptibility effect) is the key contributor to the BOLD effect and not 
blood volume. They estimated that the maximal contribution from blood volume changes 
in hypoxia amounts to less than a 12% contribution to the observed relaxation rate changes 
in each region. This corresponds to a maximal estimate of the blood volume term since it is 
assumed that the blood is completely deoxygenated in the hypoxic state.  If the blood is not 
fully deoxygenated relative to tissue then CBV effects will become smaller. This is in 
agreement with Prielmeir and colleagues (1994), who showed under hypoxia, oxygen 
saturation reached a minimum of about 40% which would reduce maximal blood volume 
contribution to only 7%. 
 
CBV in stroke 
 
Both PET (Powers, 1991) and MRI (Sorensen et al, 1996) studies have found 
inconsistencies in rCBV following stroke, in which CBV may remain unchanged, 
increased, or decreased in the ischaemic penumbra. Maeda and colleagues (1993) noted 
that, following middle cerebral artery occlusion in cats, the fall in CBF was compensated 
for by dilation of the vessels concerned, leading to an increased rCBV until the collateral 
circulation becomes insufficient. Within the infarct, autoregulatory mechanisms are 
altered, and both the rCBF and rCBV are usually decreased, and regions with reduced 
CBV may be regarded as irreversibly damaged. (Wintermark et al, 2002).   
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Figure 7.4. Graphs representing the haemodynamic or metabolic response (Y-axis) to 
stroke in five different tissue compartments (the X-axis). 
CPP = cerebral perfusion pressure; CBV = cerebral blood volume; CBF = cerebral blood 
flow; MTT = mean transit time; OEF = oxygen extraction fraction; and CMRO2 = cerebral 
metabolic rate of oxygen    (Taken from Lee et al (2005)) 
 
 
 
 
 
 
 
Area 1 is unaffected area  
(1' is autoregulating)  
 
Area 2 is benign oligaemia  
 
Area 3 is ischaemic penumbra  
  
Area 4 is ischaemic core. 
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Lee and colleagues (2005) noted that both CBF and CBV are good predictors of tissue 
outcome. By using non-enhanced CT, if CBF and CBV are severely reduced or below 
detectable levels in a specific region, this tissue is expected to be irreversibly injured, 
whereas an estimate of tissue at risk is displayed as low CBF with normal to elevated 
CBV. One can then make assumptions that a good tissue outcome occurs when the region 
has elevated CBV in an area of perfusion deficit. Hossmann (1994) and Mayer and 
colleagues (2000) used thresholds of CBF and CBV to determine the fate of ischaemic 
tissue, in which the hypoperfused regions with high CBV and low CBF were more likely to 
experience a good tissue outcome compared to a similarly hypoperfused region with lower 
CBV values.  
 
In humans, increases in rCBV in penumbra have also been shown using CT perfusion 
(Murphy et al, 2006), in which CBV in penumbra (2.15±0.43 ml/100g) was significantly 
higher than contralateral (1.78±0.30 ml/100g) and infarcted tissue (1.12±0.37 ml/100g), 
whilst CBF was significantly lower for infarct (13.3±3.75 ml/100g/min) than penumbra 
(25.0±3.82 ml/100g/min). 
 
CBV in relation to Oxygen Challenge 
 
The implications are that the vasculature within penumbra will contain more 
deoxyhaemoglobin than in normal or infarcted tissue if the regional CBV is increased, and 
therefore an amplified response in T2* % signal change to OC would be expected in this 
region. Therefore, one may speculate that CBV may have a large effect on the BOLD 
signal and its relative contribution may dominate the effect of other components 
influencing the T2* signal. Alternatively, if CBV modulates T2*OC response, then a brain 
region with increased CBV (induced by vasodilatation or otherwise, and not necessarily 
penumbra) would be expected to have an increased T2* response to OC. 
 
7.3 Further validation techniques 
 
7.3.1 Crossed cerebellar diaschisis 
 
Diaschisis refers to the loss of excitation and consequent hypometabolism of tissue that is 
anatomically distant from the region of damage (von Monakow, 1914). A subtype of 
diaschisis known as crossed cerebellar diaschisis (CCD), which can occur following stroke 
239 
 
onset and lead to hypometabolism in the contralateral cerebellar hemisphere. Dr. Krishna 
Dani, neurologist at the Southern General Hospital, Glasgow, investigated the utility of 
T2*OC and perfusion imaging in the detection of hypometabolism in 12 subjects with 
clinically-defined cortical ischaemic stroke within middle cerebral artery territory, 
consented within 24 hours of onset. He found that the mean T2* percentage signal change 
to OC in the ipsilateral cerebellar hemisphere was significantly greater (p=0.03) than the 
values in the contralateral cerebellar hemisphere (5.1±2.7%, compared to 3.8±3.1%, data 
expressed as mean±SD, Figure 7.5). Interestingly, there was no significant difference in 
perfusion between cerebral hemispheres for any subject (p=0.22). This was the first study 
that did not require perfusion imaging to identify CCD using MRI, and it suggested that 
OC-derived cerebellar asymmetry reflected CCD. This study was very useful in confirming 
that OC has the potential to identify changes in metabolism, which we have hypothesised 
is the basis for the technique in defining the ischaemic penumbra. 
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Figure 7.5. Attenuated T2* Response to oxygen challenge in the contralateral cerebellar 
hemisphere from a sample patient. A). Diffusion weighted imaging of the stroke lesion 
(identified as a region of hyperintensity), B). Diffusion weighted imaging in the cerebellum, 
in which no lesion is evident, and C). Attenuated T2* percentage signal change to oxygen 
challenge in the contralateral cerebellar hemisphere (displayed as dark blue). The colour 
scale is in units of percentage signal change 
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7.3.2 Near infrared spectroscopy (NIRS)  
NIRS is a non-invasive technique for measurement of tissue absorbance of light at 
wavelengths in the spectral region from 700-1000 um, used to determine concentration 
changes of oxy- and deoxyhaemoglobin, cerebral blood volume and blood flow 
measurements.  Since near infrared light penetrates biological tissues and even bone, such 
measurements can be performed through the intact skull.  MRI-compatible NIRS systems 
have now been developed, making it possible to coregister brain haemodynamics by 
combining NIRS and fMRI, due to the fact that the fMRI BOLD signal is proportional to 
the changes in deoxyhaemoglobin concentration (Tak and Ye, 2009; Steinbrink et al, 
2006). A setup which provides simultaneous NIRS and T2*OC MRI would provide data on 
the oxy- and deoxyhaemoglobin ratio, which is in turn influenced by OEF and would 
enable investigation of the extent to which the T2* percentage signal change to OC is due to 
changes in the relative concentration of oxy- and deoxyhaemoglobin in the blood. As this 
would provide real-time information on CBF and the amount of deoxyhaemoglobin being 
converted, it would confirm the contribution of the components influencing the BOLD 
signal.  
 
7.4 Translation of T2* Oxygen Challenge to the clinic 
 
Recently, Dani and colleagues (2010) demonstrated the first clinical application of OC 
during T2*-weighted MRI, detecting differences in vascular deoxyhaemoglobin levels 
between tissue compartments following stroke. The percentage signal change maps 
generated from the OC data could discriminate between gray and white matter on the 
contralateral hemisphere, consistent with the higher metabolic demand in gray matter. 
Regions of interest selected within the DWI lesion displayed a reduced T2* percentage 
signal change compared with the non-ischemic hemisphere. Of the four patients scanned in 
the hyperacute phase, three patients had a significantly higher T2* percentage signal change 
in penumbral tissue (defined by DWI/PWI mismatch) compared with normal tissue. This 
increase in T2* percentage signal change was less evident in patients scanned at later time 
points, in line with the likelihood that penumbral tissue may have been recruited into the 
irreversible ischemic core. These preliminary clinical data along with the CCD data 
support the potential for this novel MRI technique to delineate penumbral tissue in acute 
stroke by its metabolic status. Crucially, administration of oxygen with T2* scanning can be 
performed quickly and easily with widely available hardware. This technique may be used 
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acutely or more importantly to detect existing penumbral tissue in patients unable to 
present within the 3- to 4.5-hour time window for thrombolysis.  
 
By exploiting the different magnetic properties of oxy- and deoxyhaemoglobin, the 
dynamic response to oxygen administration may detect tissue capacity for oxygen 
utilisation and define the ischaemic penumbra on the basis of oxygen extraction and 
metabolism. Both the pre-clinical and clinical data support the potential of T2*OC to 
discriminate tissue compartments in acute stroke based on metabolic status which thereby 
provides an alternative and improved means of defining the ischaemic penumbra. 
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